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 v 
Summary 
 
One approach of molecular epidemiology of mycobacteria is the genotyping and comparison 
of DNA of infectious strains in order to monitor the transmission pathways of diseases. It is 
based on the assumption that patients infected with clustered strains are epidemiologically 
linked. Such results may help in understanding the modes of transmission and therefore in 
putting in place an adapted control strategy. To perform molecular epidemiological studies 
appropriate genotyping tools are a basic requirement. For M. tuberculosis they are well 
developed but their appropriateness has to be evaluated in the geographical area of interest. 
Like M. tuberculosis, M. bovis is also a member of the M. tuberculosis complex (MTC) and 
causes bovine tuberculosis in cattle, humans and a wide variety of other hosts. However, 
compared to M. tuberculosis, it is generally much more homogenic which renders the choice 
of an appropriate genotyping tool much more challenging. M. ulcerans appears to be even 
less diverse as, so far, strains have only been differentiated between but not within continents 
(with the exception of Australia). 
Therefore the overall aim of this study was to contribute to the development and refinement 
of innovative molecular typing tools in order to study Mycobacterium tuberculosis, bovis and 
ulcerans infections. 
Variable Number Tandem Repeats (VNTR) typing is a genotyping tool which evaluates the 
number of repeats at different loci distributed throughout the genome. We performed VNTR 
typing of 12 Mycobacterial Interspersed Repetitive Units (MIRU) and 3 Exact Tandem 
Repeats (ETR) for 40 M. tuberculosis strains from Chad. This revealed a similar 
discriminatory power to spoligotyping, which evaluates the presence or absence of 43 spacer 
DNA sequences between the 36 bp direct repeats (DRs) in the genomic DR region. Therefore, 
VNTR typing for M. tuberculosis is as valid a genotyping tool as spoligotyping. However, in 
contrast to spoligotyping, VNTR typing could also be useful in evaluating mixed infections 
within different members of the M. tuberculosis complex members in the future. 
Additionally, the use of both spoligotyping and VNTR typing could provide additional 
valuable information for future micro-epidemiological studies of the possible highly virulent 
Cameroon family clone. This clone is most prevalent in Nigeria, Cameroon and Chad, and is 
defined by the lack of spoligo spacers 23-25 and by the loss of characteristic chromosomal 
deletions. 
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We also performed spoligotyping and VNTR typing based on 16 known loci (12 MIRUs, 3 
ETRs and VNTR 3232) for 67 M. bovis strains collected sequentially at the slaughterhouse of  
N’Djaména, Chad. The strains originated from two different zebu breeds of which the 
Mbororo was found to be more susceptible than the Arabe breed. 
Genotyping of Chadian M. bovis strains confirmed the usual characteristically high 
homogenetic population structure of M. bovis. We could even identify that the 67 strains are 
members of only 2 clones. The clones were defined by spoligotyping (lack of spacer 30 vs. 
lack of spacers 20-22) and the finding of characteristic chromosomal deletions, indicating that 
the strains derived from two ancestral, single cells in the past. However, ETR A, B, C and 
MIRU 26, 27 were most appropriate for first line typing of M. bovis strains from Chad and 
superior than spoligotyping. This finding could help in identifying risk factors for inter 
animal and also zoonotic transmission and therefore have important public health 
implications.  
As VNTR-typing is very attractive for M. tuberculosis complex members, attempts for using 
VNTR typing for M. ulcerans have also recently been made.  However, the presented 
resolution was not higher than other genotyping tools. During this thesis, we identified a new 
VNTR locus, designated ST1, which did not have any orthologues in the M. tuberculosis 
genome. In combination with a previously published MIRU locus, we were able to identify 
three different genotypes within Ghanaian M. ulcerans strains and therefore demonstrate 
diversity in African strains for the first time. We further showed that DNA sequencing of the 
different VNTR loci can refine the discriminatory power if the loci are analyzed separately 
but, if analyzed commonly, doesn’t improve the overall discriminatory power. In the latter, 
agarose gel electrophoresis of the amplification products of all polymorphic VNTR loci is 
normally sufficient and sequencing does not result in further refinement. 
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Zusammenfassung 
In der Molekularen Epidemiologie der Mycobakterien können mit Hilfe der DNA 
Genotypisierung Übertragunswege infektiöse Bakterienstämme verfolgt werden. Sie basiert 
auf der Annahme, dass Patienten, welche mit gleichen (clustered) Stämmen infiziert sind, 
eine epidemiologische Verbindung haben. Die Analyse genotypischer Ähnlichkeit kann 
helfen zu besseren Bekämpfungsstrategien beizutragen. Um molekular epidemiologische 
Studien überhaupt durchführen zu können sind angepasste Genotypisierungsmethoden eine 
Grundvoraussetzung. Im Falle von M. tuberculosis sind sie gut entwickelt aber ihre 
Eignungen müssen in den jeweiligen geographischen Gebieten evaluiert werden. Wie M. 
tuberculosis ist auch M. bovis ein Mitglied des Mycobacterium tuberculosis Komplexes 
(MTC) und verursacht die bovine Tuberkulose in Rindern, Menschen und in einer grossen 
Bandbreite von anderen Wirten. Verglichen mit M. tuberculosis ist M. bovis jedoch im 
allgemeinen viel homogener und deshalb ist die Wahl der geeigneten 
Genotypisierungsmethode viel herausfordernder. Mycobacterium ulcerans scheint gar noch 
homogener zu sein, da Stämme bis jetzt nur zwischen aber nicht innerhalb der Kontinente 
unterschieden wurden (mit der Ausnahme von Australien). 
Deshalb war es das übergeordnete Ziel dieser Doktorarbeit zu Entwicklung und Verbesserung 
von innovativen, molekularen Typisierungsmethoden beizutragen um die Infektion von M. 
tuberculosis, M.bovis und M.ulcerans zu studieren. 
Das Typisieren von VNTR (Variable Number Tandem Repeats) ist eine 
Genotypisierungsmethode welche die Anzahl von Repetitionen an verschiedenen, über das 
ganze Genom verteilten Orten, evaluiert. Wir führten die Typisierung von VNTR an 12 
MIRUs (Mycobacterial Interspersed Repetitve Units) und 3 ETRs (Exact Tandem Repeats) 
für 40 M. tuberculosis Stämme vom Tschad durch. Es resultierte ein ähnlicher 
Unterscheidungsgrad wie für das Spoligotyping, welches das Vorkommen von 43 ‚Spacer’ 
Sequenzen untersucht welche sich zwischen 36 Basenpaaren langen und direkten 
Repetitionen in der DR (Direct repeat) befinden. Aus diesem Grund ist das Typisieren von 
VNTRs als Genotypisierungsmethode genauso wertvoll wie das Spoligotyping. Das 
Typisieren von VNTRs könnte jedoch, im Gegensatz zum Spoligotyping, für die Zukunft 
nützlich werden um Mischinfektionen zwischen verschiedenen Mitgliedern des MTC zu 
evaluieren. Zusätzlich könnte der Gebrauch von beiden Methoden, spoligotyping und 
VNTRs, zusätzliche und wertvolle Informationen für zukünftige mikro-epidemiologische 
Studien des möglicherweise sehr virulenten Klon der Kamerun Familie liefern. Dieser Klon 
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weist eine sehr hohe Prävalenz in Nigeria, Kamerun und Tschad auf und ist definiert durch 
den Verlust der Spacer Sequenzen 23-25 und charakteristischen chromosomalen Löschungen. 
Ebenfalls führten wir das Spoligotyping und das Typisieren der VNTRs anhand von 16 
bekannten Orten (12 MIRUs, 3 ETRs und dem VNTR 3232) für 67 M. bovis Stämme durch, 
welche sukzessive von Proben des Schlachthofs von N’Djaména, Tschad, erhalten wurden. 
Die Stämme stammten von 2 verschiedenen Rinderrassen von welchen die Mbororo 
gegenüber M. bovis empfänglicher war als die Arabe Rasse.  
Das Genotypisieren von tschadischen M. bovis Stämmen bestätigte die üblicherweise hohe 
homogene Populationsstruktur von M. bovis. Wir konnten sogar zeigen dass alle diese 67 
Stämme Mitglieder von nur 2 Klonen sind. Diese Klone wurden definiert durch das 
Spoligotyping (Verlust von Spacer Sequenzen 30 für den einen und Verlust von 20-22 für den 
anderen Klon) und den Verlust von charakteristischen, chromosomalen Löschungen, was 
darauf hinweisen könnte, dass alle Stämme von nur zwei einzelnen Zellen aus der 
Vergangenheit abstammen. Abgesehen davon zeigte das Typisieren, dass ETR A, B, C und 
MIRU 26 27 am geeignetsten für ein erstes, grobes Typisieren von M. bovis Stämmen von 
Tschad ist und dem Spoligotyping überlegen ist. Dieser Befund könnte in der Zukunft helfen 
Risikofaktoren für die zoonotische aber auch zwischen verschiedenen Tieren stattfindende 
Übertragungswege zu identifizieren und könnte deshalb wichtige Konsequenzen für das 
öffentlich Gesundheitswesen haben. 
Da das Typisieren der VNTR für MTC Mitglieder sehr attraktiv ist, wurde erst kürzlich 
Versuche gemacht dieses auch für M. ulcerans zu etablieren. Die präsentierte Auflösung war 
jedoch nicht besser als diejenige von anderen Genotypisierungsmethoden. Während dieser 
Doktorarbeit, haben wir einen VNTR identifiziert, welcher ST1 genannt  wurde und keine 
Analogien im M. tuberculosis Genom hatte. Im gemeinsamen Gebrauch mit einem bereits 
beschriebenen und publizierten MIRU gelang es uns drei verschiedene Genotypen innerhalb 
von ghanaischen Stämmen zu unterscheiden. So konnten wir zum ersten Mal Heterogenität 
innerhalb von Afrikanischen Stämmen nachweisen. Des weiteren zeigten wir, dass das 
Sequenzieren verschiedener VNTR die Auflösung verfeinern kann, wenn die polymorphen 
VNTR separat aber nicht gemeinsam analysiert werden. Im letztgenannten Fall ist die 
Agarose-Gel-Elektrophorese der amplifizierten, polymorphen VNTR Produkte normalerweise 
ausreichend und das Sequenzieren ermöglicht keine weitere Verfeinerung. 
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Résumé 
 
L’approche d'épidémiologie moléculaire des mycobactéries permet d’analyser et de comparer 
l'ADN de souches infectieuses afin de suivre les voies de transmission des maladies. Elle est 
basée sur la supposition que les patients infectés de mycobactéries génotypiquement 
identiques sont liés épidémiologiquement. Ces résultats peuvent aider à comprendre les voies 
de transmission et contribuer à adapter les stratégies de lutte.  
Pour effectuer des études d’épidémiologie, des outils appropriés pour le typage d’ADN sont 
une condition de base. Pour M. tuberculosis, ils sont bien développés mais doivent être 
évaluées pour chaque zone géographique d'intérêt. Comme M. tuberculosis, M. bovis est aussi 
un membre du complexe de M. tuberculosis (MTC) et cause la tuberculose chez le bétail, 
l’homme et une large variété d'autres hôtes. Cependant, comparé à M. tuberculosis, l’ADN de 
M. bovis est généralement beaucoup plus homogène et donc le choix de l'outil approprié pour 
le typage est beaucoup plus complexe. M. ulcerans semble d’être encore moins variable car 
jusque là, les souches ont pu être différenciées entre les continents, mais pas à l’intérieur des 
continents (à l'exception de l'Australie). 
Donc le but final de cette thèse était de contribuer au développement et au perfectionnement 
d'outils moléculaires innovateurs pour le typage des mycobactéries pathogènes (M. 
tuberculosis, M. bovis et M. ulcerans) et pour étudier l'infection causée par ces derniers. 
Le typage par VNTR (variable number tandem repeats) est un outil moléculaire qui évalue le 
nombre de répétitions à des sites différents répartis dans le génome. Nous avons effectué le 
typage par VNTR de 12 MIRU (Mycobacterial Interspersed Repetitve Units) et 3 ETR (Exact 
Tandem Repeats) pour 40 souches de M. tuberculosis du Tchad. La pouvoir de discrimination 
était semblable au spoligotyping, qui évalue la présence ou l'absence de 43 séquences de la 
région génomique DR (direct repeat) de l’ADN. Le typage de VNTR pour M. tuberculosis est 
aussi valable comme outil d’épidémiologie moléculaire que le spoligotyping. Dans l’avenir le 
typage par VNTR serait utile dans l'évaluation d'infections mixtes par les différents membres 
de MTC. L’utilisation des deux méthodes : spoligotyping et typage par VNTR, pourrait 
fournir des informations complémentaires de valeur pour des études futures sur la micro 
épidémiologie du clone de la famille camerounaise. Ce clone, qui pourrait être fortement 
virulent, est très répandu au Nigeria, au Cameroun et au Tchad et est défini par l’absence des 
séquences DR 23-25 et par des délétions chromosomiques caractéristiques.  
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Nous avons aussi effectué le spoligotyping et le typage par VNTR basés sur 16 locus connus 
(12 MIRUS, 3 ETRS et VNTR 3232) pour 67 isolats de M. bovis, collectés à l'abattoir de 
N'Djaména, Tchad. Les souches proviennent de deux races différentes de zébus dont le zébu 
de race Mbororo est plus susceptible que le zébu de race Arabe. 
Le typage moléculaire de souches tchadiennes de M. bovis a confirmé encore une fois la 
structure fortement homogène de la population de M. bovis. Les 67 souches analysées 
semblent être membres de seulement deux clones. Les clones ont été définis par le 
spoligotyping (le manque de la séquence 30 pour l’un et des séquences 20-22 pour l’autre) et 
par la découverte de délétions chromosomiques caractéristiques, indiquant que les souches 
descendent de deux seules cellules ancestrales. De plus, ETR A, B, C et MIRU 26, 27 étaient 
les plus appropriés pour un premier typage approximatif des souches de M. bovis du Tchad et 
supérieurs au spoligotyping. Cela permettrait d’identifier les facteurs de risques pour la 
transmission entre différents  animaux, mais aussi la transmission zoonotique et pourrait donc 
avoir des implications importantes pour la santé publique.  
Comme l’utilisation de typage par VNTR est très attractive pour les membres MTC, on a 
essayé récemment de l‘utiliser aussi pour M. ulcerans mais, la résolution obtenue n'était pas 
meilleure aux 'autres outils moléculaires. 
Dans le cadre de cette thèse, nous avons identifié un nouveau locus VNTR, désigné ST1, qui 
n'avait pas de séquences similaires dans le génome de M. tuberculosis. Par la combinaison 
avec un locus MIRU précédemment publié nous étions capables d'identifier trois génotypes 
différents dans les souches ghanéennes de M. ulcerans et donc de trouver pour la première 
fois une diversité parmi les souches africaines. Entre autre, nous avons pu montré que le 
séquençage d'ADN des différents VNTRs peut raffiner le pouvoir discriminatoire si les 
VNTR polymorphes sont analysés séparément, mais pas s’ils sont inclus ensemble pour 
l'analyse. Et enfin,, l'électrophorèse par gel d’ agarose des produits amplifiés de tous les 
VNTR polymorphes est suffisante et le séquençage ne contribue pas à une meilleure 
résolution. 
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1.1. Burden and epidemiology of human tuberculosis 
Despite the availability of anti-tuberculosis antibiotics, the disease burden of human 
tuberculosis remains a very serious and wide-spread public health problem. At present, 
approximately a third of the world population is infected with Mycobacterium tuberculosis, 
which is a member of the Mycobacterium tuberculosis complex (MTC) and the main 
causative organism for human tuberculosis. Today we consider that 2 million deaths and 8 
million new human infections occur every year (11).  Many of the 22 most affected countries 
identified by the WHO are developing countries (Fig. 1) (13). There are various reasons why 
tuberculosis control strategies have not yet succeeded:  
- Resistance to antibiotics used in the treatment of tuberculosis. In different countries, 
between 0 and 54 % of tuberculosis cases are multi drug resistant (15). 
- Poverty connected to the problems of unemployment, access to good quality sanitary 
services and urbanization  
          
- Exponential increase of journeys and migration  
- Co-existence of the Human Immunodeficiency Virus (HIV) fuels the epidemic of 
tuberculosis on a large scale (11). Worldwide, 70.1 % (25.3 millions) of HIV positive 
people live in sub-Saharan Africa (WHO / CDS / TB / 2002.296). In 1997, new cases 
of TB totalled an estimated 7.96 million, including 3.52 million cases (44%) of 
infectious pulmonary disease (smear-positive), with 16.2 million existing cases of 
disease. An estimated 1.87 million people died of TB and the global case fatality rate 
was 23% but exceeded 50% in some African countries with high HIV rates (11). 
Fig. 1: Estimated 
global incidence rates 
of tuberculosis (2001). 
(Source: World Health 
Organization (WHO) 
2003) 
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Infection with HIV favours a new infection with mycobateria; however, it can also 
reactivate a latent infection.  
- DOTS (Directly Observed Treatment short course), a strategy promoted by the World 
Health Organization (WHO) is either not implemented, ineffective or not feasible in 
various countries.  
- Although M. tuberculosis most often causes pulmonary tuberculosis, it is also the 
causative agent for extra pulmonary tuberculosis. This form of tuberculosis is often 
underdiagnosed. 
- Mycobacterium bovis, another member of the MTC is also known to cause clinically 
undistinguishable tuberculosis in humans. Its zoonotic importance for the burden of 
human tuberculosis is unknown and currently under research (see also chapter on M. 
bovis). 
1.2 Diagnosis of Mycobacterium tuberculosis complex 
                                                                                                
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M. tuberculosis, which is the main pathogen for human 
tuberculosis, has some specific characteristics which 
diagnostics can take advantage of. As for all 
mycobacteria, M. tuberculosis is a gram positive and rod 
shaped bacterium which posseses a thick lipid-rich cell 
wall. This allows the acid fast staining of clinical 
specimens or cultures with Carbol fuchsin in the presence 
of acetic alcohol or fluorescent auramine-rhodamine dyes.  
However, some important antigens are specific for MTC     
only including: purified protein derivative (PPD), old 
tuberculin (OT) and cord factor 
(http://www.life.umd.edu/classroom/bsci424/PathogenDes
criptions/Mycobacterium.htm). The building of cords of 
MTC can be observed in MTC positive, liquid cultures 
with a light microscope (Fig. 2) (25). Within the MTC 
complex, members can be differentiated through a 
biochemical test. As this is not very reliable, different 
PCR approaches are in use, of which the Hain test is best 
known (http://www.hain-lifescience.de). However, despite 
the performance ability of PCR, culturing remains the 
golden standard and cannot be omitted. 
 
Fig. 2.   Microscopic morphology of 
Mycobacterium species grown in 
BACTEC 12B broth and stained with 
Kinyoun acid-fast stain. (A) 
M. tuberculosis, exhibiting serpentine 
cording. (B) Mycobacterium species 
other than M. tuberculosis that exhibit 
loose aggregates, referred to as 
pseudocording (Source: McCarter et al., 
J. Clin. Microbiol. 1998) 
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1.3. Molecular epidemiology of Mycobacterium tuberculosis 
Molecular epidemiology is a powerful approach for monitoring infectious diseases (32). It is 
particularly important in the study of chronic diseases such as tuberculosis, where patients 
with recurrent tuberculosis can be chronically infected with a given strain and relapse due to 
reactivation of that strain or, in contrast, can be reinfected by a different strain after cure (42). 
A correct distinction between these alternatives is essential for accurate estimation of the 
success rates of tuberculosis programs (5). Moreover, it can give unique insights into the 
international dissemination dynamics of M. tuberculosis by the comparison of isolates from 
widespread geographic areas and allows one to analyze evolutionary changes of pathogen 
populations (38). Molecular studies of M. tuberculosis are made extensively in industrialized 
but only few developing countries. Molecular epidemiological results from developed 
countries often show high polymorphism in the genetic patterns of M. tuberculosis complex 
strains (4,19,44). This is explained by two factors (43): The relatively high percentage of 
cases in low-incidence areas due to endogenous reactivation and the large proportion of cases 
in these areas found amongst non-native populations originating from different geographical 
origins, which introduce exotic strains not known in these areas.  
However, in interpreting the proportion of clustered strains found in a study, knowledge of 
the proportion of tuberculosis cases in the community included in the study is important. A 
high number of tuberculosis cases analyzed in a community can overestimate the proportion 
of recent transmission. On the other hand, a low number of samples can underestimate the 
proportion of recent transmission because the percentage of clustered strains is known to 
increase sharply at the beginning of a study till a certain number of cases is reached. 
Furthermore, molecular epidemiological studies should give information on the study setting, 
duration of study, the recruitment period and the definition of clustering used. The data on 
clustering should be disaggregated at the very least by age, sex and immigration status (16). 
If we consider Africa, apart from studies carried out in Tunisia and Egypt, where most of the 
M. tuberculosis strains only belonged to a few genotype families (20), results have also been 
obtained from the countries of Botswana (24) and South Africa. Wilkinson et al. (47) found a 
high clustering rate of patterns (45%) in a rural area of KwaZulu Natal, South Africa. In 
contrast, quite a low clustering rate was found in Botswana (24) and in the communities of 
Ravensmead and Uitsig, Cape Town, South Africa (46). These contradicting results from high 
incidence countries show how little is known when it comes to molecular epidemiology of 
TB in Africa. In addition, many countries, like Chad, completely lack data from similar 
studies suggesting that further research in these countries is urgently needed. In order to 
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perform molecular epidemiological studies, one or more appropriate genotyping tools are 
necessary. Nowadays, there exists a number of different ‘working’ tools, which are used 
routinely or for special occasions: 
1.3.1 Spoligotyping 
This method is based on the evaluation of the presence or absence of 43 spacer DNA 
sequences between the 36 bp direct repeats (DRs) in the genomic DR region of MTC strains 
(Fig. 3). Spoligotyping pattern are obtained by PCR amplification, containing a non-and 
biotinylated Primer, of the DR region and hybridisation of the amplification products on the 
43 spacer DNA containing membrane. The visualizing of the pattern is obtained by a second 
antibody which leads to a fluorescent emission (21). The lack of certain spacers can be 
helpful for diagnosing certain M. tuberculosis strain families and different M. bovis strains 
(Table 1). 
 
 
FIG. 3: (A) Structure of the DR locus in the mycobacterial genome. M. tuberculosis H37Rv and M. bovis BCG 
contain 48 and 41 DRs, respectively (depicted as rectangles), which are interspersed with unique spacers varying 
in length from 35 to 41 bp. The (numbered) spacers used correspond to 37 spacers from M. tuberculosis H37Rv 
and 6 from M. bovis BCG. The site of integration of insertion element IS6110 is depicted.  
(B) Principle of in vitro amplification of the DR region by PCR. Any DR in the DR region may serve as a target 
for these primers; therefore, the amplified DNA is composed of a mixture of a large number of different-size 
fragments. Shown is the combination of fragments that would be produced by in vitro amplification of a DR 
target containing only five contiguous DRs. (Source: Kamerbeek et al., J. Clin. Microbiol. 1997) 
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Table 1: Diagnostic spoligo spacer missing for M. tuberculosis family members (12), M. africanum and host 
adapted M. bovis strains (35). 
M. tb family members Spacer lacking 
M. tb (Beijing) 1-34 
M. tb (Haarlem) 31, 33-36 
M. tb (Latin America) 21-24, 33-36 
M. tb (East African India) 29-32, 34 
M. tb (Central Asia) 4-7, 23-34 
M. tb (Cameroon) 23-25, 33-36 
M. africanum (Type I) 9, 39 
M. bovis (antelope) 9, 16, 39 
M. bovis (seal/vole) 3, 9, 16, 39-43 
M. bovis (caprine) 3, 9, 16, 39-43 
M. bovis (cattle) 3, 9, 16, 39-43 
M. bovis BCG 3, 9, 16, 39-43 
 
1.3.2 Variable Number of Tandem Repeats Typing 
This method evaluates the number of repeats at different loci distributed throughout the 
genome. PCR amplification and comparison of the product sizes with a molecular size marker 
on an agarose gel is normally sufficient as the size differences are within a range of 30-100 
base pairs. There are different types of VNTR. Mycobacterial interspersed repetitive units 
(MIRUs) in DNA elements are often found as tandem repeats and dispersed in intergenic 
regions of the genomes. The M. tuberculosis H37Rv reference strain contains 41 MIRU loci, 
of which 12 are polymorphic and therefore appropriate for VNTR typing (Fig. 4) (39).  
 
Fig. 4. Position of the 41 MIRU loci on the M. tuberculosis H37Rv chromosome. Arabic numbers in bold 
specify the respective MIRU locus numbers. The `c' designates that the corresponding MIRUs are in the 
reversed orientation to that defined by Cole et al. (1998). Roman numbers give the type of MIRU (type I, II or 
III). The exact positions of the MIRU loci are given in arabic numbers after the type numbers. The 12 loci 
containing variable numbers of MIRUs among the 31 analysed strains are indicated by black dots (Source: 
Supply et al., Mol. Microbiol. 2000). 
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In a different analysis of eleven tandem repeat loci, six exact tandem repeat (ETR) loci 
contained large DNA repeats with identical sequences in adjacent repeats and are therefore 
also appropriate for VNTR typing (Fig. 5) (14). Recently a number of different VNTRs have 
been presented (31,34), which are mostly used for M. bovis typing for it is not normally as 
polymorphic as M. tuberculosis. 
 
Fig. 5: Example of a VNTR locus. The figure shows genomic DNA at the ETR-B locus in M. tuberculosis 
H37Rv and M. bovis TMC 410. Amplification of this locus using PCR primers complementary to flanking DNA 
(arrows) resulted in receiving the respective 292 and 406 bp PCR products. M. tuberculosis H37Rv DNA 
contains three complete copies of the 57-bp tandem repeat, plus eight additional bases corresponding to the 
beginning of another tandem repeat. M. bovis TMC 410 DNA has five complete copies plus the same eight 
additional bases (Source: Frothingham et al., Microbiol. 1998) 
1.3.3. IS6110-RFLP and ligation-mediated PCR 
IS6110-RFLP is the current golden standard in DNA fingerprinting of M. tuberculosis 
complex members. The technique exploits the variability in both the number and genomic 
position of IS6110 to generate strain-specific patterns (41). However, the need for extensive 
strain cultivation, the high cost, the long handling procedure and the difficulty of comparing 
results between different laboratories are considerable drawbacks for this method. 
Ligation-mediated PCR uses one primer specific for IS6110 and a second specific for a linker 
ligated to SalI-restricted genomic DNA (30). In contrast to IS6110-RFLP, it is a rapid 
screening method and relatively cheap. 
1.4 Burden and epidemiology of M. bovis with particular reference to 
Africa 
Bovine tuberculosis (BTB), a disease characterised by progressive development of specific 
granulomatous lesions or tubercles in lung tissue, lymph nodes or other organs, is caused by 
Mycobacterium bovis and cattle are considered to be the primary hosts (3). However, the 
pathogen seems to have one of the broadest host ranges (27) as it is also isolated in many 
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different host species such as wild boar, deer (33) badgers, goats, sheep, rabbits and pigs (8). 
But while some species (wild boar, deer and badgers) are considered to be maintenance hosts 
and therefore are dangerous natural reservoirs, others (goats, sheep, rabbits and pigs) act only 
as a spillover for M. bovis. These hosts are infected with host adapted M. bovis substrains 
rather than with classical M. bovis strains e.g. caprae (see 1.6 Evolution and ecotypes of 
MTC). 
In many industrialized countries, like Switzerland, bovine tuberculosis has been eradicated 
due to elimination programs and milk pasteurization (29). However, the burden of disease is 
still considerable in other industrialized countries such as the U.S. and U.K as the presence of 
natural reservoirs (badgers, deer) makes eradication difficult. Although a vaccination exists, 
the currently available BCG is not effective enough to completely prevent infection and 
interferes with the PPD test and there are assumptions that the vaccination of cattle is not 
deemed financially profitable (J. Zinsstag, personal communication). Indeed, during the 4th 
M. bovis conference in 2005, policy makers agreed to vaccinate wild life reservoirs rather 
than cattle. 
In developing countries, the incidence of animal TB is especially high as control measures are 
not at all or only partially applied (3). Additionally, some of them, such as the test and 
slaughter policy are not feasible due to the lack of financial compensation (23). In Africa, 
bovine TB represents a potential health hazard to both animals and humans, as nearly 85 % of 
cattle and 83 % of the human population live in areas where the disease is prevalent (3).  
M. bovis is additionally of particular interest from a public health perspective as man is also 
susceptible to infection. The burden of tuberculosis in humans caused by M. bovis is largely 
unknown or underdiagnosed due to the lack of adequate laboratory equipment but its presence 
has been proven and infections due to M. bovis are described in various African countries (9).  
Clinically, tuberculosis caused by M. bovis is not different from that caused by M. 
tuberculosis, but M. bovis is resistant to the antibiotic pyrazinamide, which is a first line drug 
in the treatment against human tuberculosis within the program of DOTS. In developing 
countries consumption of unpasteurised milk, poorly heat-treated meat and close contact with 
infected animals represent the main sources of infection for humans (3). 
In conclusion there are three main reasons why eradication of bovine TB is recommended (3): 
- loss in productivity due to infected animals 
- animal market restrictions 
- the risk of infection to the human population 
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1.5 Molecular epidemiology of M. bovis 
Different studies on M. bovis are carried out in order to improve the traceability of the M. 
bovis infections and identification of the origin of the outbreak Haddad N. et al. (18) 
genotyped 1266 M. bovis isolates in France and observed an apparently high level of 
heterogeneity of 161 different clusters and a low frequency of the two main spoligotypes 
clusters. In contrast, similar molecular studies in island countries like Great Britain (7) or 
Australia (10) showed a low level of heterogeneity and a high frequency of the main 
spolygotype clusters. 
Again, very few such studies have been carried out in developing countries in Africa. Some 
studies in Cameroon  (26) and Tanzania (22) have shown similar results to those made in 
Great Britain or Australia with a high homogeneity and thereby indicate a high recent 
transmission rate. There have been no molecular epidemiological studies of M. bovis in Chad 
before this PhD thesis. 
There are also studies which look at transmission pathways from M. bovis between different 
animal species, from animal to human (zoonotic) and from human to human. Serraino et al. 
(33) report spoligotype clusters which include 9 strains isolated from wild boar and 11 strains 
isolated from cattle, thus confirming the possibility of transmission between the two animal 
species. V. Soolingen et al. (45) show clusters containing M. bovis isolated from humans and 
cattle using the combination of the RFLP methods IS6110 and PGRS. One of the first results 
indicating but not proving M. bovis zoonotic transmission between  cattle and humans in 
Africa is shown in a study from Tanzania, where the same M. bovis spoligotype was isolated 
from man and cattle (23). Moreover, molecular epidemiological studies  by Guerrero et al. 
(17) showed the transmission of M. bovis MDR tuberculosis between HIV-1-positive patients. 
It is suggested that transmission of M. bovis took place within hospitals and that advanced 
HIV-1 immunosuppression was associated with the development of MDR tuberculosis. 
As with M. tuberculosis, molecular epidemiology can also develop a better understanding of 
the sources and modes of M. bovis transmission thereby enabling more effective control 
measures to be implemented in bovine eradication programs. 
1.6 Evolution and ecotypes of the Mycobacterium tuberculosis complex 
Human and animal tuberculosis are caused by different members of the Mycobacterium 
tuberculosis complex (MTC), of which M. tuberculosis and M. bovis are best known and 
share 99.9 % of the same genome. 
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Brosch et al. 2002 (6) described a new evolutionary scenario for MTC members which 
concluded that all animal adopted M. tuberculosis complex strains differ to human adopted 
M. tuberculosis strains by the absence of a specific chromosomal region (RD9; Fig. 6). These 
results contradict the often presented hypothesis that M. tuberculosis evolved from M. bovis. 
It suggests that it is more likely that the common ancestor of the tubercle bacilli was M. 
tuberculosis or M. canettii alike and may already have been a human pathogen (6). 
The RD9 deleted lineage, which is almost phenotypically homogenous, excludes M. 
tuberculosis as well as M. canettii, but includes M. africanum (found in humans), M. microti 
(voles, wood mice and shrews), M. pinnipedii (marine mammals), M. caprae (goats) and M. 
bovis (associated with cattle).  
A recent study suggested using phylogenetically informative spacers, in combination with 
previously identified single nucleotide mutations and chromosomal deletions to identify 
different clades in the RD9 deleted lineage each with a separate host preference (Fig. 7) (35). 
It is therefore suggested that the MTC is rather described as a series of host-adapted ecotypes 
than attributed a broad host range of distinct members of the MTC, like it was the case for a 
long time for M. bovis (27). 
The vaccine strain (M. bovis BCG) differs from the pathogenic M. bovis strain by the absence 
of RD1 (Fig. 6). Consequently, RD1 is associated with virulence and is of great interest in 
current research (6). 
                
Fig. 6:   Scheme of the proposed evolutionary pathway of the tubercle bacilli illustrating successive loss of DNA 
in certain lineages (grey boxes). The scheme is based on the presence or absence of conserved deleted regions 
and on sequence polymorphisms in five selected genes (Source: Brosch et al., PNAS, 2002) 
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Fig. 7 (bottom): The phylogeny of the RD9 deleted lineage and M. tuberculosis showing the informative 
deletions (RD deletions), single nucleotide mutations and deleted spoligotype spacers used to define the clades. 
The hypothetical ancestors, anc1–anc7, are shown as open circles (Source: Smith et al., J. Theor. Biol. 2005) 
1.7 Disease burden caused by Mycobacterium ulcerans  
Mycobacterium ulcerans, the causative agent of Buruli ulcer (BU), is an emerging pathogen 
particularly in Sub-Saharan African countries, and is also found in tropical and sub-tropical 
regions of Asia, the Western Pacific and Latin America (2). However, reported incidences 
probably do not give a complete picture as under-reporting has to be assumed. More than 
30,000 cases have been estimated in West Africa. After M. tuberculosis and M. leprae, M. 
ulcerans is the third most frequent mycobacterium causing infections in humans. BU is 
characterized by chronic, necrotic lesions of subcutaneous tissues. Due to the lack of an 
established effective antimicrobial therapy, surgical excision and skin grafting is currently the 
recommended treatment (40).  
1.8 Using molecular typing tools to study M. ulcerans transmission 
While it is known that proximity to slow flowing or stagnant water bodies is a risk factor for 
M. ulcerans infection, the exact mode of transmission is unknown. Molecular typing methods 
such as multi-locus sequence typing, 16S rRNA sequencing (28), restriction fragment length 
polymorphism, the 2426 PCR analysis (36), IS2404-Mtb2 PCR (1) and VNTR typing (37) 
have revealed a remarkable lack of genetic diversity of M. ulcerans and a clonal population 
structure within given geographical regions. The discriminatory power of all these methods is 
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particularly insufficient to differentiate between African isolates. Innovative molecular 
genetic fingerprinting methods are therefore required for local epidemiological studies aiming 
to reveal transmission pathways and environmental reservoirs of M. ulcerans. 
1.9. Rationale and research frame work 
While a number of molecular epidemiological studies of M. tuberculosis are performed in 
industrialized countries, data from similar works from the African continent, where incidence 
rates are high, are rare. However, this data is needed as it could prove useful in the 
tuberculosis control strategy of the different countries. In Chad, the results of molecular 
epidemiological studies could help in proposing new and innovative control strategies, 
showing for example risk factors for recent transmission of drug sensitive and resistance 
strains and researching the degree of mixed infections. Furthermore, it could help in 
evaluating the percentage of human tuberculosis infections due to M. bovis and in finding the 
sources of infections. 
Appropriate genotyping tools are a prerequisite for performing molecular epidemiological 
studies of Mycobacterium tuberculosis complex and M. ulcerans strains. For M. tuberculosis, 
these tools are well established and their degrees of appropriateness may only vary slightly 
depending on geographical area. M. bovis, despite also being a member of the M. tuberculosis 
complex, is generally much more homogenetic and the discriminatory power of the different 
tools has to be evaluated with great care. Even less genomic diversity seems to be attributed 
to M. ulcerans for which no typing tool was able to discriminate strains within the African 
continent. 
In an attempt to develop and evaluate innovative genotyping tools for the M. tuberculosis 
complex in Chad and M. ulcerans strains in Ghana, a scientific partnership was established 
between the Noguchi Memorial Institute for Medical Research of Legon and the Tema 
Municipal Health Directorate of Tema in Ghana and the Laboratoire de recherches 
vétérinaires et zootechniques de Farcha (LRVZ) and Centre de Support en Santé International 
(CSSI) in Chad. An evaluation of VNTR for genotyping the M. tuberculosis complex and M. 
ulcerans and its potential to enable micro epidemiological studies in the near future is 
presented. 
 
This thesis is co-funded by the NCCR North-South 
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2.1. Goal 
 
To contribute to the development and refinement of innovative molecular typing tools for the 
study of Mycobacterium tuberculosis, bovis and ulcerans infections. 
2.2. Objectives 
 
- Evaluation and analysis of the population structure of drug sensitive and resistant 
Mycobacterium tuberculosis isolates from Chad 
 
- Finding of possible human to animal transmission of MTC strains in Chad 
 
- Evaluation and analysis of the population structure of Mycobacterium bovis in the varyingly 
susceptible mbororo and arabe cattle breeds from Chad 
 
- Evaluation of the most discriminative and appropriate typing tool to study Mycobacterium 
bovis transmission in Chad 
 
- Development of Variable Number of Tandem Repeats typing to study Mycobacterium 
ulcerans infection 
 
- Evaluation of the sequencing of different VNTR loci to enhance the discriminatory power 
within M. ulcerans. 
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Abstract 
The establishment of a new mycobacteriology unit at the National Veterinary Laboratory of 
Farcha, Chad, allowed us to identify the first cultures of Mycobacterium tuberculosis from 
human patients in Chad. Of the 40 isolates obtained, thirty-three were tested for their 
susceptibility to five drugs: streptomycin, isoniazid, rifampicin, ethambutol and 
pyrazinamide. Thirteen (39%) were resistant to at least one of the drugs tested with resistance 
to isoniazid, a first line drug in Chad, as most frequent (27%).  
The use of spoligo- and MIRU/ETR typing for the strains’ molecular characterization 
identified 13 isolates (32.5%) that all lacked Direct Repeat spacers 23-25 and therefore were 
members of the “Cameroon family”. Members of this family are therefore endemic in Chad 
as in Cameroon and Nigeria. Using microarray-based comparative genomics, two unique 
deletions were identified and can be used for easy diagnostic strain identification by PCR and 
to epidemiologically trace back this clone. Furthermore, spoligo-and MIRU/ETR typing 
identified members of the Haarlem family, which may be inherently isoniazid resistant. The 
added value and feasibility of performing modern, molecular typing techniques in resource-
poor settings is discussed. 
 
Keywords: Mycobacterium tuberculosis, drug resistance, Cameroon family, spoligotyping, 
VNTR-typing, microarray- based comparative genomics, Chad 
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Introduction 
In Chad, the annual incidence rate of pulmonary tuberculosis was estimated at 60-
120/100,000 in 1990 (24), but increased to 370/100,000 in 2000 (39) making Chad a high 
incidence country. Together with the HIV/AIDS epidemic, tuberculosis became a major 
public health problem (34). The current gold standard for diagnosis, recommended by the 
WHO, is culture confirmation of Mycobacterium tuberculosis, the causative agent. However, 
in Chad, the routine detection of M. tuberculosis by cultures has not been done due to the lack 
of an adequate laboratory. Direct smear microscopy of sputum was the only method used and 
false-positive, and false-negative classifications of tuberculosis cases must be assumed. The 
WHO recommended treatment strategy for patients with open and extra-pulmonary 
tuberculosis is directly observed chemotherapy (DOTS) and is adopted in most African 
countries and specifically in Chad. An increase of drug resistances is feared due to non-
compliance during treatment, however, the lack of baseline data on drug resistance from these 
countries makes monitoring difficult. 
Next to drug resistance testing, it became routine practice to characterize and fingerprint M. 
tuberculosis complex members with molecular typing tools and various reasons justify this. 
Molecular typing is particularly recommended in the study of chronic diseases such as 
tuberculosis, where patients with recurrent tuberculosis can be chronically infected with a 
given strain and relapse due to reactivation of that strain or, patients could be reinfected by a 
different strain after cure (37). A correct distinction between these two options is essential for 
accurate estimation of the success rates of tuberculosis treatment programs (1). Furthermore, 
typing data assists in identification of the source of infection and can serve as a laboratory 
quality control for cross-contamination. Finally, fingerprinting data provides unique insights 
in the national and international dissemination dynamics of M. tuberculosis by comparison of 
isolates from different geographic areas and also allows to analyze evolutionary changes of 
pathogen populations (32).  
Recently, a variety of different molecular genetic typing tools for M. tuberculosis complex  
isolates have been developed (38) with the most widely-used, IS6110 typing, as the gold 
standard. However, spoligo-(16) and MIRU/ETR-typing (33) have shown advantages as they 
are more cost-effective and easier to perform and to compare results between laboratories.  
Most recently, microarray-based comparative genomic analysis of the M. tuberculosis 
complex has defined a set of chromosomal deletions that are unique polymorphisms marking 
all descendants of an ancestral strain (3,15,17,25,27,35). While these comparative studies 
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initially made use of genome sequence information, the microarrays allow the screening of a 
high number of M. tuberculosis strains for genomic deletions. This screening identified 
‘diagnostic’ deletions which nowadays facilitate the unequivocal placing of an isolate in a 
strain family, e.g. using genome level informed PCR (GLIP) (27,31).  
In 2000, a mycobacteriology unit at the National Veterinary Laboratory of Farcha 
(Laboratoire de Recherches Vétérinaires et Zootechniques) in Chad was setup. This unit 
cultures, characterizes and tests for drug resistance of mycobacteria and is at the moment the 
only one to do so in Chad. The outcome of the drug resistance tests of the first M. 
tuberculosis isolates and the implications for public health and treatment control are shown 
and discussed in this study. Furthermore, we show how fingerprinting and genome level 
informed PCR (GLIP) can quickly provide information about drug resistance and other 
epidemiologically important strains. 
Materials and Methods 
1. Clinical Specimens 
Between March and July 2001, and February and October 2002, a total of 357 sputum and 
282 urine samples were collected from tuberculosis patients at the National Reference 
Hospital (Hôpital Général de Référence Nationale- HGRNT) in the Chadian capital 
N’Djaména and at four rural health centres that were 50 to 300 kilometres away from 
N’Djaména (Figure 1).  
In the laboratory of the Reference Hospital, patient’s specimens (sputum and urine) were 
collected with the patient’s consent and smears were processed twice per week. At the rural 
health centres, a questionnaire was filled in with patients that were suspected to be 
tuberculosis positive by the head of the health centre and specimens were collected with the 
patient’s consent. Specimens were transported to the LRVZ on ice. The collection of 
specimens in Nigeria and the isolation of strains used in this study was previously described 
(5).  
2. Specimen processing and cultivation of acid fast bacilli AFB 
All specimens (sputum and urine) were decontaminated with N-acetyl-L-cysteine sodium 
hydroxide (0.5% NALC in 2% NaOH) (18) and inoculated onto two Löwenstein–Jensen (LJ) 
slants, one containing 0.75% glycerol and the other containing 0.6% sodium pyruvate. In 
addition, liquid Middlebrook 7H9 medium containing OADC and PANTA (polymyxin, 
amphotericin B, nadilixic acid, trimethoprim, azlocillin) was used in the latter parts of the 
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study. The inoculated media were incubated at 37°C without CO2 for 8 weeks. Smears were 
made from the sediment and were stained by the Ziehl-Neelsen method (18). 
3. Identification, spoligotyping, and MIRU/ETR analysis of mycobacterial isolates 
Growth of mycobacteria was confirmed by smear. AFB-positive colonies were subcultured 
on 3 LJ slants and a Middlebrook 7H10 agar plate. Three biochemical tests (nitrate, niacin, 
and 68°C catalase) (18) were used to identify M. tuberculosis complex from non-tuberculous 
mycobacteria (NTM). The Lebeek test was used as an additional phenotypical test to 
distinguish between the complex members (14). 
The standard method for molecular identification of Mycobacterium tuberculosis complex 
members was performed by real time PCR as described previously (19). Genotyping and 
identification of M. tuberculosis isolates was done by spoligotyping (16) and obtained 
spoligotypes were compared to the international database (SpolDB3.0)  (10). 
The reaction mixture for MIRU and ETR typing contained 1x Taq PCR buffer, 
deoxynucleoside triphosphates (0.2 mM each), 1 U of AmpliTaq Gold DNA polymerase 
(Perkin-Elmer Applied Biosystems), a 0.5 µM concentration of the primer pairs and 
mycobacterial DNA in a final volume of 20 µl. 12 MIRU and 3 ETR primer pairs were used 
(6,12). The reactions were carried out as previously described (14). 
4. Microarray analysis and sequencing 
DNA of two Cameroon family isolates (29) from Chad with spoligotypes 852 and 838 
(SpolDB3.0) were applied to an M. tuberculosis amplicon-array and fluorescence scanned 
with an Affymetrix 428 scanner as described (13). Data were analysed using GeneSpring 5.0 
(Silicon Genetics, Redwood City,CA) and Mathematica (Wolfram Research). A cut-off for 
the normalised test/control ratio of <2.0 was used and results were entered into gene deletion 
lists.  
PCR-Products of the deletions B and E were received as described (14) with the primers:  
BF 5’ AACTAGTTGGGGCAGAAAGAAC / BR 5’ CTGAGTGCCCTTACCTCCAAG  
EF 5’ AGCAAAAACATTGCTAGGTTCG / ER 5’ GGGTGGTGCTCTATTTGCAC 
PCR products were sequenced directly with an ABI Prism 310 Genetic Analysis System. 
The flanking sequences for Deletion B and E for two M. tuberculosis strains has been entered 
in the EMBL database under accession numbers AM063041/AM063042 and 
AM063039/AM063040, respectively.   
5. Drug susceptibility test 
Drug susceptibility testing was performed in the BACTEC MGIT 960 instrument (BD 
Biosciences, Sparks, Md., USA): isoniazid (INH) 0.1µg/ml, rifampicin (RMP) 1µg/ml, 
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ethambutol (EMB) 5µg/ml and pyrazinamide (PZA) 100µg/ml. Streptomycin (SM) 2µg/ml 
and 10µg/ml was tested by the agar proportion method (18). 
6. Data analysis 
Cluster analysis was done with SAS (Statistical Analysis Systems Inc., Cary, USA, Version 
8.02 Proc cluster) using the UPGMA algorithm.  
Results and Discussion 
Culturing of mycobacteria  
In 2001 and 2002, a total of 357 sputum specimens and 282 urine samples were transported to 
the mycobacteriology unit of the LRVZ (Table 1). 169 cultures from 123 sputum and 46 urine 
samples showed growth of acid-fast bacilli on at least one medium. Additionally, one culture 
was obtained from an extra-pulmonary sample. Subsequent performing of real time PCR 
identified 34/123 (27.6 %) isolates from sputum, 5/46 (10.6 %) from urine and the extra 
pulmonary sample as M. tuberculosis complex (MTC). Few of the remaining non-
tuberculosis mycobacteria (NTM) could be further characterized (8) while others were 
considered to be environmental contaminants. A very high contamination rate with NTM was 
observed for cultures obtained in 2001 when only solid media (Löwenstein) was used. 
Consequently, a liquid media with antibiotic supplements (PANTA) was introduced which 
led to higher proportions of MTC cultures. Still, of the samples collected in rural health 
centres only few MTC in comparison to NTM isolates were obtained (Table 1; Fig. 1). 
Considering the high number of clinically positive tuberculosis cases in these areas, this 
relative paucity of MTC positive-cultures may be explained by inadequate sample collection, 
long transport times and insufficient decontamination, rather than lower occurrence of the 
disease.  
Diagnosis of M. tuberculosis  
In this study, real time PCR and spoligotyping were used as a reference method for 
diagnosing MTC and M. tuberculosis isolates, respectively. As these methods are not yet 
established in the Chadian mycobacteria laboratory we compared the PCR-based results to 
those obtained with the biochemical tests (catalase, nitrate, niacin) and Lebeek media for 
agreement assessment. With real time PCR, 40 MTC-positives were identified and 
subsequent performing of spoligotyping resulted in 40 M. tuberculosis isolates. In 
comparison, 35/40 strains showed a biochemical pattern of M. tuberculosis complex (heat-
resistant catalase negative), with 22/40 characterized as M. tuberculosis (heat-resistant 
catalase negative, nitrate positive, and niacin positive). All of these isolates were aerophilic 
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on Lebeek media (indicating M. tuberculosis rather than M. bovis or M. africanum). Thus 
18/40 M. tuberculosis isolates were not detected with biochemical testing. Additionally, a 
number of isolates were false classified as MTC by biochemical testing compared to real time 
PCR, too (data not shown). Possible interference of NTM might explain the low predictive 
value of the biochemical tests in our study and caution in interpreting biochemical tests is 
suggested if comparison to other reference methods are lacking. 
Considering the geographic location of Chad (Central Africa), we were surprised that 
spoligotyping failed to reveal any M. africanum type I and II in our strain collection. M. 
africanum I (lack of spoligo spacer 37-39) is very frequent in West Africa and found in 
neighbouring Cameroon. However, it was suggested that there has been a decreasing trend of 
M. africanum type I transmission in the last three decades (29). M. africanum II (lack of 
spacer 40) is predominantly isolated in Uganda (28) and although we obtained 6 spoligotypes 
lacking spacer 40 all of ours were aerophilic on Lebeek media which is not coherent with M. 
africanum. Indeed, a recent study (26) on genomic analysis has not been able to differentiate 
M. africanum sub-type II from modern M. tuberculosis, casting doubt on whether sub-type II 
should be considered as separate to M. tuberculosis. 
Molecular characterization of M. tuberculosis and identification of the Cameroon family 
clone 
In total, spoligotyping identified 26 different spoligotypes (Fig. 2). When compared with the 
international database (SpolDB3.0) 8/26 spoligotypes are described for the first time (T1-T8) 
(Figure 2). Twenty-one (52.5 %) isolates were clustered within 7 spoligotypes (DB 50, 52, 
848, 244, 61, 838 and T1) while 19 spoligotypes were unique. With a total of 25 different 
genotypes, of which 7 and 18 were clustered and unique, respectively, MIRU/ETR-VNTR 
typing showed a similar degree of discrimination of M. tuberculosis isolates.  Thirteen strains 
(DB 61, 838, T1 and T6) had the Cameroon family spoligotype with lacking DR 23 – 25 (29). 
This family was first described in Cameroon (29) to be an endemic strain family and its 
presence in Chad is not surprising since everyday transborder movements of people are 
frequent. Within this clone, clustering of the VNTR types differs the clusters received by 
spoligotyping (Fig. 2). Therefore combined spoligo- and MIRU/ETR typing data could 
provide valuable additional information for future micro-epidemiological studies of this 
clone. Additionally, one VNTR cluster (V3) and three spoligotypes (T1, T6, T7) have not yet 
been previously described in Cameroon (30) and possibly indicate that sub-clones are 
spreading in Chad and in Cameroon (Fig. 2).  
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Microarray-based comparative genomics showed 5 deletions (Table 2, A-E) for two M. 
tuberculosis isolates from the Cameroon family. While deletions A, C and D are already 
published in a comparable form in previous studies but with a different nomenclature 
(2,3,11,15,17,27,35) the Deletions B and E are described only partly (15,35) or for the first 
time here, respectively. Deletion B was found to be split in two sub-deletions of 1941 bp and 
1381 bp with a conserved, but inversed, 240 bp region within Rv1674 (Table 2); sequence 
characterization of Deletion E revealed to be 1749 bp, removing Rv3486 and parts of Rv3485 
and Rv3487. All 13/13 from Chad and 14/14 test strains from Nigeria were positive while 
27/27 control strains from Chad were negative for the deletions. These findings facilitate a 
diagnostic PCR which can be used for improved back-tracing of this epidemiologically 
important clone in Central Africa. From a public health perspective to trace back this clone 
and try to interrupt its transmission pathways could prove effective in the tuberculosis control 
strategy if proven that the high frequency of these strains arose because of the biological 
differences in the organism. However, as for the Beijing strains (22), this remains to be 
identified but could be investigated with a population-based assessment of transmission of 
this clone related to the underlying levels of drug resistance, clinical and socio-economic 
characteristics of human tuberculosis.  
Demographic and resistance data of the M. tuberculosis isolates 
Most M. tuberculosis isolates (23/40; 57 %) originated from male patients of the HGRNT in 
N’Djaména (Figure 1 and 2). Drug susceptibility testing of 33 M. tuberculosis isolates 
showed that 20 (60.6%) were susceptible to all drugs, while 13 (39.4%) were resistant to at 
least one drug (Figure 2). Resistance to isoniazid was the most frequent (9 patients [27.3 %]; 
associated with resistance to ethambutol in 3 patients [9.1 %]). Resistance to ethambutol was 
observed in four isolates (12.1%) and to pyrazinamide in 3/30 isolates (10 %). We did not 
find any isolate that was resistant to rifampicin or streptomycin. 
Looking at the resistance data, the level of resistance to INH is alarming (9/ 33; 27.3%) when 
one considers that INH is used as a first line drug in Chad. Primary resistance to INH in other 
African countries is usually lower: 8.3% in Ethiopia (4), 12.5% in Equatorial Guinea (36), 
12.1% in Western province of Cameroon (20), and 6.6% in Northern Nigeria (9). However, 
we did not find any strains resistant to both streptomycin and rifampicin. Usually, resistance 
to these drugs is very common in Africa, except in Guinea Bissau (resistance to INH only; (7) 
and in Congo (no RMP-resistant isolates; (21). The rate of resistance of the other drugs was 
low compared to INH.  
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Interestingly only 1/9 tested Cameroon family isolates showed resistance to commonly used 
anti-mycobacterials.  This indicates that resistance to drugs does not necessarily contribute to 
the high frequency of this family. In contrast, the Haarlem family members (lack of spacer 
31) showed resistance to INH. This could confirm data on Haarlem strains from Tunisia 
which were also associated with resistance (23). However, our sample size is too small to 
draw any general conclusion at this point. 
Concluding remarks 
This study makes several recommendations on how to culture and diagnose Mycobacterium 
complex strains in a setting with infrastructural constraints and a high prevalence of not only 
M. tuberculosis but also non-tuberculosis mycobacteria (NTM).  First drug resistance results 
of Chadian patients infected with M. tuberculosis show a high level of resistance to isoniazid, 
a front-line drug for treatment. Molecular characterization revealed the presence of an 
endemic clone (Cameroon family) which is based on the absence of spacer 23-25 and two 
specific large genomic deletions and it seems that this clone has high prevalences in Chad, 
Cameroon and Nigeria. Whether the dominance of these strains in this area is because of 
biological differences in the mycobacterium remains to be identified but could become 
important in the tuberculosis control strategy in the future.  However, Microarray analysis led 
to the proposition of a single deletion PCR that can be used in resource-poor countries for 
easy detection of the Cameroon family strains  
The new mycobacterial unit of the laboratory in Farcha will allow generating crucial 
information to improve clinical care for TB patients and a basis for planning a National 
Tuberculosis Program in Chad in the future. 
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Table 1: Specimens collected in 2001 and 2002, proportion of AFB positive smears and 
positive cultures at least one medium 
 
Site and year of 
collection 
Nature of 
clinical 
specimen 
Number of 
specimens 
N° of AFB-
positive smear 
(%) 
N° of AFB-
positive culture 
(%) 
2001     
Sputum   87 17 (19.5) 26 (29.8) 
N’Djaména 
Urine   51   3 (5.8)   5 (09.8) 
Sputum   73   7 (9.5) 26 (35.6) 
Am Doback 
Urine   78   0  22 (28.2) 
Sputum   23   2 (8.7)   9 (39.1) 
Dourbali 
Urine   23   0    1 (4.3) 
2002     
Sputum   91 20 (21.9) 49 (53.8) 
N’Djaména 
Urine   45   4 (08.8)   9 (20.0) 
Sputum   44   0    4 (9.1) 
Massaguet 
Urine   47   0    5 (10.6) 
Sputum   39   2 (5.1)   9 (23.1) 
Mandalia 
Urine   38   2 (5.2)   4 (10.5) 
Sputum 357 48 (13.4) 123 (34.4) 
Total 
Urine 282   9 (3.2)   46 (16.3) 
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Table 2: Genomic divergence of M. tuberculosis Cameroon family strains relative to 
tuberculosis H37Rv. Nomenclature of deletion are described in  +(3), ++(17), *(35), and  **(2). 
+ and – indicate presence and absence of regions. 
Deletion 
number 
Region ORF/ Gene 
name 
 H37Rv / 
Cameroon 
family 
Sequence confirmed 
 
Rv-1573  Probable phiRV1 phage protein + / – 
Rv-1574  Probable phiRV1 phage related 
protein 
+ / – 
Rv-1575  Probable phiRV1 phage protein + / – 
Rv-1576c  Probable phiRV1 phage protein + / – 
Rv-1577c  Probable phiRv1 phage protein + / – 
Rv-1578c  Probable phiRv1 phage protein + / – 
Rv-1579c  Probable phiRv1 phage protein + / – 
Rv-1580c Probable phiRv1 phage protein + / – 
Rv-1581c Probable phiRv1 phage protein + / – 
Rv-1582c Probable phiRv1 phage protein + / – 
Rv-1584c Possible phiRv1 phage protein + / – 
Rv-1585c Possible phage phiRv1 protein + / – 
 
A 
 
RD3+ 
 
 
Rv-1586c Probable phiRv1 integrase + / – 
No 
Rv-1672c Probable conserved integral 
membrane transport protein  
+ / – 
 
Rv-1673c  Conserved hypothetical  protein + / – 
Rv-1674c Probable transcriptional 
regulatory protein 
+ / – 
CDC-1713  hypothetical protein + / – 
B1 
 
 
 
 
B2 
150* 
 
 
 
 
New 
(CamFa1) 
Rv-1675c  Probable transcriptional 
regulatory protein 
+ / – 
1897543-1899483 
(deletion) 
1899484- 1899723 
(inversion) 
1899724-1901104 
(deletion) 
Rv-1758 Probable cutinase cut1 + / – 
Rv-1759c PE-PGRS family protein + / – 
Rv-1760  conserved hypothetical protein + / – 
Rv-1761c hypothetical exported protein + / – 
C 152* 
DS6 (12) 
DS6L (12) ++ 
RD14 (17) + 
 
Rv-1762c hypothetical protein + / – 
No 
Rv-3343c PPE family protein (PPE 54) + / – 
Rv-3345c PE-PGRS family protein (PE-
PGRS 50) 
+ / – 
Rv-3347c PPE family protein (PPE 55) + / – 
Rv-3348 Probable transposase + / – 
D MTCDC1551 
MiD3** 
 
Rv-3349c Probable transposase + / – 
No 
Rv-3485c  Probable short-chain type 
dehydrogenase/reductase 
+ / – 
Rv-3486  conserved hypothetical protein + / – 
E New 
(CamFa2) 
 
 
Rv-3487c Probable esterase/lipase lipf + / – 
3904958-3906706 
(deletion) 
AF-1785c   – / + 
AF-1786  – / + 
6 RvD1+ 
 
 
AF-1787  – / + 
No 
RvD2+ AF-2048c  – / + 7 
 AF-2049c  – / + 
No 
  
 
Figure 2: Molecular characteristics and results of drug resistance testing of 40 isolates 
SP: sputum; UR: urine; T1- 8: novel spoligotype described in this study; C1-3: unique spoligotype first described in Cameroon; a: lacking 53 bp repeat at MIRU 4 (2nd column); MIRU 4 and 
MIRU 31 (10th column) correspond to ETR D and ETR E (12);  INH, PZA, ETB, RIF and SM: Isoniazid, Pyrazinamide, Ethambutol, Rifampicin and Streptomycin respectively; ‘: susceptible; 
R: resistant. N.I.: not identified; N/D: not done; HGRNT, LRVZ and Clin: Hospital, laboratory, and Clinique of N’Djaména; respectively. Man.: Mandelia; Dour.: Dourbali; Am: Am Dobak. M: 
male; F: female
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Abstract 
During a prospective study (July to August 2002) at the slaughterhouse in N’Djaména, Chad, 
meat inspectors have condemned 727/10’000 cattle carcasses due to tuberculosis-like lesions. 
A significantly higher proportion of Mbororo than Arab cattle carcasses were entirely 
declared unfit in comparison to partial condemnation of carcasses (33% versus 9%, p = 
0.002). Microbiological examination of 201 lesions from 75 Mbororo zebu and 124 Arab 
zebu carcasses confirmed bovine tuberculosis for 55 animals by isolation of Mycobacterium 
bovis. M. bovis was more often cultured from specimens of Mbororo than of Arab cattle (p = 
0.004). Spoligotypes of 53 out of 55 (96.4%) isolates showed lack of the spacer 30 as has 
been described for isolates from Cameroon. Our strains were isolated from a slaughterhouse 
with a bovine tuberculosis prevalence of 7% and 92.7% of strains were clustered. This 
indicates a high recent transmission rate.  
 
Keywords: Mycobacterium bovis, zebu, Arab breed, Mbororo breed, slaughterhouse, 
spoligotyping, Chad 
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Introduction 
M. bovis is the causative agent of bovine tuberculosis in livestock such as cattle and farmed 
deer. The disease is among these, which may affect trade between countries and is under OIE 
(Office International des Epizooties) List B diseases i.e. transmissible diseases that are 
considered to be of socio-economic and/or public health importance within countries and that 
are significant in the international trade of animals and animal products. According to OIE 
records for bovine tuberculosis of the past five years (1998-2003), 31 out of 50 African 
countries have reported the occurrence of the disease in their respective countries (1). 
Developing countries do not have the same means available for control and elimination as 
industrialized countries had few decades ago. However, control measures have been put in 
place in 35 of the 50 African countries reporting to OIE.  
Furthermore, M. bovis is also recognized as a zoonotic pathogen that infects many people, 
particularly in the developing world with highest prevalences of bovine tuberculosis and 
HIV/AIDS co-infection (2).  
In order to improve the traceability of the M. bovis infections and identify the origin of the 
outbreak, different genotyping studies were made. An apparently high level of heterogeneity 
of individual strains by the use of spoligotyping was observed in France (3). In contrast, 
similar molecular studies in island countries as Great Britain (4) and Australia (5) showed a 
low level of heterogeneity suggesting a high recent transmission rate between livestock. For 
developing countries, particularly for Africa, few molecular genotyping studies - as 
prevalence and incidence surveys in general - have been undertaken. Studies in Cameroon (6) 
and Tanzania (7) show low heterogeneity of isolated strains as in Great Britain and Australia. 
The slaughterhouse of Farcha (Société Moderne des Abattoirs) in N’Djaména is the largest 
one in Chad. Among the 50’000 animals that are slaughtered annually, the main species are 
cattle followed by small ruminants (8). The cattle population of Chad was estimated to be 
5’595’000 in 2000 and is mainly composed of the zebu breeds (Bos indicus) Arab, Peul, 
Mbororo, with the Toupouri and Kouri breeds (Bos taurus) less common. It is estimated that 
90% of all slaughtered cattle are of the Arab breed, with 7% Mbororo and 3% Kouri (9). 
Several studies in slaughterhouses have demonstrated that tuberculosis is an important cause 
of condemnation, causing approximately 9% of all inspected carcasses to be condemned (10). 
A retrospective study on causes of condemnation after meat inspection at the slaughterhouse 
of Farcha showed that (i) most carcasses with tuberculous lesions were detected between the 
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months of July and November, and (ii) more Mbororo cattle than animals of other breeds had 
tuberculosis-like lesions (42/60 versus 132/1539) (11). 
Tuberculin-positive cattle have been detected in Chadian cattle herds (12;13). At the 
slaughterhouse, the diagnosis of tuberculosis is mainly based on the typical macroscopic 
lesions of the organs rather than on Ziehl-Neelsen stained smears. Confirmation of a 
suspected diagnosis of bovine tuberculosis after meat inspection has so far not been 
confirmed by the isolation of M. bovis in Chad.  
This study was aimed at isolating M. bovis from specimens of Mbororo and Arab cattle in 
Chad, at characterizing the strains with molecular methods, and at comparing the isolates with 
M. bovis strains from Cameroon (14).  
 
Materials and Methods 
 
1. Carcasses and specimens 
At the Farcha slaughterhouse 727/10'000 cattle carcasses (7397 zebu Arab, 2596 zebu 
Mbororo and 7 Kouri cattle) were condemned due to tuberculous lesions upon meat 
inspection between July 1st and August 31st 2002. A sample from approx. every fourth 
condemned carcass was collected between July 11th and August 29th 2002. Specimens from 
201 affected organs (lymph nodes, lungs, and liver) from 199 carcasses were transported on 
ice to the Chadian National Veterinary and Animal Husbandry Laboratory (Laboratoire de 
Recherches Vétérinaires et Zootechniques de Farcha) and stored there at -20 °C prior to 
processing. For each specimen, the following information was collected by two trainees: 
breed, sex, partial or total condemnation of the carcass, date of collection, and nature of 
specimen (15).  
2. Specimen processing and cultivation of acid-fast bacilli (AFB) 
Specimens were washed three times with sterile, distilled water. Tissue samples were cut into 
5 or 6 pieces and put in a sterile plastic bag containing 10 ml of sterile saline for 
homogenization. Samples were homogenized in a blender (type STOMACHER 80; Seward 
Laboratory Systems, Bristol, U.K.) for 1 min, and repeated three time. Ten millilitres of the 
suspension were transferred into a 50 ml conic FALCON® tube for decontamination. 
Homogenized suspensions were decontaminated with N-acetyl-L-cysteine sodium hydroxide 
(0.5% NALC- 2% NaOH) (16) and inoculated on two Löwenstein-Jensen (LJ) slants 
containing a) glycerol (0.75%) and b) pyruvate (0.6%), but no glycerol. In addition, 
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Middlebrook 7H9 medium containing OADC and PANTA (polymyxin, amphotericin B, 
nadilixic acid, trimethoprim, azlocillin) was prepared. Inoculated media were incubated at 
37°C (without CO2) for 8 weeks. Smears were prepared with one drop of the sediment after 
centrifugation of the homogenized suspensions for detection of AFB by microscopy. 
3. Identification of mycobacterial isolates 
Growth of mycobacteria was confirmed by smear (stained by the Ziehl-Neelsen method). 
AFB-positive colonies were subcultured on 3 LJ slants and a Middlebrook 7H10 agar plate. 
Three biochemical tests (nitrate, niacin, and 68°C catalase) (17) were used to identify 
mycobacteria and to distinguish between M. tuberculosis complex (MTC) and non-
tuberculous mycobacteria (NTM). 
Species identification was performed by real time PCR (16) to confirm MTC isolates. 
4. Genotyping of MTC strains 
Genotyping of M. tuberculosis complex (MTC) strains was done at the National Centre for 
Mycobacteria (NCM) by spoligotyping (18) and IS6110-based analysis of restriction 
fragment length polymorphism (RFLP) (19). The latter was carried out with 50 % of 
spoligotypes. Spoligotyping of all strains was repeated at the Veterinary Laboratories Agency, 
Weybridge, to confirm the results of the first spoligotyping round.  
Additionally, the presence of spacers 14 and 15 for 15 strains with weak or absent signals in 
spoligotyping was confirmed by a PCR reaction with a primer-pair bridging the DNA region 
from spacer 14 (3’ gtgtgatgcggatggtcggctc 5’) to 22 (5’ tgtctcaatcgtgccgtctgcgg 3’) (20). The 
PCR reaction mixture contained 1x Taq PCR buffer, deoxynucleoside triphosphates (0.2 mM 
each), 1 U of AmpliTaq Gold DNA polymerase (Perkin-Elmer Applied Biosystems), a 0.5 
µM concentration of the primer pair and mycobacterial DNA to a final volume of 20 µl. After 
10 min at 95°C, the PCR was performed for 40 cycles of 0.5 min at 94°C, 0.5 min at 65°C 
and 1 min at 72°C. The reactions were terminated after an incubation of 10 min at 72°C. PCR 
fragments were analyzed by agarose gel electrophoresis using 2 % NuSieve agarose. The size 
of the amplicons was compared with a positive control of spacers 14 and 15. 
5. Statistical analysis 
A Chi-square test was used to analyze the co-variables (condemnation, culture growth) 
between breeds. A multivariate regression model with M. bovis isolation as the outcome was 
adjusted for co-variables. Cluster analysis was done with SAS (Version 8.02 Proc cluster, 
USA Statistical Analysis Systems Inc., Cary, NC/ USA). The relationship of clusters to 
geographical origin of animals, breed and type of condemnation was done by the Fisher test 
(SAS, proc freq). 
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Results 
 
The overall prevalence of suspect lesions was 7.3%. A significantly higher (p = 0.04) 
prevalence was found among Mbororo (8.2%; 212/2596) than Arab cattle (7%; 515/7397) 
(15). Lesions were mainly found in the lymph nodes and lungs (Table 1). At the 
slaughterhouse and in the sub-sample of 199 animals, entire condemnation of the carcass in 
comparison to partial condemnation was observed more often among Mbororo than Arab 
cattle (p ≤ 0.001 and p = 0.002) (Table 2). This difference between the two breeds was even 
more accentuated in female cattle. 
The proportion of positive specimens smears was relatively low (21.6%), with was no 
difference evident between the two breeds (Table 3). Most AFB-positive smears originated 
from lymph nodes (18%) and lungs (26%), while liver specimens (n=5) were always AFB-
negative. Of 201 specimens which were inoculated onto three types of media, 132 (65.7%) 
showed growth of mycobacteria on at least one medium, whereas 55 (27.3%) remained 
culture negative. Fourteen (7%) cultures were contaminated (Table 4). Ninety-eight of 161 
(61%) AFB smear-negative specimens became culture positive. 
Culture morphology and biochemical tests identified 58 MTC and 26 Non-Tuberculosis 
Mycobacteria (NTM) strains. Real-time PCR confirmed that 56 strains belonged to MTC and 
28 strains were NTM. 55 MTC strains were of the M. bovis spoligotype, while 1 failed to give 
a spoligotype pattern. Overall, M. bovis was isolated from more than a fourth of tissues in 
which tuberculosis had been suspected and in 42% of all positive cultures. There were 
significantly more M. bovis strains isolated from Mbororo zebu (30/75) than from Arab zebu 
(26/124) (p = 0.004) (Table 4). The difference remained statistically significant when 
including the type of condemnation and type of organ in a multivariate logistic regression 
model.  
In total, twelve different spoligotypes were found among the 55 M. bovis isolates, with only 
four spoligotypes were unique. Eight clusters of spoligotypes were identified. The number of 
strains per cluster varied between 22 and 2 (Figure 1). We found that 5/8 clusters were 
composed of strains which have been isolated from Mbororo and Arab zebus. The 
distribution of the two breeds (Mbororo and Arab) within cluster differ significantly (p < 
0.01). 
All strains lacked spacers 3, 9, 16, 39-43 which is a characteristic of M. bovis. In addition, 
53/55 strains did not have spacer 30. Upon RFLP analysis, the cluster 5 identified by RFLP 
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was distinct in its spoligotypes (SP5 & 6); however, other RFLP clusters could not be further 
distinguished by spoligotypes (Figure 2). For clusters RFLP1, 3b, 5 and 6a, a second band 
was visible, while a second band was missing for RFLP2, 3a, 4 and 6b.  
All Chadian strains showed a different RFLP pattern when compared with the BCG reference 
strain of the NCM Zurich (clinical M. bovis BCG isolate after BCG vaccination at the 
paediatric hospital of Zurich in 1999).  
 
Discussion 
 
For the first time, M. bovis has been isolated in specimens from Chad. The prevalence of 
tuberculin-positive cattle was 0.8% (95% confidence interval 0.2- 1.4%) in the East (Ouaddaï 
region) (12) and 16.9% (95% CI 10.4 – 23.5%) in the West of Chad (Chari- Baguirmi and 
Kanem regions) (13). The latter study has been continued with 476 additional cattle in 34 
herds and a prevalence of 11.5% (95% CI 6.9 – 18.5%) was found when considering the 
herds as a random effect in the model. More tuberculin reactors were found among Mbororo 
than Arab zebus (p = 0.02).  
Usually, cattle breeds are not restricted to specific geographical zones in Chad; however, a 
high proportion of Mbororo cattle was found in the West of the country (21). At Farcha, the 
most frequently slaughtered breeds were Mbororo and Arab zebus. Mbororo zebu showed 
generalized tuberculosis more often than Arab zebus which was reflected in the data through 
a higher proportion of these animals having their entire carcass condemned. Similarly, a 
higher susceptibility of Mbororo cattle to tuberculosis infection was also observed in 
Cameroon (14). It would be interesting to understand the immunological basis of this 
susceptibility in greater depth since it may have a bearing on the development of an improved 
livestock vaccine.  
Sixty-five percent of specimens with tuberculosis lesions were culture-positive; however, 
only one fifth (21%) were smear positive. In this study, the proportion of smear-positive 
specimens was low in comparison to Sudan (53%; (22). Spoligotyping was used as a 
diagnostic tool, but also yielded important insight into the epidemiology of M. bovis. The 
spectrum of spoligotype clusters differed between Mbororo and Arab zebus, but not between 
the type of condemnation. Spoligotype clusters could not be related to geographical origin. 
However, most of the cattle were bought at local markets and their geographical origin was 
not known. The finding that 51/55 isolates (92.7%) were in 8 clusters indicates a substantial 
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degree of recent transmission, an observation that is underlined when the prevalence of 
tuberculosis lesions at the slaughterhouse is considered (7%).  
Similar to Cameroonian M. bovis strains, our isolates most often lacked spacer 30, the only 
exception being SP11 (Figure 2). A possible explanation for this observation is the cross 
border movement of Chadian cattle to Cameroon. As in the study conducted by Njanpop-
Lafourcade et al. in Cameroon (14), the pre-dominant spoligotype in our study is SP1 (Figure 
1) with a cluster of 22 strains (40%). SP1 corresponds to the pattern of cluster C1 in the 
Cameroonian study and two other clusters described in Cameroon were found in Chad (C1 an 
C5, similar respectively to SP2 and SP4 in this work). Certain Cameroonian clusters (C7, C8, 
C9 and C10; (14)  were only detected in the Adamaoua region but not in northern Cameroon 
or in Chad (our study). Apparently, the established measures of the Cameroonian government 
to prevent movement of cattle between the Adamaoua and the two regions of the North are 
effective. As to the other neighbouring countries, we have not found any publications related 
to molecular typing of M. bovis strains.  
The comparison of the patterns found in Chad with the M. bovis spoligotype database 
(www.mbovis.org) showed that SP1, 2, 4 and 10 have already been described. All other 
patterns have never been described (www.bovis.org). All strains lacking spacers 27 and 28 
(Figure 1 and Table 5) were isolated from Arab cattle. No other characteristics were observed 
within the spoligotypes for strains isolated from Arab and Mbororo cattle. Fifteen strains (8 
from Arab and 7 from Mbororo zebu) were typed with the IS6110 method, of which 11 and 4 
isolates contained 2 or 1 band, respectively. Therefore, Chadian M. bovis strains belong to 
low IS6110 copy number strains. Strains lacking spacer 30 had a band at 1.9 kB, in 
accordance to the findings in Cameroon (14). Cousins et al. (5) found that 85 % of M. bovis 
strains showed one band which was mainly at 1.9 kB. No association was found between the 
number of bands and the cattle breed. IS6110 typing revealed 6 clusters and, thus, is of lower 
discriminatory power than spoligotyping. However, spoligopatterns were differentiated by 
RFLP due to the number of visible bands. Earlier, Zumarraga et al. (23) concluded that 
spoligotyping alone is not sensitive enough for the discrimination of M. bovis strains for in-
depth epidemiological study. It would be interesting to see whether VNTR-typing (24) can 
improve strain discrimination. 
The recent establishment of the first mycobacterial laboratory in Chad allowed a confirmation 
of the presence of bovine tuberculosis in Chadian herds. Future molecular epidemiology 
studies are needed to shed light on the transmission of M. bovis between Chadian and 
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Cameroonian cattle. Furthermore the observed higher susceptibility of Mbororo than Arab 
zebus to M. bovis disease should be followed-up by immunological investigations.  
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Table 1: Specimens collected at the main slaughterhouse of N’Djaména, Chad, and 
specifications of the condemned carcasses 
 
Organ/ Tissue n Condemnation Breed Sex 
  Entire Partial Arab Mbororo Male Female 
Lymph nodes 116 17 99 67 49 8 108 
Lungs 75 13 62 51 24 1 74 
Lungs and 
lymph nodes 2 0 2 2 0 0 2 
Liver 5 0 5 4 1 0 5 
Miliary tuberculosis 1 0 1 0 1 0 1 
Total 199 30 169 124 75 9 190 
 
Table 2: Slaughterhouse data of investigated zebu carcasses at the slaughterhouse of 
N’Djaména, Chad 
Breed 
Condemnation 
Arab Mbororo 
Total p 
Partial 113 56 169  
Entire 11 19 30 0.002 
Total 124 75 199  
 
 
Table 3 Microscopy results of specimens from Chadian Mbororo and Arab cattle 
Breed 
AFB-smear 
Arab Mbororo 
Total p 
Positive 26 17 43  
Negative 100 58 158 0.734 
Total 126 75 201  
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Table 4 M. bovis and NTM cultures from Chadian Mbororo and Arab cattle 
Breed p 
Cultures 
Arab Mbororo 
Total 
 
M. bovis 26 30 56 0.004 
NTM 55 21 76 0.592 
Negative 37 18 55  
Contaminated 8 6 14  
Total 126 75 201  
 
 
 
 
Figure 1 Spoligotypes obtained from 55 M. bovis isolates from Chadian zebus.  
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Figure 2 RFLP patterns of 15 Chadian M. bovis strains of which 14 were within spoligotype 
Clusters 
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Abstract 
 
The discriminatory power of Variable Number of Tandem Repeats (VNTR) typing based on 
16 known loci (12 MIRUs, 3 ETRs and VNTR 3232) was assessed for Mycobacterium bovis 
strains collected sequentially at the slaughterhouse of  N’Djaména, Chad. Of 67 M. bovis 
strains analysed, 67 % were clustered. In this study, VNTR typing was highly discriminative 
with an overall allelic diversity (ho.a) of 0.922.  We defined five loci (ETR A, B, C and MIRU 
26, 27) as highly (h > 0.25), two loci (MIRU 4, and VNTR 3232) as moderately (0.11 < h < 
0.25) and three loci (MIRU 16, 20, 31) as poorly (0.01 < h < 0.11) discriminative. Six loci 
(MIRU 2, 10, 23, 24, 39, and 40) showed no polymorphism at all. VNTR typing of the five 
highly discriminative loci (h = 0.917) proved to be most appropriate for first line typing of M. 
bovis strains of Chad and superior than spoligotyping (hsp. = 0.789). In contrast to M. 
tuberculosis strains, a consensus on VNTR loci needs to be found for M. bovis strains. The 
selection of a generally agreed set of VNTR loci for molecular discrimination of M. bovis in 
different geographical settings is discussed.  
Keywords: Mycobacterium bovis; VNTR typing; spoligotyping 
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Introduction 
Bovine tuberculosis is caused by a member of the Mycobacterium tuberculosis complex, 
Mycobacterium bovis. The disease has one of the broadest host ranges (O’Reilly and Daborn, 
1995) and leads to economic losses in livestock production and agriculture in many countries. 
In addition, M. bovis is a classical zoonosis and was the main reason for the heavy promotion 
of pasteurization in the early 20th century (Pritchard, 1988). Today, bovine tuberculosis 
affects mainly people in developing countries but its role in the human TB epidemic fostered 
by HIV/AIDS is not known (Cosivi et al., 1998). This is mainly due to the lack or inabilities 
of laboratories in developing countries to isolate and diagnose M. bovis. In addition, only few 
epidemiological studies aiming at identifying the proportion of M. bovis infection among 
tuberculosis patients have been conducted in developing countries (Cosivi et al., 1995).  
The promotion of prevention of transmission of M. bovis is often hampered by the lack of 
epidemiological data. With the recent description of molecular epidemiological tools, the 
possibilities for finding answers to key questions like the importance and risk factors of inter-
bovine transmission and the role of wild animals as reservoirs are improved.  
Insertion sequence 6110 restriction fragment length polymorphism (IS6110 RFLP) analysis is 
the current “gold standard” and the most widely applied typing method for molecular 
epidemiology of the M. tuberculosis complex (van Soolingen, 2001). However, this typing 
method has important drawbacks as the method requires previous extensive strain cultivation 
is technically demanding and expensive and results are difficult to compare between 
laboratories because comparison of profiles requires sophisticated software for image analysis 
and well trained users. Furthermore, the discrimination of strains with a low number of 
IS6110 copies is insufficient, and this is especially true for M. bovis strains (Serraino et al., 
1999 and Kremer et al., 1999).  
The spoligotyping (“spacer oligonucleotide typing”) method describes the presence or 
absence of 43 spacer DNA sequences between direct repeats (DR) in the DR region of 
tuberculosis complex (TBC) strains. This well established PCR-based method does not 
require extensive culturing is more discriminative than RFLP for strains with no or few 
copies of IS6110 and classifies the members of M. tuberculosis complex with a high level of 
confidence (Kamerbeek et al., 1997).  
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The variable number tandem repeat (VNTR) typing is a recently developed PCR-based 
method without requiring large quantities of DNA. Sequences including exact tandem repeats 
(ETR) (Frothingham and Meeker-O’Connell, 1998), mycobacterial interspersed repetitive 
units (MIRUs) (Supply et al., 2000 and Mazars et al., 2001) and two sets of Queen's 
University Belfast (QUB) VNTRs (Roring et al., 2002 and Skuce et al., 2002) were presented. 
The two main advantages of VNTR typing are: (i) the good stability of markers, and (ii) 
results are easily comparable between laboratories (digital expression of results). VNTR 
typing is highly discriminative for M. tuberculosis and has also the potential to be the method 
of choice for M. bovis typing. However, it is not yet standardized and allelic diversity of loci 
can vary from country to country and between M. tuberculosis complex species.  
In this study, different VNTRs were used on a panel of 67 M. bovis strains isolated from 2000 
to 2002 in Chad (Diguimbaye, unpublished data). The objective was to asses the 
discriminatory power of each polymorphic locus and in combination with others to evaluate 
the most appropriate combination of VNTRs for molecular-epidemiological studies of M. 
bovis in Chad.  
Materials and methods 
Bacterial strains and spoligotyping 
Sixty-seven M. bovis strains were isolated from the continuously collected samples from the 
slaughterhouse in N’Djaména, Chad. Tuberculous lesions of carcasses and organs were from 
two different zebu (Bos indicus) cattle breeds: Arab and Mbororo. Strains (8, 6 and 53) were 
isolated in 2000, 2001 and 2002, respectively. All 67 strains were characterized by 
spoligotyping (Kamerbeek et al., 1997).  
VNTR–PCR analysis 
The reaction mixture for all loci contained 1× Taq PCR buffer, deoxynucleoside triphosphates 
(0.2 mM each), 1 U of AmpliTaq Gold DNA polymerase (Perkin-Elmer Applied 
Biosystems), a 0.5 µM concentration of the primer pairs and mycobacterial DNA in a final 
volume of 20 µl. 12 MIRU, 3 ETR and VNTR 3232 primer pairs were used (Cowan et al., 
2002 and FMO’Connell, 1998’Connell, 1998; Roring et al., 2002).  
The reaction was carried out with a Perkin-Elmer 9600 cycler starting at a denaturing step of 
10 min at 95 °C. After denaturation, the PCR was performed for 40 cycles of 0.5 min at 
94 °C, 0.5 min at 65 °C and 1 min at 72 °C. The reactions were terminated by an incubation 
of 10 min at 72 °C. PCR fragments were analyzed by agarose (Sigma) gel electrophoresis 
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using 2% NuSieve agarose. The size of the amplicons was estimated by comparison with Size 
Marker VIII (Roche Diagnostics).  
Allelic diversity 
The allelic diversities (h) of VNTRs, individually and in combination were calculated using 
the following equation: , where n is the number of isolates and xi the 
frequency of the ith allele at the locus (Selander et al., 1986). We considered h > 0.25 as 
highly, 0.11 < h < 0.25 as moderately and 0.01 < h < 0.11 as poorly discriminative.  
 
Results 
PCR products of 16 published loci (12 MIRUs, 3 ETRs and VNTR 3232) of all 67 M. bovis 
strains isolated were analyzed by agarose gel electrophoresis and repeated copy numbers 
were determined (not shown). Allelic diversities (h) differed greatly for individual loci and 
ranged from 0.00 (MIRU 2, 10, 23, 24, 39 and 40) to 0.74 (ETR B). Five loci (ETR A, B, C 
and MIRU 26, 27) were highly (h > 0.25), two loci (MIRU 4, and VNTR 3232) moderately 
(0.11 < h < 0.25) and three loci (MIRU 16, 20, 31) poorly (0.01 < h < 0.11) discriminative 
(Table 1). These allelic diversities were compared to a M. bovis study from Northern Ireland 
and to studies on M. tuberculosis complex strains from USA, France and South Africa (Table 
2).  
 Based on all VNTRs, a total clustering rate of 67.2% and 33 different types (h = 0.922) were 
identified whereof 22 unique and 11 clustered. Clusters ranged from 2 (n = 6) to 12 (n = 1) 
identical strains (Table 3, set no. 4). The 12 MIRUs (Table 3, set no. 1) identified 18 different 
types (h = 0.754) and regrouped a large cluster of 30 strains.  
With solely 3 ETRs (A, B, C) we received 22 types (h = 0.906, set no. 2) thus this set was 
already more distinctive than MIRUs or spoligotyping. Spoligotyping alone resulted in 16 
types (h = 0.789, set no. 5) but increased the power of discrimination (h = 0.944, set no. 6) 
when compared to VNTRs alone (h = 0.922, set no 4).  
By adding the highly discriminative loci MIRU 26, 27 we obtained 28 different types 
(h = 0.917, set no. 3), which we consider to be distinctive enough for initial molecular 
epidemiological studies.  
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Discussion 
Despite the publication of different typing methods for M. bovis strains (IS6110, VNTR and 
spoligotyping) the best methods for the discrimination of M. bovis remains to be defined. We 
did not apply IS6110 in our study because its discriminatory power for M. bovis strains is too 
low (Serraino et al., 1999 and Kremer et al., 1999; Diguimbaye, unpublished data). With the 
expectation that 12 MIRU loci and spoligotyping would reasonably differentiate M. bovis 
strains, we applied these two methods in a first step. However, this did not result in a 
satisfying result (high clustering proportion of 84%). Therefore, the usefulness of 3 ETRs (A, 
B and C) and the VNTR locus 3232 were further investigated. The 3 ETRs showed to be the 
most discriminative VNTR loci.  
A study on 47 M. bovis strains from Northern Ireland (Roring et al., 2004) found six highly 
(h > 0.25) discriminative loci of which in our study 3 (ETR A, B and MIRU 26) and 1 
(VNTR 3232) were highly and moderately discriminative, respectively. Two loci (MIRU 24, 
40) did not show any polymorphism at all in our study. Aiming at standardization, ETR A, B, 
MIRU 26 and VNTR 3232 are appropriate to use within both settings when comparing only 
these two studies.  
Analyses of the 12 MIRU loci on M. tuberculosis shows that M. tuberculosis is more 
polymorphic than M. bovis. Published MIRU data on M. tuberculosis from France (Mazars et 
al., 2001) South Africa (Savine et al., 2002) and USA (Cowan et al., 2002) showed higher 
allelic diversities in all loci except MIRU 27 and MIRU 24 than in our and the Northern 
Ireland study. Therefore, typing of M. tuberculosis is easier and evaluation of best typing 
method for M. bovis needs to be established independently.  
In view of the definition of an agreed set that will be discriminatory enough for M. bovis in all 
geographical settings, we conclude that it is important to carry out more studies with all 
VNTRs. Ideally, such a set will necessitate few loci (i.e. <10) to ensure a cheap and non-
laborious typing of M. bovis strains.  
For the Chadian strains, we suggest to add the most discriminative MIRU loci 26, 27 to ETR 
A, B, C for first line typing. In contrast to IS6110 and spoligotyping, we consider the PCR 
amplification of these five loci and subsequent agarose gel separation for visualization of the 
heterogeneity as most appropriate. This approach is also manageable, reproducible and cost-
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effective for a laboratory in the South. However, for in-depth studies we recommend not only 
to use all polymorphic loci (ETR A, B, C; MIRU 4, 16, 20, 26, 27, 31; and VNTR 3232) but 
also spoligotyping because this ensures the highest power of discrimination.  
The results of this study are used within a molecular epidemiology study aiming at 
identifying risk factors for recent transmission of M. bovis. Results will also clarify the trade 
and trans-border translocations of cattle between Cameroon and Chad. In both countries, M. 
bovis strains lacking DR spacer 30 have been found (Diguimbaye, unpublished data; 
Njanpop-Lafourcade et al., 2001). Improved discrimination of strains is needed for better 
tracing back of animals. Furthermore, VNTR typing ensures a good quality control for 
laboratory cross-contaminations of M. bovis cultures especially useful for laboratories with 
infrastructural restraints.  
In conclusion, this work illustrates the necessity of defining the appropriate combination of 
heterogenic loci for each country and M. tuberculosis complex panel studied and therefore 
advises caution in comparing results of different studies. Furthermore, a first line and in-depth 
panel of heterogenic loci is suggested for M. bovis typing in Chad. Once more studies from 
other settings are available, a set of most discriminatory VNTRs could be agreed on for M. 
bovis strains.  
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Table 1: Determination of heterogeneity at each locus. 
 
Locus no. at MIRU Locus no. at ETR 
Locus 
no. at  
3232 a 
No. of 
copies 
2a 4 b 10 16 20 23 24 26 27 31 c 39 40 A B C  
0 - - - - - - - - - - - - - - - - 
1 - 4 - - 1 - - 2 7 - - - - - - - 
2 66 1 67 3 66 - 67 1 11 2 67 67 1 - - - 
3 - 60 - 63 - - - 2 49 64 - - 7 12 6 - 
4 - 2 - 1 - 67 - 2 - 1 - - 48 3 14 - 
5 - - - - - - - 55 - - - - 7 25 41 - 
6 - - - - - - - 5 - - - - 1 16 5 - 
7 - - - - - - - - - - - - 3 3 1 3 
8 - - - - - - - - - - - - - 7 - 60 
9 - - - - - - - - - - - - - - - 2 
10 - - - - - - - - - - - - - - - - 
12 - - - - - - - - - - - - - 1 - - 
16 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
1 
 
Allelic 
diversity d 0.00 0.18 0.00 0.10 0.02 0.00 0.00 0.30 0.41 0.07 0.00 0.00 0.45 0.74 0.55 0.16 
 
a Locus MIRU 2 and 3232 did not amplify in one sample. 
MIRU 4 (b) and MIRU 31 (c) correspond to ETR D and ETR E as defined by other studies. 
d Allelic diversity (h) at a locus was calculated as follows: h = 1 – Σ xi2[n/(n-1)], where xi is 
the frequency of the ith allele at the locus and n is the number of isolates. 
 
Table 2: Allelic diversities of different loci from M. bovis from Northern Ireland and 
Chad (our study) and M. tuberculosis from S. Africa, USA and France.  
Allelic diversity in MIRU locus Locus no.  
at ETR 
 
2 4 a 10 16 20 23 24 26 27 31 b 39 40 A B C 
Locus 
no. at  
3232 
67 M. bovis 
Chad 0.00 0.18 0.00 0.10 0.02 0.00 0.00 0.30 0.41 0.07 0.00 0.00 0.45 0.74 0.55 0.16 
47 M. bovis  
 N. Ireland 0.00 0.00 0.00 0.02 0.00 0.00 0.37 0.52 0.00 0.00 0.06 0.27 0.40 0.37 0.00 0.60 
180 M.tbc  
USA 0.08 0.22 0.44 0.42 0.09 0.12 0.16 0.54 0.09 0.47 0.22 0.63 - - - - 
209 M. tb       
S. Africa 0.14 0.26 0.70 0.28 0.06 0.54 0.00 0.59 0.14 0.55 0.36 0.65 - - - - 
72 M. tb  
France 0.02 0.35 0.69 0.52 0.29 0.58 0.24 0.67 0.19 0.37 0.34 0.74 - - - - 
 
MIRU 4 (a) and MIRU 31 (b) correspond to ETR D and ETR E as defined by other studies. 
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Table 3: Determination of allelic diversities of different heterogeneity loci.  
Discrimination profile of M. bovis strains (ntot = 67) 
Cluster no. with size Set No. 
VNTR loci 
combination 
Allelic 
diversity unique 
no. 2 3 4 5 6 7 11 12 13 26 30 
1 MIRUs 0.754 11 3 1 - - 1 - 1 - - - 1 
2 ETR A,B,C 0.906 9 5 4 - - 1 1 1 1 - - - 
3 ETR A,B,C & MIRU 26, 27 0.917 15 7 2 1 1 - - 1 1 - - - 
4 All VNTRs 0.922 22 6 2 1 - - - 1 1 - - - 
5 Spoligotyping 0.789 7 4 2 - - - 1 - - 1 1 - 
6 All combined 0.944 27 5 3 1 - 1 - 1 - - - - 
 
Allelic diversity (h) for each combination was calculated as follows: h = 1 – Σ xi2[n/(n-1)], 
where xi is the frequency of the ith allele for the combination of VNTRs ( Set no. 1 to 6) and 
n is the number of isolates. 
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Abstract 
By using microarray-based comparative genomics, large genomic deletions define 63 and 4 
M. bovis isolates from Chad as 2 different clones, respectively. The implications for the 
molecular epidemiology and the choice of antigens used in a diagnostic mix for M. 
tuberculosis complex are discussed. 
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Microarry based comparative analysis of members of the Mycobacterium tuberculosis 
complex has defined a set of chromosomal deletions which mark all descendants of an 
ancestral strain (1,8,9,12,14,19). This has allowed ‘diagnostic’ deletions to be identified that 
allow an isolate to be unequivocally placed in a strain family. The value of genomic deletions 
for finding large family groups has been found to be superior to all other genotyping methods 
(e.g. Spoligotyping) (6). Additionally, knowledge of the genome organization across M. 
tuberculosis strains allows us to inform the choice of antigens used in a diagnostic mix. 
Based on previous molecular typing data that allowed us to define phylogenetic extremes (3), 
the genomic DNA of 4 M. bovis strains from Chad with the most divergent spoligotypes 
(Table 1) were applied to an M. tuberculosis amplicon-array and fluorescence scanned with 
an Affymetrix 428 scanner as described (5). Data were analysed using GeneSpring 5.0 
(Silicon Genetics, Redwood City,CA) and Mathematica (Wolfram Research). A cut-off for 
the normalised test/control ratio of <2.0 was used and results were compared to the control to 
create gene deletion lists.  
Clone 1 
For two M. bovis strains with spoligotypes 1 and 6 (Table 1), lacking spacer 30, microarray 
analysis revealed one large genomic deletion, which is described for the first time in this 
study. Subsequently, primers for amplification of the flanking regions of the deletion were 
designed (664100 5’ actggaccggcaacgacctgg and 669951-5’cgggtgaccgtgaactgcgac). By 
performing PCR reactions as described (1) for all 67 M. bovis strains from Chad and 15 
strains from Nigeria (2) and following gel electrophoresis, the size of the amplicons could be 
estimated by comparison with Size Marker VIII (Roche). PCR products of the two strains 
analysed by microarray were sequenced with an ABI Prism 310 Genetic Analysis System.  
Sequence characterization revealed a deletion of 5320 bp (664281-669600 bp), removing 
Rv572c-574c and parts of Rv571c and Rv575c.  The flanking regions of the deletion showed 
no similarity to insertion sequences and occurred in a non variable region. The sequences of 
the junction regions were exactly the same for the two strains analyzed. 
63/67 and all the Nigerian strains lacked this deletion while this region wasn’t deleted for 
4/67 M. bovis strains from Chad which lacked spacer 22-24. From this analysis and from the 
fact that the population structure of M. bovis is strictly clonal (1), we conclude that most 
(63/67) of the Chadian and all of the Nigerian M. bovis strains belong to the same clone and 
therefore must have derived from a single, common cell in the past (18). Additionally, we 
assume that also the M. bovis strains from Cameroon belong to this family as they also all 
lack spacer 30 although we didn’t check these strains for the deletion.  The reasons why there 
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is so little heterogeneity within strains of these countries can be many. For M. tuberculosis the 
finding that one strain is causing most of the disease cases in a population would confirm the 
suspicion of an outbreak and imply a failure to stop transmission (10). Indeed control 
programs e.g. vaccination campaigns of test and slaughter policies to stop recent transmission 
are basically inexistent in Chad, Cameroon and Nigeria. However, the existence of 
homogeneity of these strains can also mean that there is little competition of other strain 
families or that this particular strain family is especially good adapted to host and/or the 
environment. In a recent study was shown, that Mbororo are more susceptible to the Chadian 
strains than the Arabe breed (3).  
The fact that most of the Chadian and Nigerian strains belong to one cluster raises important 
implications for molecular epidemiological studies. Standard molecular typing tools may not 
be discriminative enough to distinguish between epidemiologically unlinked strains. In a 
recent study, a minimum of 5 VNTR loci was defined resulting in a sufficient discriminatory 
power (7). However, spoligotyping of strains of Nigeria, Cameroon and Chad showed the 
same genotypes for some of the strains. Although we know that the pastoralists in this area 
migrate long distances we think that it is more likely that most of these strains have no direct 
epidemiological link. If we exclude convergent evolution, we think a clonal expansion 
scenario of some subclones as shown in a recent study from the UK (18), is most likely. 
However, we cannot draw any conclusion which country is the origin and which is the 
direction of expansion. 
Clone 2 
While it is known for M. bovis to have lost the ESAT-6 family proteins esxOP (RD 5) and 
esxVW (RD 8) (Table 1) 2/4 of our M. bovis strains analyzed by comparative genomics had 
additionally the deletions of Rv3019c/Rv3020c (esxSR) and Rv3890/3891 (esxCD). We 
confirmed this finding by DNA sequencing and revealed deletions of 2439 bp (esxSR) and 
8077 bp (esxCD) compared to H37Rv. Subsequent PCR reactions on all 67 strains isolated in 
Chad showed the presence of these deletions in 4 strains.  
ESAT-6 family proteins are encoded by 23 genes (esxA-W) and are promising targets for new 
diagnostics and novel vaccine candidates. The hallmark members of this family, esxA (ESAT-
6) and esxB (CFP-10) are absent from M. bovis BCG (due to the RD1 deletion) and have 
therefore been extensively studied for their role in virulence and for their diagnostic utility 
(6,16). Additionally, proteins encoded by esxH (TB10.4) and its homologues esxR (TB10.3) 
and esxQ (TB12.9) are strongly recognized T-cell antigens in humans and animals (17). 
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However, when choosing vaccine or diagnostic candidates it is important to survey clinical 
isolates for variation in these targets. Deletion of esxSR has been previously described in M. 
tuberculosis strains from France (EMBL accession AJ583832) (11) and the UK (15) and in 
M. microti (EMBL accession AJ550619) (5). To our surprise, using the primers as described 
(5), sequencing revealed that the deletion of esxSR in our M. bovis strains from Chad had 
occurred at exactly the same position to that previously reported for M. tuberculosis and M. 
microti, suggesting that this locus is prone to deletion events due to the highly repetitive 
PE/PPE gene sequences that flank the region. However, we also uncovered a deletion of 
esxCD which isn’t the first time found to be deleted too. However, the position of the deletion 
characterized in our study doesn’t equal the one found (13). Adding these new deletions to 
previous findings (Table 1) shows the high variability of ESAT-6 family members in the M. 
tuberculosis complex.   
In the study of Gao et al (4), transcriptome analysis across 10 clinical isolates of M. 
tuberculosis revealed that esx genes vary in their expression levels between strains. The 
deletion and variable expression of genes encoding ESAT members suggests that they may be 
under strong selective pressures linked to immune escape.  Hence while ESAT family 
members are potent antigens, genome analysis has revealed that their encoding genes are 
frequently deleted, suggesting caution in their use as stand-alone diagnostic reagents. 
Knowledge of the genome organization across M. tuberculosis strains therefore allows us to 
inform the choice of antigens used in a diagnostic mix. 
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Table 1: Spoligotypes of chosen M. bovis strains for microarray analysis 
 
 
Table 2: ESAT-6 family variation in MTC members 
 
 Gene name 
mRNA  
expression (M. 
tuberculosis) 
Deletion detected  MTC species occurrence of 
variation (Reference) 
Rv0287 esxG (TB 9.8) consistently  ND  
Rv0288 esxH (CFP-7,  TB 10.4) variable   ND  
Rv1037c esxI variable   ND  
Rv1038c esxJ variable   ND  
Rv1197 esxK variable   ND  
RV1198 esxL unknown ND  
Rv1792 esxM consistently  ND  
Rv1793 esxN variable   ND  
Rv2346c esxO variable   truncation (RD5) M. bovis, M. microti (vole) 
Rv2347c esxP variable   deletion (RD5) M. bovis, M. microti (vole) 
Rv3017c esxQ (TB 12.9) unexpressed ND  
Rv3019c esxR (TB 10.3) low   deletion (MiD4) 
M. microti (5) 
M. bovis (this study)  
M. tuberculosis (11,15) 
Rv3020c esxS low   deletion (MiD4) 
M. microti (5)  
M. bovis (this study) 
M. tuberculosis (11,15) 
Rv3444c esxT unexpressed ND  
Rv3445 esxU unknown ND  
Rv3619c esxV consistently  deletion (RD8) M. microti, M. bovis (1) 
Rv3620c esxW variable   deletion (RD8) M. microti, M. bovis (1) 
Rv3874 esxB (CFP-10) variable   deletion (RD1mic) deletion (RD1) 
M. microti (5) 
M. bovis BCG (1) 
Rv3875 esxA (ESAT-6) variable   deletion (RD1mic) deletion (RD1) 
M. microti (5) 
M. bovis BCG (1) 
Rv3890c esxC low   
deletion 
deletion 
truncation 
M. bovis (13) 
M. bovis (this study) 
M. tuberculosis (19) 
Rv3891c esxD variable   deletion M. bovis (13) M. bovis (this study) 
Rv3904c esxE unknown ND  
Rv3905c esxF low   ND  
  
ND: None detected at sensitivity of array used 
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Abstract 
Molecular typing methods applied so far for Mycobacterium ulcerans isolates have not been 
able to identify genetic differences among isolates from Africa. This apparent lack of genetic 
diversity among M. ulcerans isolates is indicative for a clonal population structure. We 
analysed the genetic diversity of 71 African isolates, including 57 strains from Ghana, by 
variable number of tandem repeats (VNTR) typing based on a newly identified polymorphic 
locus designated ST1 and the previously described locus, MIRU 1. Three different genotypes 
were found in Ghana, demonstrating for the first time genetic diversity of M. ulcerans in an 
African country. While the ST1/MIRU 1 allele combination BD/BAA seems to dominate in 
Africa, it was only rarely found in isolates from Ghana, where the combination BD/B was 
dominating and observed in all districts analysed. A third variant genotype (C/BAA) was 
found only in the Amansie-West district. Results are indicative for the emergence and 
spreading of new genetic variants of M. ulcerans within Ghana and support the potential of 
VNTR-based typing for genotyping of M. ulcerans.  
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Introduction 
Mycobacterium ulcerans, the causative agent of Buruli ulcer (BU) is an emerging pathogen 
particularly in Sub-Saharan African countries, and is also found in tropical and sub-tropical 
regions of Asia, the Western Pacific and Latin America (4). BU is characterized by chronic, 
necrotic lesions of subcutaneous tissues. Due to the lack of an established effective 
antimicrobial therapy, surgical excision and skin grafting is currently the recommended 
treatment (27).  
While it is known that proximity to slow flowing or stagnant water bodies is a risk factor for 
M. ulcerans infection, the exact mode of transmission has remained an enigma (4). This is 
partly because no molecular typing method is available that has sufficiently high resolution 
for micro-epidemiological analyses. The apparent lack of genetic diversity of M. ulcerans 
within individual geographical regions (7, 8, 16, 19-21) is indicative for a clonal population 
structure. Genetic analyses suggest the recent divergence of M. ulcerans from M. marinum (5, 
26), which is well known as fish pathogen and can cause limited granulomatous skin 
infections in humans (10, 11, 13). One of the hallmarks of the emergence of M. ulcerans as a 
more severe pathogen is the acquisition of a 174-kb plasmid bearing a cluster of genes 
necessary for the synthesis of the macrolide toxin mycolactone responsible for the massive 
tissue destruction seen in BU (22).  
Variable number of tandem repeat (VNTR) typing is a PCR-based technique identifying 
alleles of defined regions of DNA that contain a variable number of copies of short sequence 
stretches. Resolution of the method is cumulative and can be increased by inclusion of 
additional loci. Tandem repeats are easily identified from genome sequence data, 
measurement of PCR fragment sizes is relatively straightforward and VNTR typing data can 
be digitalized and compared between different laboratories. Availability of complete genomic 
sequences has facilitated identification of repetitive genetic elements of M. tuberculosis (12, 
15, 24, 25), M. bovis (14, 18) and M. avium (6), including short tandem repeats designated 
exact tandem repeats (ETRs) and mycobacterial interspersed repetitive units (MIRUs). Strain 
typing with these sets of polymorphic loci is developing into an important tool in the 
epidemiological analysis of tuberculosis (9) and ordinary agarose gel electrophoretic 
separation of PCR products is usually sufficient to estimate the number of repeat units in an 
allele. In a study of M. bovis strains from Chad, VNTR-typing of a distinct number of loci is 
most discriminative for strains of the same clone (14). 
More recently, MIRUs and other VNTRs have also been described for M. ulcerans and M. 
marinum (3, 23) typing. Most of the described sequences are orthologues of the M. 
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tuberculosis genome database and their resolution seems to be comparable to that of the 
currently most discriminatory methods, the 2426 PCR analysis (19) and IS2404-Mtb2 PCR 
(2) which discriminate among isolates from different geographical origin, but not among 
strains from different endemic regions of Africa.  
We describe in this report a new M. ulcerans specific VNTR locus (ST1) which together with 
the previously described MIRU 1 (23) differentiated clinical isolates from Ghana into three 
VNTR allele combinations.  
Methods  
Identification of the VNTR locus ST1: A tandem repeat finder software 
(http://www.c3.biomath.mssm.edu/trf.thml) was used to screen the M. marinum sequence 
data bank (www.sanger.ac.uk/projects/M_marinum) and identified a tandem repeat 
containing locus which was designated ST1. This locus is present both in M. marinum and in 
M. ulcerans (http://genopole.pasteur.fr/Mulc/BuruList.html), but not in M. tuberculosis 
(http://www.sanger.ac.uk/Projects/M_tuberculosis). A forward (ctgaggggatttcacgaccag) and a 
reverse primer (cgccacccgcggacacagtcg) located in the sequences flanking the identified locus 
and yielding a PCR product of 423 bp was designed. Genomic sequences corresponding to 
the primers were 100 % identical for M. marinum and M. ulcerans.  
Bacterial strains: A panel of 11 M. ulcerans clinical isolates of human origin from diverse 
geographical origin and of 6 M. marinum clinical isolates of human origin from Switzerland 
was used to assess the polymorphism of ST1 (Table 1). The M. marinum isolates were from 
patients living in the agglomeration of Zurich, except for M. marinum N119 that was isolated 
from a patient living in Biel. The year of isolation was 1995 for strains 853 and 894, 1997 for 
strains 8972 and 946 and 1998 for strains N119 and 3023. In order to analyse the diversity of 
African M. ulcerans strains, 66 additional clinical isolates (12 from Benin and 54 from 
Ghana) were included in this study. The Ghanaian strains were isolated (28) between 2001 
and 2003 from patients being treated at the Amasaman Health Centre in the Greater Accra 
Region of Ghana (48 isolates) or the Saint Martin Hospital Agroyesum in the Ashanti Region 
of Ghana (6 isolates). The residential origin of the isolates is as indicated in the supporting 
table. 
DNA Extraction: DNA was extracted as described (17). Briefly, small bacterial pellets were 
heated for 1 h at 95°C in 500 µl of an extraction mixture (50 mM Tris-HCl, 25 mM EDTA, 
and 5% monosodium glutamate). One hundred microliters of a 50-mg/ml lysozyme solution 
was then added and incubated for two hours at 37°C.  70 µl of proteinase K-10x buffer (100 
mM Tris-HCl, 50 mM EDTA, 5% sodium dodecyl sulphate [pH 7.8]) and 10 µl of a 20-
Chapter VII: Genetic diversity in Mycobacterium ulcerans isolates from Ghana 
__________________________________________________________________________________________ 
  
 73 
mg/ml proteinase K solution was added. After incubation at 45°C overnight, 300 µl of 0.1-
mm-diameter zirconia beads (BioSpec Products) were added to each sample and vortexed at 
full speed for 4 min. Beads and large debris were removed by brief centrifugation, and the 
supernatants were transferred to fresh tubes for phenol-chloroform (Fluka) extraction. The 
DNA contained in the upper phase was precipitated with ethanol and re-suspended in 100 µl 
of water. 
PCR analysis and sequencing of PCR products: PCR reaction mixtures contained 1x Taq 
PCR buffer, deoxynucleoside triphosphates (0.2 mM each), 1 U of AmpliTaq Gold DNA 
polymerase (Perkin-Elmer Applied Biosystems), a 0.5 µM concentration of the primer pair 
and mycobacterial DNA in a final volume of 20 µl. Addition of 5 % DMSO to the reaction 
mix improved the yield of PCR products. The reaction was carried out using a Perkin-Elmer 
9600 cycler starting with a denaturing step of 10 min at 95°C. After denaturation, the PCR 
was performed for 40 cycles of 0.5 min at 94°C, 0.5 min at 65°C and 1 min at 72°C. The 
reactions were terminated by an incubation of 10 min at 72°C. PCR fragments were analysed 
by agarose gel electrophoresis using 2% NuSieve agarose. The size of the amplicons was 
estimated by comparison with Size Marker VIII (Roche). PCR products were directly 
sequenced with an ABI Prism 310 Genetic Analysis System. PCR products for ST1 of 423 bp 
and 369 bp corresponded to a copy number of 2 and 1, respectively. For MIRU 1, copy 
numbers were assigned as described (23). 
 
Results 
Identification and characterization of a new VNTR locus found in M. ulcerans and M. 
marinum  
A new VNTR locus designated ST1, was identified by screening of the M. marinum sequence 
data bank with a tandem repeat finder software. Orthologues of ST1 were found in M. 
ulcerans, but not in M. tuberculosis. Its repeat length of 54 bp is suitable for size analysis by 
standard agarose gel electrophoresis. In contrast to MIRUs (23), ST1 is not intergenic, but 
part of a pseudogene and therefore of no known functional interest (personal communication). 
When eleven M. ulcerans isolates of geographically diverse origin were typed by agarose gel 
electrophoresis of PCR products, two different alleles of ST1 were identified (Table 1). While 
eight strains had two repeats, two isolates, one from French Guyana and one of the two 
analysed isolates from Ghana had only one repeat. Of seven M. marinum clinical isolates 
tested, all five strains from patients in the agglomeration of Zurich (strains 8972, 946, 3023, 
853 and 894) had three repeats, whereas strain N119 isolated from a different part of 
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Switzerland and the reference strain used for the M. marinum genome sequencing project, 
both had two repeats. Sequence analysis of PCR products reconfirmed the size differences 
observed by agarose gel electrophoresis and identified six sequence variants of the repeat unit 
(designated A – F; Fig 1). Unlike many other VNTRs (1), ST1 showed no micro-deletions, 
but only single nucleotide polymorphisms (SNPs) within the sequence variants. The M. 
ulcerans strains from China and Japan turned out to have a different allele (CF; Table 1) than 
the other M. ulcerans strains with two repeats (BD). A third allele with two repeats (AC) and 
an allele with three repeats (ACE) was found in M. marinum (Table 1). Thus sequencing of 
ST1 improved the discrimination power of M. ulcerans and M. marinum strains compared to 
gel electrophoresis analysis alone and revealed distinctive genotypes for M. marinum 
compared to M. ulcerans.  
 
Diversity of M. ulcerans isolates from Ghana 
Evidence for diversity of the ST1 locus in African isolates (Table 1) prompted us to analyse 
additional collections of 12 disease isolates from Benin and 54 isolates from Ghana (Table 2). 
All strains from Benin and the majority of Ghanaian strains had an ST1 allele (BD) with two 
repeats. However, in most strains from the Amansie West district (including ITM-970359; 
Table 1), a second allele with only one repeat (C) was identified (Table 2). When the 
Ghanaian isolates were tested also for diversity in the loci MIRU 1 (23), VNTR 8, 9 and 19, 
previously described as polymorphic within M. ulcerans strains of different geographical 
origin (3), diversity was also found in locus MIRU 1. Sequence analysis of PCR products of 
selected strains reconfirmed the size differences observed by agarose gel electrophoresis and 
identified two sequence variants of the MIRU 1 repeat unit (designated A and B; Fig 1).  
Altogether three VNTR allele combinations were found among the clinical isolates from 
Ghana (Table 2, Fig. 2 and 3). While all isolates from the Ga, Akwapim South, Ahafo-Ano 
North and Akim Abuakwa districts had the ST1/MIRU 1 allele combination 1 (BD/B), two 
allele combinations, i.e. 1 and 2 (C/BAA) were found among the five isolates from the 
Amansie-West district. A third allele combination (BD/BAA) was found in two strains 
(Agy99 from the Ga district and ITM 97-0359 from the Ashanti region) isolated before 2000 
in Ghana and in all other African isolates.  
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Discussion 
Molecular typing methods such as multi-locus sequence typing, 16S rRNA sequencing, 
restriction fragment length polymorphism and variable number of tandem repeats typing have 
revealed a remarkable lack of genetic diversity of M. ulcerans and a clonal population 
structure within given geographical regions. The discriminatory power of all these methods is 
particularly insufficient to differentiate between African isolates. Innovative molecular 
genetic fingerprinting methods are therefore required for local epidemiological studies aiming 
to reveal transmission pathways and environmental reservoirs of M. ulcerans. First attempts 
to use VNTR typing for M. ulcerans (3, 23) have identified variable loci suitable for 
discrimination of disease isolates at continental level. In this study we used a newly identified 
(ST1) and four previously described VNTRs to analyse genetic diversity within a collection 
of 71 M. ulcerans strains from Africa, including 57 isolates from Ghana. Three of the 
previously described VNTRs i.e. VNTR 8, 9 and 19 (3) were not able to discriminate among 
the African strains. Yet MIRU 1 (23) and the newly identified locus (ST1) defined three 
subgroups within the Ghanaian strains.  
The fact that two allele combinations (BD/B and C/BAA) differing from the common African 
combination (BD/BAA) were found within a recent (2001-2003) collection of Ghanaian 
isolates is indicative for an ongoing microevolution of M. ulcerans and for the spreading of 
new variants within Ghana. It is tempting to hypothesize that allele combination 3 (BD/BAA) 
represents an ancestral like genotype and that the others evolved by reduction in the repeat 
unit numbers in the ST1 locus (from BD to C) or in the MIRU 1 locus (from BAA to B), 
respectively. While conversion of the MIRU 1 locus from BAA to B could be explained by 
deletion of the two A repeat units, conversion of the ST1 locus from BD to C by a deletional 
mechanism would require that a central sequence stretch of the BD repeat region comprising 
portions of both the B and the D repeat unit would have been lost, yielding the hybrid repeat 
unit C. 
While allele combination 3 seems to be the most common in Africa, most of the M. ulcerans 
strains from Ghana analysed, had the allele combination 1. This genotype was found in all 
Ghanaian districts included in this study. Allele combination 2 dominated in the Amansie 
West district, but was found exclusively there. Follow up of the temporal and spatial patterns 
of emergence and spreading of genotypes may contribute in future to our understanding of the 
transmission and epidemiology of Buruli ulcer. From the present data, we cannot draw any 
conclusions why certain variant appear to be the more successful than others. The fact, that 
we were not able to sub-group the 47 isolates from the Ga district by VNTR (with the only 
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exception of the ‘older’ isolate Agy99) reconfirms that M. ulcerans has a clonal population 
structure associated with a low rate of genomic drift. Availability of the fully assembled and 
annotated genome sequence of M. ulcerans in the near future will facilitate identification of 
further polymorphic VNTR loci potentially contributing to further refinement of genetic 
fingerprinting of M. ulcerans isolates.  
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Table 1: ST1 alleles of M. ulcerans and M. marinum disease isolates 
Species Isolate 
Country of 
origin 
Number of 
repeats 
Arrangement of the variant 
repeat DNA sequences 
M. ulcerans 
 
ITM 8756 
ITM 980912 
ITM 941328 
ITM 884 
ITM 9357 
ITM 7922 
ITM 970359+ 
ITM 970321 
ITM 940886 
ITM 940662 
ITM 960658 
Japan 
China 
Malaysia 
Australia 
PNG 
French Guyana 
Ghana 
Ghana 
Benin 
Côte d'Ivoire 
Angola 
2 
2 
2 
2 
2 
1 
1 
2 
2 
2 
2 
C F 
C F 
B D 
B D 
B D 
C 
C 
B D 
B D 
B D 
B D 
M. marinum 
 
894/1995 
853/1995 
8972/1997 
946/1997 
3023/1998 
N119/1998 
M. marinum* 
Switzerland 
Switzerland 
Switzerland 
Switzerland 
Switzerland 
Switzerland 
unknown 
3 
3 
3 
3 
3 
2 
2 
A C E 
NOT DONE 
NOT DONE 
NOT DONE 
NOT DONE 
NOT DONE 
A C 
 
*isolate used for the M. marinum genome sequencing project 
+isolated in 1997 from a patient living in the Amansie West district 
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Table 2: ST1 and MIRU 1 allele combinations of M. ulcerans strains from Africa 
Country of 
origin 
District Number 
of strains 
ST1 allele MIRU 1 allele 
Allele 
combination 
Ga district 47 2 (BD) 1 (B) 1 
Ga district 1 2 (BD) 3 (BAA) 3 
Akwapim South 1 2 (BD) 1 (B) 1 
Akim Abuakwa 1 2 (BD) 1 (B) 1 
Ahafo-Ano  1 2 (BD) 1 (B) 1 
Amansie West  1 2 (BD) 1 (B) 1 
Amansie West  4 1 (C ) 3 (BAA) 2 
Ghana 
unknown○ 1 2 (BD) 3 (BAA) 3 
Benin  13 2 (BD) + 3* (BAA)+ 3 
Côte d'Ivoire  1 2 (BD) 3* 3 
Angola   1 2 (BD) 3* 3 
 
VNTR copy numbers for ST1 and MIRU 1 were determined and allele combinations assigned 
(1-3). Sequence profiles of M. ulcerans strains are shown in brackets. ○isolated at the Saint 
Martin’s hospital in the Ashanti region; * MIRU 1 copy numbers as previously described 
(23); +only one strain (ITM 94-0886) was analysed by sequencing (23). 
 
Allele ST1 repeat unit sequences 
A CCGGTTCTGTTTCGTCCGGTGCGACCGCTGGCACTGTCTCGACCGGTGCGACGA 
B .........................................G....C....... 
C .........................................G...........G 
D .......G...G.C...........................G...........G 
E -T.....G...G.C...........................G...........G 
F .......G...G.C....A......................G...........G 
 
Allele MIRU 1 repeat unit sequences 
A* ATGAGCCAGCCGGCGACGATGCAGAGCGAAGCGATGAGGAGGAGCGGCGCCAG   
B G...A..C..T.......................................... 
 
Figure 1: Sequence variation of ST1 and MIRU 1 tandem repeat units  
 (-): Base deletions; (.): identical sequence positions.  
*Allele A of MIRU 1 corresponds to variant A2 (23). 
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Figure 2: Map of southern Ghana showing the residential districts of patients from 
whom the Ghanaian isolates analysed in this study were obtained 
ST1/MIRU 1 allele combinations are genotype 1: BD/B, genotype 2: C/BAA and genotype 3: 
BD/BAA. 
 
 
 
Figure 3: Agarose gel electrophoretic analysis of PCR products from amplifications with 
MIRU 1 primers (upper Panel) and STI primers (lower panel) 
Results with selected isolates are shown. 1: strain (Amansie-West district); 2: strain 
(Amansie-West district); 3: strain (Ga district); 4: strain (Ga district); 5: strain (Ga district); 6: 
strain (Amansie-West district); 
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Abstract 
We analyzed a set of variable-number tandem-repeat (VNTR) loci to assess their nucleotide 
sequence diversity in isolates of three Mycobacterium ulcerans genotypes. Sequence variants 
in two loci resulted in intraspecies resolution of Southeast Asian and Asian genotypes in 
contrast to a homogenous sequence composition among African isolates. Nucleotide sequence 
polymorphism in repeat units can enhance discrimination of VNTR loci.  
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Mycobacterium ulcerans causes Buruli ulcer, a necrotizing skin disease in tropical and 
subtropical regions (4, 10). The epidemiology of Buruli ulcer is poorly understood, due in part 
to the highly restricted genetic diversity in M. ulcerans, especially among isolates with 
common geographic origins (1, 2, 5, 6, 11, 13, 14), and also to the difficulty in obtaining 
cultures from environmental specimens (1, 10).  
Tandem-repeat (TR) loci have enormous potential as highly evolving genomic regions 
suitable for typing species with low genetic diversity. Their use in molecular epidemiology 
studies have contributed significantly to the identification of sources of infection, a better 
understanding of disease transmission, and strain-trait correlations (8, 9, 12).  
To investigate the potential of TRs in providing highly discriminatory markers for studying 
molecular diversity in M. ulcerans, we demonstrated allele-length polymorphism associated 
with nine variable-number tandem-repeat (VNTR) loci. This allowed inter- and intraspecies 
differentiation in a representative collection of Mycobacterium marinum and M. ulcerans (2). 
Intraspecies discrimination in M. ulcerans was, however, limited among isolates within the 
same geographic region (2). Different isolates from Africa, Southeast Asia, or Asia could not 
be distinguished by allele-length analysis, after PCR amplification of nine VNTR loci. Such 
isolates were also not distinguished by multilocus sequence typing (15), mycobacterial 
interspersed repetitive unit-VNTR typing (16), and IS2404-restriction fragment length 
polymorphism typing (5).  
In this study, we carried out a comparative sequence analysis of the VNTR loci to further 
assess the contribution of nucleotide sequence polymorphism to allelic diversity in isolates 
belonging to the African, Southeast Asian and Asian M. ulcerans genotypes. The investigation 
involved sequence analysis of nine VNTR loci in three isolates (including sequence strain) 
belonging to the African genotype, and four loci (8, 9, 18, and 19) in isolates of the Asian and 
Southeast Asian type (Table 1). The African isolates were of Angolan, Beninese, and 
Ghanaian (sequence strain) origins. The Southeast Asian genotype comprises isolates of 
Australian, Papua New Guinean, and Malaysian origins, while isolates from Japan and China 
formed the Asian genotype. All M. ulcerans isolates were subcultured (from frozen stocks of 
the collection of the Institute of Tropical Medicine, Antwerp [ITM]) onto Löwenstein-Jensen 
medium and incubated at 32°C for 4 weeks. Isolates were further characterized 
phenotypically and tested for the presence of IS2404 and IS2606 insertion sequences as 
previously described (13, 18).  
TR loci were bioinformatically identified by applying the TR Finder algorithm on M. 
marinum genome sequences (available M. ulcerans genome sequences not accessible for TR 
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Finder analysis), which also generated a consensus pattern for each locus. Details of TR 
discovery, DNA extraction, PCR primers, and amplification conditions have been previously 
described (2). Purified PCR products were sequenced by using the ABI 310 genetic analysis 
system.  
For each locus, TR sequences of the different isolates were aligned and compared with the 
consensus pattern. All nine loci were found to consist of heterogeneous arrays of repeat units 
(variants) with deletions and/or nucleotide substitutions (Table 2). Locus 8 was the most 
conserved in both species, with no nucleotide deletion and two substitutions in sequence 
variants among all M. ulcerans isolates.  
For each locus, the individual repeat variants were assigned designations (Table 2). While 
some repeat variants were found exclusively either in M. ulcerans (e.g., G19, H19, or D18) or in 
M. marinum (e.g., A18 or B19), others variant occurred in both species (e.g., A8 or A9).  
Sequence profiles were generated at each locus for the isolates by combining these 
designations. Comparison of the sequence profiles (which defines an allele at a given locus) 
facilitates the identification of sequence types (Table 3).  
Among the African isolates, corresponding loci featured 100% TR sequence identity; 
consequently, intraspecies differentiation within this genotype was not possible. Among 
Southeast Asian isolates, nucleotide sequence homology was complete in all except for loci 9 
and 18, for which point mutations resulted in different allelic states. In locus 9, a single-
nucleotide deletion in a repeat variant in the Malaysian isolate (ITM 94-1328, with profile 
A9A9C9) differentiated it from the Australian isolate (ITM 94-1324) and Papua New Guinean 
isolate (ITM 94-1331), both with the A9A9D9 sequence profile. Each of the isolates, however, 
harboured a unique sequence variant at locus 18 (D18, C18, and E18, respectively, for isolates 
ITM 94-1328, ITM 94-1324, and ITM 94-1331), permitting the complete resolution of the 
Southeast Asia genotype. Locus 18 also resolved the Asian type into China and Japan 
genotypes (Table 3).  
Although polymorphism at TR loci can occur either as a result of variation in the number of 
repeat units (length polymorphism) or as a result of nucleotide sequence changes between 
individual repeat units (sequence polymorphism) (12), the practical ease and lower cost of 
analyzing length polymorphism (by agarose gel electrophoresis) over sequencing have 
promoted the use of the former approach for routine typing purposes. Few studies on sequence 
polymorphism in TR loci have yielded mixed results. While some studies have indicated 
incremental gain in strain discrimination when length polymorphism data were complemented 
with sequence analysis (3, 7), this has not been realized in others (9, 17).  
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In this study, we showed the occurrence of sequence polymorphism in two TR loci, which 
exhibit no length polymorphism among isolates of two M. ulcerans genotypes. A general 
trend of TR sequence conservation in isolates from the same geographic region was noticed. 
This was most pronounced among the African isolates, which displayed complete sequence 
homology across the nine VNTR loci. Consistent with previous data (1, 2, 5, 6, 11, 14-16), the 
lack of sequence variants in this investigation further emphasizes the clonal homogeneity and 
recent evolutionary origin and distribution of the African genotype (15).  
In contrast, sequence analysis revealed three Southeast Asian alleles and two alleles within 
the Asian genotype. Notably, the discrimination of these genotypes corroborates the data from 
IS2404-Mtb2 PCR (which differentiates between the isolates from China and Japan and also 
among the three Southeast Asian isolates) (1) and 2426 PCR (14), which discriminates among 
the Southeast Asian but not between the Asian isolates. Isolates of these two genotypes show 
limited differences in their repetitive-sequence-based PCR profiles. Differences in their 
VNTR sequence profiles therefore are significant in further highlighting differences among 
these isolates. A combination of the sequence and length polymorphism data results in a total 
of 11 M. ulcerans alleles compared to 8 indexed by length polymorphism analysis alone and 
10 alleles by IS2404-Mtb2 PCR on the same set of isolates. The conservation of TR loci in the 
two Mycobacterium species and with much sequence degeneration in M. ulcerans is 
consistent with the proposed origin of M. ulcerans from M. marinum through a reductive 
genome evolution (15).  
Sequence polymorphisms among M. ulcerans isolates involved single-nucleotide substitutions 
and microdeletions. For clonal organisms, and also across VNTR loci, such point mutations 
are often not considered major sources of genetic variation among isolates. However, data 
accruing from whole-genome sequence analyses of a number of organisms and also from 
sequence analysis of several genetic markers indicate that even in highly clonal species like 
Mycobacterium tuberculosis, Bacillus anthracis, and Yersinia pestis, many thousands of point 
mutations can be discovered when large portions of genomes are investigated (8). This theme 
is thus further reinforced by sequence data from this investigation. Complementation of 
sequence and length polymorphism data should potentially increase the discriminatory power 
of the VNTR-typing method. It is envisaged that this approach would be more useful for 
genotyping M. ulcerans and other highly monomorphic species.  
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Table 1: VNTR profiles of M. ulcerans and M. marinum 
VNTR Allelic Profile (by locus no.) Species Isolatesa Origin 1 4 6 8 9 14 15 18 19 
VNTR/MLST/IS2404           MIRUc-VNTR 
RFLPb Type                            Type 
M. ulcerans ITM 94-1324 Australia  1 2 1 3 3 1 1 1 2 South East Asian                   Asian 
 ITM 94-1328 Malaysia 1 2 1 3 3 1 1 1 2              South East Asian                   Asian 
 ITM 94-1331 Papua N.Guinea  1 2 1 3 3 1 1 1 2 South East Asian                   Asian 
 ITM 98-912 China 1 2 2 3 4 3 1 2 4              Asian                                     Asian 
 ITM 8756 Japan 1 2 2 3 4 3 1 2 4 Asian                                     Asian 
 ITM 97-658 Angola 1 1 1 3 2 1 1 1 2 African                                  African 
 ITM 97-104 Benin 1 1 1 3 2 1 1 1 2 African                                  African 
 Seq.strain Ghana 1 1 1 3 2 1 1 1 2 African                                  African 
 ITM 842 Surinam 2 1 1 1 2 2 2 1 3   
M.marinum Seq. strain  5 4 5 2 3 4 3 2 9             
 
a
 The profile of the Surinam type was included to indicate polymorphism, at loci 1, 8, and 15. ITM, Institute of Tropical Medicine.  
b
 MLST, multilocus sequence typing (15); RFLP, restriction fragment length polymorphism (5).  
c
 MIRU, mycobacterial interspersed repetitive unit (16).  
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Table 2: Multiple sequence alignment of repeat unita 
Locus  Sequence           Variant     Species 
           Occurring 
1  ATCGCCCGACTCCTCCTCCGGCCTCACCGGCCGGTATCGTCGCCGCGCACCACCCCA   A1  MM 
..................................C.............---------   B1  MU 
..................................C......................   C1  MM 
..........................T..............................   D1 MM 
..........................T.....................---------   E1 MM 
 
4  GGTCGCCTCGCTCCCATCACTCGCCAAGCTCGCTCTGCTCGCTCGGCTCCCAAACCCAACA  A4 MM 
..........................C..................................  B4 MM 
....................................................GG.....--  C4 MU 
....................................................GG.......  D4 MM 
....................................................---------  E4  MM 
 
6  GTGGTGGTCGCGAAACCGGCGAAGCCGGGCGAAGCGGGCCACCACCGACAAGCCCC   A6 MM 
........................................----------------   B6 MM 
..........T.............................----------------   C6 MU 
----------------.......................................   D6 MM 
 
8  AGTGGTGACCGCCAGCGCGGCGGGGAGCCGGGCGCAGCGGGTCGCCACCATCAAATCC  A8 MM/MU 
................A.........................................  B8 MU 
......................A...................................  C8 MU 
 
9  GTGGCGATCGCAAGCGCGGCCCAGCCGGGGGCAGCGGGTCGCCACCAAGGTGGCGGC   A9 MM/MU 
.........................................---------------   B9 MM 
..........T....T.............---------.T....-------------   C9 MU 
..........T....T.............---------.T....-------------   D9 MU 
..........G.....T........................................   E9 MU 
.G........T....T.............---------......-------------   F9 MU 
 
14  GCCCTCGGTCGCGACCCGCCGCGCCCGGCTCCGCCGCGCTCGCGATCGCTCCAC   A14 MM 
...................................A..................   B24 MM 
...........................---------------------------   C14 MM 
.A.........................---------------------------   D14 MU 
 
15  AGCCGGCTCCGCTCAGCCGGCTCCGGCTCAATTCGCCGACTTCGCTCGCCGGCC   A15  MM 
......................--------------------------------   B15  MM 
..A...................--------------------------------   C15 MU 
 
18  CCGGTTCCCCCGGTATCACCAGTACCGCTCCCCGTACCACCCGTATCACCGGTACCGCCGCTC  A18 MM 
...T.G...............................................C.........  B18 MU 
..TT.G............CGGCACC......................TGGC..C.........  C18  MU 
.GT.AC...........CGGCAC........................TGGC.ATGGTGGTG..  D18 MU 
.GTT.G.........................................TGGC.ATGGT-G....  E18 MU 
.G..GA.......GG..C.GG..A........GTG.......C....CTG...CTG.TG.TGA  F18 MU 
.G..GA...........C.GG..C.G.....GGTG.......C....CTG...C.G.TG....  G18 MU 
...TAG....C.TGG.G.TA..GG...A.....A....GAA.CGG.G.....G..G.---..T  H18 MU 
...T.G....A.TGG.G.T...G....A.....A....GAA.CGG.G.....G..G.---..T  I18  MU 
 
19  GGGGATCGCAAGCCCGGCGACGCCGGGCGCCGCGGGTCACCACCAACAATTCCCGC   A19 MM 
................................................G.......   B19 MM 
.......................................................T   C19 MM 
.............................................T...C......   D19 MM 
......................................G......GA..-------   E19 MM 
...............................A......G......T...C......   F19 MU 
---------------------------------.....G......T...C......   G19 MU 
---------------------------------.....G......-----------   H19 MU 
.........GC....................A.................G......   I19  MU 
.................................................C......   J19 MU 
......................................G......-----------   K19 MU 
 
a
 -, base deletion; ., identical nucleotide position; MM, M. marinum; MU, M. ulcerans. 
 
 
 
 
 
 
  
Table 3: Sequence profiles of M. ulcerans isolates and the M. marinum sequence strain 
      
 Sequence profile  Sequence profile  Sequence profile 
Locus 1  Locus 4  Locus 6  
      
M. marinum(Seq. Strain) A1 C1 C1 D1 E1 M. marinum(Seq. Strain) A4 B4 D4 E4 M. marinum(Seq. Strain) A6 A6 A6 B6 D6 
M. ulcerans (Seq. Strain) B1 M. ulcerans (Seq. Strain) C4 M. ulcerans (Seq. Strain) C6 
ITM 96-658 B1 ITM 96-658 C4 ITM 96-658 C6 
ITM 97-104 B1 ITM 97-104 C4 ITM 97-104 C6 
      
      
Locus 8  Locus 9  Locus 14  
      
M. marinum(Seq. Strain) A8 A8 M. marinum(Seq. Strain) A9 A9 B9 M. marinum(Seq. Strain) A14 A14 B14 C14 
M. ulcerans (Seq. Strain) A8 A8 B8 M. ulcerans (Seq. Strain) A9 C9 M. ulcerans (Seq. Strain) D14 
ITM 96-658 A8 A8 B8 ITM 96-658 A9 C9 ITM 96-658 D14 
ITM 97-104 A8 A8 B8 ITM 97-104 A9 C9 ITM 97-104 D14 
ITM 1324 A8 A8 B8 ITM 1324 A9 A9 D9   
ITM 1328 A8 A8 B8 ITM 1328 A9 A9 C9   
ITM 1331 A8 A8 B8 ITM 1331 A9 A9 D9   
ITM 8756 A8 C8 C8 ITM 8756 A9 A9 E9 F9   
ITM 98-912 A8 C8 C8 ITM 98-912 A9 A9 E9 F9   
      
      
Locus 15  Locus 18  Locus 19  
      
M. marinum(Seq. Strain) A15 A15 B15 M. marinum(Seq. Strain) A18  A18 M. marinum(Seq. Strain) A19 B19 B19 B19 C19 C19 D19 E19 
M. ulcerans (Seq. Strain) C15  M. ulcerans (Seq. Strain) B18 M. ulcerans (Seq. Strain) F19 G19 H19 
ITM 96-658 C15  ITM 96-658 B18 ITM 96-658 F19 G19 H19 
ITM 97-104 C15  ITM 97-104 B18 ITM 97-104 F19 G19 H19 
  ITM 1324 C18 ITM 1324 F19 H19 
  ITM 1328 D18 ITM 1328 F19 H19 
  ITM 1331 E18 ITM 1331 F19 H19 
  ITM 8756 F18 H18 ITM 8756 F19 I19J19 K19  
  ITM 98-912 G18 I18 ITM 98-912 F19 I19J19 K19  
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9.1 Abstract 
The aim of this section is to review the studies whose evaluations of the discriminatory power 
of the three popular typing methods for M. tuberculosis complex (MTC) strains reach the 
conclusions that IS6110 RFLP has a higher discriminatory power than MIRU-VNTR which 
itself is more discriminative than spoligotyping. In contrast, we additionally show that 
spoligotyping can be more discriminative than MIRU-VNTR typing, depending on the 
geographical location and genotype family chosen. Furthermore, we review that these 
genotyping tools are stable enough over time thus justifying their usage although possible 
convergent evolution and little heterogeneity may require the use of several different and 
appropriate genotyping tools to exclude biases. This is particularly recommended in high 
incidence countries where heterogeneity within strains is low and convergent evolution more 
probable. 
We also review the importance of factors such as the awareness of reinfection versus relapse 
and mixed infections versus microevolution of a single strain to human tuberculosis control, 
especially in high incidence, African countries. Furthermore, knowledge about the degree and 
risk factors of ongoing tuberculosis transmission could reveal new target groups and result in 
suggesting an improved Direct Observed Treatment Short course (DOTS). However, adapting 
DOTS to distinct population groups cannot be suggested without knowing the variability of 
locally perceived tuberculosis. Therefore the linking of social science with molecular 
epidemiological studies is suggested. 
The same molecular epidemiological methods prove additionally useful in investigating MTC 
transmission within or between different animal species. In the case of M. bovis, some 
animals were reviewed to act as maintenance and spillover hosts, respectively. The 
knowledge of the natural reservoirs of M. bovis is important as it has potential to be 
transmitted to humans. However, so far, no M. bovis has been found in human samples of 
Chad and there are several possible explanations for this discussed. 
We conclude this chapter with a short overview of the genotyping of a different 
mycobacterium, M. ulcerans. In contrast to tuberculosis much less is known about the 
transmission of Buruli Ulcer, the disease caused by M. ulcerans, but a new VNTR typing may 
be very promising for micro epidemiological studies in the future. 
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9.2 Features of molecular epidemiological typing tools 
9.2.1 Discriminatory power of IS6110 RFLP, spoligotyping and MIRU-VNTR 
Today, a large number of genotyping tools for the fingerprinting of MTC exists, of which 
IS6110-RFLP, spoligotyping and MIRU-VNTR are very commonly used. Recently, the 
discriminatory power of these tools has been evaluated on representative strain collections 
from different geographical regions. In a test panel of 90 M. tuberculosis complex strains 
from 38 countries, the discriminatory power of the IS6110-RFLP was shown to be the most 
discriminatory tool compared to spoligo- and MIRU-VNTR typing (25). A different study 
showed MIRU-VNTR to be more discriminative than spoligotyping in a strain collection 
containing 90 M. tuberculosis complex and 10 non-M. tuberculosis complex strains, as well 
as 31 duplicated DNA samples (24). 
However, although such evaluation of the discriminatory power on representative strain 
collections is valid, results can vary if evaluations focus on strains from only one 
geographical area or on a specific member of the MCT. When analyzing the Beijing strain of 
M. tuberculosis, spoligotyping has a lower discriminatory power compared to the other typing 
tools, because spoligospacers 1-34 are naturally deleted (14). However, for the Cameroon 
family strains from Chad, MIRU-VNTR typing is slightly less discriminative than 
spoligotyping (9). Strains of the Cameroon family have mainly been isolated in Cameroon, 
Chad and Nigeria. Characteristic chromosomal deletions are described and strains 
furthermore unequally lack spacers 23-25 in their spoligotyping patterns. 
Evaluation of the discriminatory power of Mycobacterium bovis of Ireland revealed a higher 
allelic diversity of MIRUs compared to spoligotyping (0.69 vs. 0.74) (33). In contrast, allelic 
diversity for M. bovis strains from our study from Chad were 0.75 and 0.79, for MIRUs and 
spoligotyping, respectively (18).  
These results show that the standardization of a molecular genotyping approach, which is 
valid for all MTC members, is difficult. Therefore evaluating of the discriminatory powers 
within strains of the same geographical area or within the same strain family before 
performing molecular epidemiological studies is recommended.  
9.2.2 Molecular clock 
Besides the ability to discriminate between strains, typing tools also have to be robust enough 
to show which strains belong to the same cluster. This is also dependent on the molecular 
clock of the typing tools and should be taken into consideration when using a typing tool. The 
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faster a molecular clock the more discriminative it is if horizontal gene transfer is excluded. 
In various recent studies, molecular clocks have been evaluated.  
- IS6110 RFLP vs. spoligotyping 
An analysis of 165 serial M. tuberculosis isolates obtained from 56 patients revealed that 5 
(9%) were infected with isolates with changes in their IS6110 fingerprint patterns but no 
changes were observed for spoligotyping. A statistically significant correlation could be 
found between changes in insertion sequence (IS) patterns and the increased time intervals 
over which the isolates were obtained  (29). In a different study, based on serial isolates 
spanning for the most part <3 months, the half-life for a change in IS6110-RFLP was 
extrapolated to be 3.2 years (95% confidence interval, 2.1–5.0) (8). In M. tuberculosis strains 
from South Africa evolutionary changes were observed in 4% of the strains, and a half-life 
(t1/2) of 8.74 years was calculated, assuming a constant rate of change over time. This rate 
may be composed of a high rate of change seen during the early disease phase (t (1/2) 0.57 
years) and a low rate of change seen in the late disease phase (t (1/2) 10.69 years). The early 
rate probably reflects change occurring during active growth prior to therapy, while the low 
late rate may reflect change occurring during or after treatment (42). 
- MIRU-VNTR vs. IS6110 
To assess the temporal stability of MIRUs, 123 serial isolates belonging to a variety of 
distinct IS6110 restriction fragment length polymorphism (RFLP) families were genotyped 
and separated by up to 6 years. All 12 MIRU VNTR loci were completely identical within the 
groups of serial isolates in 55 of 56 groups (98.2%), although 11 pairs of isolates from the 
same patients with conserved MIRU VNTRs displayed slightly different IS6110 RFLP 
profiles. These results indicate that MIRU VNTRs are relatively stable over time (34). 
These studies show that the present genotyping tools are stable enough over time and their 
use therefore justified. 
- Large genomic deletions received by micro array analysis 
Recently, large genomic deletions of M. tuberculosis (5, 20, 38) and their use for genome 
level informed PCR (GLIP) (28, 31) and deligotyping (16) have been presented. The 
deletions are supposed to happen unidirectional and are researched with the microarray 
technique (22, 27, 28). Three different types of large genomic deletions were distinguished 
(5). The first type describes the deletion of mobile genetic elements (prophages and insertion 
sequences) and the second and third the IS6110 and non repetitive mediated deletions, 
respectively. Research into the presence of large sequence deletions resulted in the definition 
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of epidemiologically important clones (22, 28, 31). Furthermore, the deletions often hamper 
or delete potential ORF and might therefore affect the feature of the pathogen.  
The non repetitive mediated deletions (Type 3) are also called diagnostic deletions and allow 
an isolate to be unequivocally placed in a strain family. The value of genomic deletions for 
finding large family groups is considered to be superior as the turnaround time is slower than 
for all other genotyping methods. Based on the assumption that all stains of a strain family 
represent a cluster, the further use of genotyping methods leads to more refinement and 
eventual subclustering. 
9.2.3 Low heterogeneity and Convergence: the need for higher discriminatory 
power 
- Adding of VNTRs 
Comparison of our data from Chad with Ireland (18, 33) showed a low discriminatory power 
of MIRUs compared to similar studies on M. tuberculosis. However, the VNTR typing was 
shown to become more discriminative when adding further VNTRs e.g. exact tandem repeats 
(ETRs) to the 12 MIRUs. Adding ETR A, B, and C resulted in higher discrimination than the 
use of all 12 MIRUs combined. Therefore a combination of different types of VNTRs is 
suggested (18, 33). 
- Convergence in VNTR typing because highly polymorphic loci lower sensitivity of 
clustering 
VNTR typing of MTC strains from different settings have shown different allelic diversities 
at the VNTR loci. However, MIRU 40 and 26 seem to be very polymorphic for M. 
tuberculosis. MIRU 26 is also polymorphic for M. bovis with, in contrast, ETR A and B much 
more diverse than MIRU 40 (18). 
The higher turnaround time of certain VNTR loci can result in a convergent evolution of 
epidemiologically unlinked strains and therefore lower the sensitivity of clustering which 
means that certain strains found in Nigeria (6) have the same VNTR type as strains from 
Chad and convergence cannot be excluded. However, this problem can best be addressed by 
the inclusion of a second genotyping method, e.g. spoligotyping and a sensitivity of clustering 
of mostly 100% is common. 
- Convergence Spoligotyping 
Possible convergent evolution of spoligotyping has also been shown. Homologous 
recombination between adjacent IS6110 elements leads to extensive deletion in the DR 
region, again demonstrating a dependent evolutionary mechanism. Different isolates from the 
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same strain family and isolates from different strain families were observed to converge to the 
same spoligotype pattern (41). 
9.3 Practical usage of molecular epidemiological results with special 
consideration of Africa 
In recent years, molecular typing of the M. tuberculosis complex has greatly increased our 
knowledge about the mode of disease transmission. Molecular typing can help in suggesting 
adapted control strategies and potentially tackles and provides links to many important topics 
related to the disease.  
9.3.1 Reinfection versus relapse or mixed infection versus micro evolution: the 
‘correct’ diagnosis  
A study from South Africa showed that 19% of all patients were simultaneously infected with 
Beijing and non-Beijing strains, and 57% of patients infected with a Beijing strain were also 
infected with a non-Beijing strain. These results suggest that multiple infections are frequent, 
implying high reinfection rates and an absence of efficient protective immunity conferred by 
the initial infection (43).  Because Cameroon family strains are so predominant in our study 
(9) this raises the question, whether these particular M. tuberculosis strains play a similar role 
in Chad, Cameroon and Nigeria. Multiple infections with Cameroon and non-Cameroon 
family strains could be investigated in a similar manner by a 2 strain specific PCR (9). 
A different study of clinical data, also using samples from South Africa, suggests that first-
line therapy can select for a resistant subpopulation, whereas poor adherence or second-line 
therapy resulted in the re-emergence of the drug-susceptible subpopulations (40). This is 
important for treatment control. 
However, care must be taken not to confuse mixed infection with microevolution of a single 
strain. While a classic mixed infection consists of 2 or more completely different strains 
(different strain families) a heterogeneous mycobacterium population structure can also 
evolve because of a mutation of one infectious agent in the reproduction process within the 
same host.  
In a recent study investigating mixed infections, the MIRU-VNTR technique was applied to 
search for cases infected by more than one clone. Clonal variants within the same host were 
detected in 3 out of 115 cases (2.6%), including cases with clones which were 
indistinguishable by restriction fragment length polymorphism or spoligotyping. In one case, 
coinfecting clonal variants differed in antibiotic susceptibilities (15). 
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In another study, infections with different bacterial subpopulations were detected in samples 
from eight patients (8.2%), with the frequency of detectable mixed infections in the study 
population estimated to be 2.1%. Genotypic variations were found to be independent of drug 
susceptibility, and the various molecular markers evolved independently in most cases (35). 
In conclusion, we suggest that MIRU-VNTR typing is a potentially valuable tool to 
investigate reinfection, mixed infection, microevolution or the relapse of tuberculosis. These 
results may prove especially important for adapted human tuberculosis control in high 
incidence countries such as Chad 
9.3.2 Degree of ongoing transmission, global mycobacterial population structure 
and outbreak investigations 
While the basic principles of tuberculosis transmission are well understood, the advent and 
use of molecular methods in epidemiological studies have shown that traditional contact 
tracing may not always be accurate, leading to identification of previously unrecognized 
source cases. The assessment of recent transmission and/or reactivation (44) remains of 
particular interest in resource poor settings where scarce resources for control need to be 
directed to transmission hotspots. In Chad, the overall heterogeneity using spoligotyping and 
MIRU/ETR typing was high in 40 M. tuberculosis samples analyzed, however we also found 
that a substantial proportion of strains (33 %) are part of the Cameroon family. Within this 
family, strains evolved differently and therefore have slightly different VNTR and/or 
spoligotypes (9). We propose that evolved strains, derived from a common ancestor should be 
considered together with clustered strains to represent chains of ongoing transmission. In a 
recent study, a data set which identifies newly evolved strains has been generated. Inclusion 
of these evolved strains into various molecular epidemiological calculations significantly 
increases the ability to estimate ongoing transmission in a particular high incidence study 
setting (39).  
In our study the Cameroon family was the most predominant group of M. tuberculosis strains 
which is also most common for Nigeria, Cameroon and Chad (9). In the future, investigation 
into the reasons why some strains are predominant may clarify which bacterial factors 
contribute to disease. This knowledge has the potential to influence control and prevention 
strategies for tuberculosis (26). Predominant strains should also be identified in developing 
countries to study the differential pathogenesis between strains (12) and also to reveal the true 
extent of genetic diversity of the pathogen (4).  
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Additionally, genotyping studies could also enhance the investigation of outbreaks. In a study 
of a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis 
in 31 patients, 30 of whom were also infected with human immunodeficiency virus, all 31 
died of progressive tuberculosis. All M. bovis strains had identical spoligotyping patterns and 
showed resistance to 12 antituberculosis drugs. Reinfection was suggested in 11 cases and 
confirmed in 4 by molecular typing methods (32). In 2001 the largest recognized outbreak of 
tuberculosis in a United Kingdom school was detected in Leicester (31). The index patient 
was a 14-year-old student who had been complaining of a chronic cough for 9 months prior to 
being diagnosed with sputum smear-positive cavitary pulmonary tuberculosis (13). 
In high incidence countries tuberculosis outbreaks are rarely investigated because of a lack of 
genotyping facilities, but it is important as it could contribute to innovative control strategies. 
9.3.3 Linking epidemiological and social science studies 
Within the framework of NCCR North-South, our molecular epidemiological data is linked to 
a social science study on the perception of tuberculosis by Moustapha Ould Taleb. He found 
that biomedical tuberculosis symptoms of nomads in Mauritania and Chad correspond to 
various perceptions of illness categories. For example the terms "Kouha" (cough) and 
"Soualla" (cough) correspond to perceived hereditary tuberculosis and "Lebroud or Legtoua" 
to tuberculosis acquired through cold temperatures, nutrition (e.g. powdered sugar is 
particularly incriminated as a cause in Chad) or hard work (understood here as the hardship of 
pastoralist work). The modern Arabic medical terminology "Soul" for tuberculosis is 
unknown to nomads of Mauritania who continue to use names which either correspond to 
single symptoms such as the cough ("kouha"), fatigue ("Azer") or to stigmatizing images such 
"Sahat elmoumnin",( the illness of the believers) "kouha Elkahla" (serious cough) etc.  
The aims behind joint collaboration are as follows:  
a) To evaluate the variability of local perceptions of TB. As local perceptions of illness 
determine treatment seeking behaviour this is crucial in adapting DOTS to mobile 
populations. 
b) To compare perceptions of TB with prevalence of the disease. Although people 
associate many terms with suffering from tuberculosis not all are related to clinical 
diagnosed TB.  
c) To investigate the type of perception compared with the clustering of molecular 
characterized TB strains. This would reveal if certain perceptions are risk factors for 
clustering and therefore for recent transmission. 
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d) To evaluate whether certain strains exclusively match certain types of tuberculosis e.g. 
"Kouha" and "Soualla". If different tuberculosis strains or strain families show slightly 
different clinical symptoms, this could have far reaching implications for our 
understanding of the tuberculosis disease. 
e) To research whether perceived inherited tuberculosis indicates high ongoing 
transmission at the household level. As "Kouha" and "Soualla" are considered to be 
inherited tuberculosis, this probably indicates that tuberculosis transmission often 
takes place at the household level (M. Ould Taleb personal. communication).  Were 
this to be proven by molecular epidemiology, it would suggest the need for enforced 
tuberculosis control at the household level.  
9.3.4 Inter animal species transmission 
Molecular typing methods can clarify the sources of infection and the major routes of the 
transmission and spread of bovine tuberculosis (TB) and their risk factors (36). They are also 
necessary for eco-systemic analyses of transmission chains between wildlife and livestock 
(17). For control polices of eradicating M. bovis in cattle, it is important to know whether a 
wildlife species act as a maintenance or spillover host. A recent study in the UK showed that 
the culling of badgers reduces cattle TB incidence in the areas where culling takes place, but 
increases incidence in adjoining areas (11). Additionally, studies have revealed that deer (7, 
17), wild boars (17) and brushtail possum (7) also act as maintenance hosts. Other animal 
species rather act as spillover hosts, for example goats, sheep, rabbits and pigs (7). Today it is 
assumed that spillover hosts are mainly infected by host adapted M. bovis substrains rather 
than by classical M. bovis strains e.g. goats which are infected with M. bovis sups. caprae. 
Therefore, these animal species are considered to contribute to the transmission pathways of 
the classic M. bovis strains to a far lesser extent. In high incidence countries like Chad, the 
natural reservoir and spillover hosts of the classical M. bovis are largely unknown. Future 
research on different hosts, particularly camels in the Chad setting, is therefore highly 
recommended. 
Future studies may even show M. bovis strain preference within different cattle breeds. 
Preliminary results show that the M. bovis population structure of the more tuberculosis 
susceptible mbororo is slightly more homogenic than of the arabe breed from Chad. This 
seems to indicate that the breed mbororo is more likely associated with recent transmissions 
which raises the question if M. bovis is better adapted towards this breed (10). 
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9.3.5 Zoonotic transmission 
 Last but not least, molecular epidemiology can also investigate the transmission of 
tuberculosis between animals and humans. M. bovis is considered to have zoonotic potential 
and it is certainly very important to know the percentage of human tuberculosis caused by M. 
bovis especially in high incidence countries (3). In Nigeria the rate of M. bovis from humans 
was 4 M. bovis strains from 102 sputum samples (21) and 3 M. bovis strains cultured from 55 
sputum samples (6). However,  spoligo- and VNTR-typing in the latter study revealed that the 
three M. bovis strains isolated from humans did not match the 15 M. bovis strains isolated 
from cattle.  This was despite the fact that they all had spoligotyping patterns similar to the 
dominant pattern found in cattle. This surprising result may be due to the small number of 
strains analyzed from cattle but it also raises questions about direct animal to human 
transmission. Similarly, the spoligotypes of 4/5 M. bovis strains isolated from humans from 
Tanzania did not match the types of 31 M. bovis strains from Tanzanian cattle (23). In 
Cameroon, only a single M. bovis strain was isolated from 455 human specimens suggesting 
the low importance of M. bovis in the overall burden of human tuberculosis in this country 
(30). 
To prove zoonotic transmission was one of the objectives of this thesis. It was thought that 
the combination of high prevalence of M. bovis in cattle and the habit of drinking 
unpasteurized milk and eating raw meat presented significant risks for transmission. 
However,  no M. bovis has so far been found in human samples of Chad.  Here are several 
possible explanations: 
a) Insufficient numbers and incorrect study populations 
The numbers of isolated MTC strains from humans and animals from Chad are very few but 
are the very first ones isolated in this country (9, 10). As the first objective of the thesis of C. 
Diguimbaye was to establish a mycobacterial laboratory in Chad, attention has not been given 
to a high number or a careful selection of isolates. Only pulmonary and a few urine samples 
of human patients from the main hospital of N’Djaména were included (9).  
An ongoing study currently additionally analyzes extra pulmonary tuberculosis in children 
from N’Djaména. However, preliminary results show that M. bovis is not present in these 
samples. In future, the inclusion of extra pulmonary samples of adults is also planned. 
Additionally, we plan to evaluate the burden of M. bovis infection within nomadic pastoralists 
who have close contact with cattle and are therefore at high risk.  
b) Reduced risk of transmission in semi-arid climates and in extensive livestock systems 
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The sampling of tuberculosis specimens from Chad took place in N’Djaména where the 
climate is dry and semi-arid. There are indications that zoonotic transmission is more 
probable in humid areas and therefore inclusion of a more southerly region should be taken 
into consideration. Furthermore, the extensive livestock systems used by the pastoralists does 
not involve the use of stables. This may also reduce the risk of zoonotic transmission. 
c) Less pathogenic strains 
It is known that humans are not natural reservoirs for M. bovis, but can act as spillover hosts. 
However, it is not known whether certain M. bovis strains are more pathogenic for humans 
than others. As no M. bovis in humans has been found, this may mean that the Chadian strains 
are less pathogenic for humans.  
9.4 Genotyping in M. ulcerans 
While there are many studies evaluating genotyping methods for MTC, the situation for M. 
ulcerans is so far not as developed. The discriminatory power of genotyping methods is still 
insufficient for performing micro epidemiological studies. Therefore new genotyping 
methods have to be developed and evaluated. 
As for MTC, VNTR typing of MIRUs (37) and other VNTRs (2) have been implemented for 
M. ulcerans. Evaluations of the discriminatory power showed the ability to separate isolates 
on a continental level but not within the contents. A study evaluating the sequences of VNTR 
loci showed that sequencing does not enhance the discriminatory power (1). It is therefore of 
special importance that a new VNTR-locus (designated STI) and a previously presented 
MIRU locus have recently been shown to discriminate between M. ulcerans strain within 
Ghana, and therefore within Africa, for the first time (19).  
9.5 Ten key messages and recommendations of this thesis 
1. MIRU/VNTR typing for M. tuberculosis strains from Chad is as discriminative as 
spoligotyping. Recommendation: MIRU-VNTR typing is a very promising tool for 
investigating mixed infection which might occur in high percentages in high incidence 
countries like Chad (Chapter III). 
2. Using microarry analysis, the Cameroon family was identified as a highly prevalent clone 
and characterized 33 % of M. tuberculosis strains of Chad. Fortunately, this clone is not 
currently associated with drug resistance. Recommendation: Evaluation of risk factors for 
recent transmissions of Cameroon family members could lead to recommendations on how to 
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interrupt the transmission of this clone and contribute to alternative control strategies 
(Chapter III). 
3. Although the risk of infection with M. bovis is high for humans in Chad, analysis of 40 
pulmonary and urine samples of clinical suspected tuberculosis cases revealed that none of 
the patients were infected by M. bovis (Chapter III). Recommendation: Evaluation of extra 
pulmonary samples from risk population groups (e.g. pastoralists). It is also recommended to 
look at M. bovis as a possible subpopulation of mixed infections in humans. 
4. Drug resistance testing of 40 M. tuberculosis cases from Chad revealed a high percentage 
of Isoniazid resistance (33 %) (Chapter III). Recommendation: Carry out molecular 
epidemiological studies analyzing the risk factors of transmission of drug resistant strains. 
Implementation of a method permitting faster detection of resistance is also desirable. 
5. A study carried out in a slaughter house in Chad revealed that the mbororo breed is more 
susceptible to M. bovis than the arabe breed. Recommendation: Investigate the 
immunological and genetic consequences (Chapter IV). 
6. Spoligo- and MIRU-VNTR typing revealed a remarkably homogenetic population structure 
within M. bovis strains. However, the use of 2 MIRUs and 3 ETRs allows reasonably high 
discrimination to take place. Recommendation: Use these 5 loci to investigate and prove 
possible animal to human transmission and other molecular epidemiological objectives in the 
future (Chapter V). 
7. A high proportion of Chadian (63/67), Nigerian and Cameroon M. bovis strains are 
members of the same clone defined by a large genomic deletion. There are indications that 
subclones found in the different study sites are due to clonal expansion. Recommendation: 
Investigate the possible spread of M. bovis strains from one country to the other (Chapter VI). 
However, we also recommend looking at different hosts (camels, goats) in order to show if 
other animal reservoirs (maintenance hosts) exist for this particular M. bovis clone. 
8. A high proportion of Chadian strains showed deletion affecting ESAT-6 family members, 
which are promising targets for new diagnostics and novel vaccine candidates. 
Recommendation: Investigate genome organization across M. tuberculosis strains to inform 
the choice of antigens used in a diagnostic mix (Chapter VI). 
9. A new and a previously described VNTR locus revealed genetic diversity within African 
M. ulcerans strains for the first time. Recommendation: Use these two VNTRs for extended 
analysis on various panels of M. ulcerans. However, development of new genotyping tools 
has to continue as the discriminatory power is still low. This could allow for micro 
epidemiological studies in the future (Chapter VII). 
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10. Sequencing of various VNTRs revealed that the discriminatory power of sequencing is 
only slightly higher than that of Agarose Gel electrophoresis. Recommendation: Given that 
sequencing does not significantly enhance the discriminatory power, and is more laborious 
and expensive, it is not recommended for use, especially not within laboratories with 
infrastructural constraints (Chapter VIII). 
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Abstract 
Mycobacterium tuberculosis remains a major cause of morbidity and mortality worldwide. 
Studies have reported human pathogens to have geographically structured population 
genetics, some of which have been linked to ancient human migrations. However, no study 
has addressed the potential evolutionary consequences of such longstanding human-pathogen 
associations. Here we demonstrate that the global population structure of M. tuberculosis is 
defined by six phylogeographical lineages, each associated with specific, sympatric human 
populations. In an urban cosmopolitan environment, mycobacterial lineages were much more 
likely to spread in sympatric than in allopatric patient populations. Tuberculosis cases that did 
occur in allopatric hosts disproportionately involved high-risk individuals with impaired host 
resistance. These observations suggest that mycobacterial lineages are adapted to particular 
human populations. If confirmed, our findings have important implications for tuberculosis 
control and vaccine development. 
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Introduction 
Several studies have reported geographically structured populations in human pathogens (1-
4). Recently, the genetic population structure of Helicobacter pylori and Mycobacterium 
leprae have been linked to ancient human migrations (1, 4, 5). Such long-standing host-
pathogen associations could lead to adaptive genetic changes between interacting host and 
pathogen populations. Studies in invertebrate model systems have shown that pathogens can 
adapt to specific host species (6). However, no example of host-specific pathogen adaptation 
has yet been documented in pathogens affecting different human populations. The 
observation of geographically structured populations of human pathogens  implies that 
particular strains and their corresponding patient populations can be classified as sympatric or 
allopatric (6). Compatibility, defined as the ability of a given pathogen to infect a given host, 
often differs in sympatric versus allopatric host-pathogen combinations with  sympatric 
combinations usually displaying a greater compatibility (6). 
M. tuberculosis occurs world-wide and is still killing 2-3 million people each year (7). New 
tools for tuberculosis control are urgently needed, including a more effective vaccine (8). A 
series of genotyping tools for M. tuberculosis have been developed (9).  Most of these make 
use of mobile genetic elements or repetitive DNA. Even though these tools have been 
invaluable for detecting ongoing tuberculosis transmission, the markers upon which they are 
based change relatively rapidly, making it difficult to define deep phylogenetic relationships 
(4). In contrast, large sequence polymorphisms (LSPs) represent unique event polymorphisms 
that can be used to construct robust phylogenies for M. tuberculosis (10). An additional 
advantage is that once LSPs have been identified (e.g. by comparative whole-genome 
hybridization), simple PCR can be used to screen large numbers of strains in a high-
throughput fashion. 
In this study, we used comparative genomic and molecular epidemiological tools to define the 
global population structure of M. tuberculosis and to investigate its influence on the 
transmission dynamics of M. tuberculosis in San Francisco during an eleven-year period. 
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Materials and Methods 
Molecular epidemiology in San Francisco. In an ongoing population-based molecular 
epidemiological study in San Francisco, California (11), 2807 tuberculosis patients were 
enrolled between January 1991 and December 2001. Of these patients, 2382 (84.9%) had M. 
tuberculosis isolated in culture. Demographic and epidemiological data, including place of 
birth and self-defined ethnicity, were recorded for each patient and IS6110 restriction 
fragment length polymorphism (RFLP) genotyping was performed on 2141 (89.9%) of the 
bacterial isolates following standardized methods (11). Isolates with matching (clustered) 
RFLP patterns were considered part of a chain of tuberculosis transmission. The protocols 
and the procedures for the protection of human subjects were approved by Stanford 
University and the University of California, San Francisco. 
 
Global sample of M. tuberculosis. Fifty of the strains included in the global sample had 
unique RFLP patterns and were isolated from US-and foreign-born patients from San 
Francisco. We previously reported that these patients represented cases of reactivation of 
infections acquired in their respective country of origin and that the genomic deletion profiles 
of these strains were associated with the respective patient’s place of birth (10). Therefore, 
the unique foreign-born cases from San Francisco could be used to sample the diversity of M. 
tuberculosis. We validated this approach in 108 reference strains obtained from several 
additional strain collections representative of specific geographic areas (Supplementary Table 
1). These reference strains were selected because they represented the most common 
genotypes in the corresponding geographic areas based on our previous molecular 
epidemiological studies (9, 12) (B.D., S.Na., M.N., S.Ni., and M.H. unpublished). We then 
screened an additional 709 unique strains isolated from US-and foreign-born patients from 
San Francisco. Eight strains from different patient clusters comprising only US-born 
individuals were also included. 
 
Identification of large sequence polymorphisms. Comparative whole-genome hybridization 
was performed using an Affymetrix DNA chip (Santa Clara, CA, USA) following procedures 
described previously (13). Genomic regions putatively deleted in the test strains compared to 
the sequenced reference strain H37Rv were identified using the DelScan software (AbaSci, 
San Pablo, CA, USA). Putative deletions were confirmed by PCR and sequencing (13).  
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Lineage determination by PCR and multiplex real-time PCR. We used the 
phylogenetically informative LSPs to screen by PCR and/or TaqMan multiplex real-time PCR 
(Applied Biosystems, Foster City, CA, USA ) an additional 679 unique strains, as well as one 
isolate representative of each of the 184 (97.7% of all) patient clusters that occurred in San 
Francisco between 1991 and 2001. The screening results from the clustered isolates were 
extrapolated to the remaining isolates of the respective clusters. The primer and probe 
sequences used in this study are shown in Supplementary Tables 2 and 3. The Euro-American 
lineage was defined based on a characteristic seven base pair deletion in pks15/1 (ref. (14))  
or the ctg to cgg substitution at codon 463 of katG (ref. (15)), which are known to be 
equivalent markers (14, 16). 
 
Lineage-specific transmission in San Francisco. Of 2141 patients with available RFLP 
data, 1849 (86.4%) were born in the US, China, The Philippines, Central America including 
Mexico, and Vietnam. This set of 1849 patients represented our sampling frame. We 
classified these patients as follows: all clustered patients, all cases with drug-resistance, all 
patients born in Vietnam or in Central America for which DNA was available, and a random 
selection of strains with unique RFLP patterns recovered from patients born in the US, China 
or The Philippines (the three largest patient populations in San Francisco). Overall, 71.4% of 
eligible patients (1321 patients) and their isolates were included in this part of the study, 
comprising 66.6% (493/740) patients born in the US, 67.3% (301/447) patients born in China, 
69.5% (251/361) patients born in The Philippines, 89.7% (140/156) patients born in Central 
America, and 93.8% (136/145) patients born in Vietnam. 
 
Statistical analysis. The number of secondary cases in each lineage was determined by 
subtracting the number of RFLP clusters from the total number of clustered cases (17). 
Because prevalent bacteria have a greater opportunity to transmit we translated the number of 
secondary cases in each lineage into lineage-specific secondary case rates by dividing the 
number of secondary cases in a lineage by the sum of all index cases (the number of clusters 
plus all the unique cases) belonging to the same lineage. To compare transmission rates 
between lineages, we then transformed the lineage-specific secondary case rates into 
secondary case rate ratios by dividing the secondary case rate of the lineage of interest by the 
secondary case rate of the other two lineages combined. To calculate the host population-
specific secondary case rate we made the simplifying assumption that any index case in San 
Francisco, regardless of which host population he or she belonged, could have infected the 
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secondary case in question. Thus, we used as the denominator the sum of the number of 
clusters plus unique cases for the whole of San Francisco. A total of 188 patient clusters with 
604 secondary cases occurred in San Francisco between 1991 and 2001. For the analysis, 
there were 184 clusters (97.9%), with their corresponding 596 (98.7% of all) secondary cases, 
with at least one isolate with DNA available for screening. Overall, 1349 tuberculosis cases 
with a unique RFLP pattern occurred during the same time period, 754 (55.9%) of which had 
lineage information available (including 213 cases who were not part of the five main patient 
populations). To account for the number of unique cases which were not screened for lineage-
defining markers, we weighted the denominator of the secondary case rate by multiplying the 
number of unique cases in each lineage by 1.79 (1349 total unique cases/754 screened unique 
cases).  
In order to identify the risk determinants of transmission of allopatric strains in the US-born 
population, we sought associations between the three lineages and patient characteristics 
using univariate analyses with a 3 x 2 χ2 test of proportions with two degrees of freedom. 
Variables with a p-value < 0.20 in the 3 x 2 comparison were further tested by individual 2 x 
2 comparisons using the regular χ2 test of proportions or the Fisher’s two-tailed exact test. All 
variables with a p-value < 0.20 in the 2 x 2 univariate analysis and biological plausibility 
were considered for the multivariate logistic regression model. We performed forward 
stepwise model construction and compared the log likelihood ratios of successive models 
until the final, most parsimonious model was identified. We used the Hosmer-Lemeshow 
goodness-of-fit test to validate the final models (18). Statistical analyses were performed with 
Stata (version 7E; Stata Corporation, College Station, Texas, USA). 
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Results and Discussion 
In order to define the global population structure of M. tuberculosis, we performed genomic 
deletion analysis on a global sample of 875 strains originating from 80 countries (Table 1 and 
Supplementary Table 1). This sample included strains isolated from foreign-born tuberculosis 
patients in San Francisco who contracted the infection in their country of origin, and was 
complemented with geographically representative strains from other reference collections. 
We analyzed a subset of 111 strains by comparative whole-genome hybridization (13).  The 
results of 74 of these experiments were published elsewhere (13, 19, 20), and 37 are reported 
here. We identified 19 phylogenetically informative and lineage-specific LSPs (Fig. 1a and 
Supplementary Table 2). These LSPs were confirmed by sequencing, validated by PCR and 
sequencing in 72 additional strains, and used to screen the remaining 692 strains by PCR or 
multiplex real-time PCR (Supplementary Tables 2 and 3). We used as additional phylogenetic 
markers the previously reported regions of difference (RD) TbD1 and RD9 (ref. (21)), the 
seven base pair deletion in the pks15/1 locus (14),  and the katG463 ctg to cgg substitution 
(15). 
 The analysis of our global sample of 875 strains revealed six main lineages and 15 
sub-lineages of M. tuberculosis (Fig. 1a, Table 1, Supplementary Tables 1 and 4). Some of 
these lineages correspond to strain groupings that have previously been reported. For 
example, the Indo-Oceanic lineage includes a group of strains that have been referred to as 
‘ancestral’ due to the fact that they conserve the TbD1 genomic region, which is deleted in 
‘modern’ strains of M. tuberculosis (21). The East-Asian lineage includes, but is not limited 
to, the Beijing family of strains (20). The West-African lineages 1 and 2 correspond to strains 
that have traditionally been named M. africanum (19), and the Euro-American lineage 
regroups strains that have generally been described as principal genetic group 2 and 3 (ref. 
(14-16)).  
 Besides confirming some of the mycobacterial groupings that have been described 
previously, our analysis of an extended global strain collection revealed that the population 
genetics of M. tuberculosis is highly geographically structured. Each of the six main lineages 
was associated with particular geographical areas, and the lineage names reflect these 
geographical associations (Fig. 1b and Table 1). For example, the East-Asian lineage is 
dominant in many countries of the Far East, and the Indo-Oceanic lineage occurs all around 
the Indian Ocean. The Euro-American lineage is clearly the most frequent lineage in Europe 
and the Americas, but specific sublineages within the Euro-American lineage predominate 
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also in different regions of Africa and the Middle East (Fig. 1a and b). While we did observe 
such geographical substructuring within the Euro-American lineage, no other sub-lineage was 
associated with any specific geographical area (results not shown). 
Though most other areas were associated with only one or two lineages, all six main lineages 
were represented in Africa (Fig. 1b). These included the two West-African lineages that did 
not occur elsewhere, as well as the Indo-Oceanic lineage, the most ancestral of the six 
lineages, which was associated with East Africa. A recent study suggests that ancestral 
mycobacteria may have already affected early hominids in East Africa around 3 million years 
ago (22). Taken together, these findings are consistent with a scenario for the origin and 
evolution of human tuberculosis, in which M. tuberculosis expanded and diversified during 
its spread out of East Africa. This speculative scenario suggests that M. tuberculosis might be 
significantly older than previously estimated (15). As a consequence, different M. 
tuberculosis lineages may have adapted to different human host populations. 
Taking advantage of the cosmopolitan setting of San Francisco, with its diverse tuberculosis 
patient and bacterial populations, we investigated the effects of host-pathogen mixing on the 
occurrence of secondary cases of tuberculosis. We used multiplex real-time PCR to screen for 
the main lineages of M. tuberculosis in a stratified random sample of 1321 isolates, 
corresponding to 71% of all tuberculosis cases reported in San Francisco between 1991 and 
2001 who were born in the United States (US), China, The Philippines, Vietnam, or Central 
America. These patients represent the five largest tuberculosis patient populations in San 
Francisco. This sample included all the RFLP clustered cases belonging to any of these five 
populations as well as a random sample of unique cases. The clustered cases were considered 
part of relatively recent chains of tuberculosis transmission in San Francisco and the unique 
cases were considered to have developed tuberculosis as a consequence of reactivation of 
latent infection (11). 
Our results showed that 99.6% of all isolates in San Francisco belonged to three of the six 
main lineages. Twenty-six percent of the 1321 isolates belonged to the Indo-Oceanic lineage, 
26% to the East-Asian lineage, and 48% to the Euro-American lineage. When we stratified 
the bacterial lineage data by the five patient populations, a strong association was evident 
(Fig. 2a; Pearson χ28=1295, p<0.0001). In four of the five patient populations, one specific 
lineage accounted for at least 72% of all tuberculosis cases. 
We explored whether the association between lineage of M. tuberculosis and human 
population reflects host-specific differential transmission of mycobacterial lineages, using 
RFLP clustering as a proxy for transmission (17). We hypothesized that lineages that are rare 
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in a specific human population are not adapted to transmit and cause secondary cases in this 
specific human population. We first calculated the secondary case rate ratios of the three M. 
tuberculosis lineages irrespective of the patient’s place of birth. All three lineages had 
statistically different secondary case rate ratios (Supplementary Table 5). In San Francisco, 
patients infected with the Euro-American lineage were three times more likely to generate a 
secondary case during the eleven-year study period than patients infected with any other 
strain. The Indo-Oceanic lineage had a significantly lower secondary case rate ratio and the 
East-Asian lineage the lowest. When we calculated the lineage-specific secondary case rate 
ratios stratified by human population, we found that in every instance, the secondary case rate 
ratios of sympatric lineages was significantly greater in comparison to that of allopatric 
lineages in the same population (Fig. 2b and Supplementary Table 5). Taken together, these 
observations suggest that particular lineages of M. tuberculosis might be adapted to specific 
human populations and mal-adapted to others. 
Given that some tuberculosis cases were caused by allopatric lineages, we investigated the 
characteristics of patients with disease caused by allopatric lineages. We chose to look at the 
US-born population because it represents the largest patient population in San Francisco (Fig. 
2a) and that sociological determinants of transmission are well documented. The 
characteristics of the US-born patients, stratified by the three lineages of M. tuberculosis, are 
presented in Supplementary Table 6. Significant variables were selected for multivariate 
logistic regression modelling. The multivariate analysis revealed that US-born patients of 
self-defined Chinese and Filipino ethnicity tend to harbour the same strains as patients born in 
China and the Philippines, respectively (Table 2). Because self-defined ethnicity is a good 
predictor of human genetic ancestry (23) these findings provide significant  additional support 
for the importance of this host-pathogen association. 
Another study has reported similar associations between M. tuberculosis strain families and 
human populations (16). Such host-pathogen associations, while indicative, do not by 
themselves provide proof that specific host-pathogen adaptations occur. They can also be 
explained by sociological and epidemiological factors (6). For example, social mixing is non-
random among ethnic groups in San Francisco, which certainly impacts transmission of M. 
tuberculosis between US-and foreign-born individuals in the short term (24, 25). However, 
some foreign strains, for example those associated with Chinese immigrants, must have been 
introduced into San Francisco repeatedly since the beginning of the Gold Rush in the 1800s 
(26). We propose that over such large time frames, there has been ample opportunity for the 
spread of foreign strains into the US-born population. 
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We cannot exclude the possibility that social factors contribute or even drive our observation 
of lineage-specific association with particular human populations. However, further results 
from our multivariate analysis support biological causality for the observed host-pathogen 
association. US-born tuberculosis patients of non-Chinese and non-Filipino ethnicity infected 
with allopatric strains (i.e. belonging to the Indo-Oceanic or East-Asian lineages) were more 
likely to be HIV positive or homeless (Table 2). This suggests that although these lineages are 
less adapted to transmit and cause disease in fully competent members of allopatric human 
populations, they can do so in the context of impaired host resistance. Such differences in 
host-pathogen compatibility or local adaptation have been associated with host-specific 
pathogen adaptation and demonstrated in several invertebrate host-pathogen model systems 
(6). 
Overall, our findings demonstrate a global genetic population structure for M. tuberculosis, 
and support the notion that this pathogen has adapted to specific human populations. These 
results have implications for tuberculosis control efforts, especially for the development of 
new vaccines. The importance of strain genetic variation for vaccine escape has been 
documented in several bacterial species (27-29). In Bacille Calmette-Guerin (BCG), the 
currently available tuberculosis vaccine, significant geographical variation in protective 
efficacy has been observed (8). Environmental factors and differences in vaccine strain have 
been invoked (8, 30-32), but our findings suggest that regional differences in host-pathogen 
interactions could be partially responsible. Although recent progress has been made in the 
development of new tuberculosis vaccines (33), the global population structure of M. 
tuberculosis and host-specific pathogen adaptation may need to be considered when 
engineering and evaluating new vaccine candidates.  
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Table 1. Assignment of 875 strains of M. tuberculosis from 80 countries to six main phylogenetic lineages in eleven geographic regions 
 
Geographic region 
(number of countries) 
Total strains Indo-Oceanic 
lineage 
East-Asian 
lineage 
East-African-
Indian lineage 
Euro-American 
lineage 
West-African 
lineage 1 
West-African 
lineage 2 
Americas (18) 207 6 7  194   
Europe (14) 35 1 4  30   
North Africa/Middle East (6) 10    10   
West Africa (8) 28    12 9 7 
Central Africa (5) 15   1 14   
South Africa (1) 5  2  3   
East Africa (6) 20 3  8 9   
Indian Subcontinent (4) 17 3 1 10 3   
Southeast Asia (9) 272 169 73 1 29   
East Asia (7) 262 17 190  55   
Pacific Islands (2) 4    4   
Total (80) 875 199 277 20 363 9 7 
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Table 2. Risk factors independently associated with one of three M. tuberculosis lineages 
in 490 US-born patients from San Francisco 
 
 
 
 
 
 
 
Note: CI=confidence interval 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M. tuberculosis 
lineage Risk factor 
Adjusted 
odds ratio (95% CI) P-value 
East-Asian Chinese ethnicity 19.8 (4.6-84.2) <0.001 
 Homelessness 3.0 (1.4-6.2) 0.004 
Indo-Oceanic Filipino ethnicity 43.2 (5.6-335) <0.001 
 Age ≥ 45 years 3.9 (1.5-10.1) 0.004 
 HIV positive 3.4 (1.3-8.7) 0.01 
Euro-American Chinese ethnicity 0.18 (0.06-0.6) 0.004 
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Fig. 1. The global population structure and geographical distribution of M. tuberculosis. (a) 
Large sequence polymorphisms (LSPs) define a global phylogeny for M. tuberculosis. The 
name of the lineage-defining LSPs or regions of difference (RDs) are shown in rectangles. 
The geographic regions associated with specific lineages are indicated. (b) The six main 
lineages of M. tuberculosis are geographically structured. Each dot corresponds to one of 80 
countries represented in the global strain collection. The colours of the dots relate to the six 
main lineages defined in Fig. 1a and indicate the dominant lineage(s) in the respective 
countries. 
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Figure 2. Lineage-specific prevalence and transmission of M. tuberculosis in San Francisco 
(1991 to 2001). (a) Prevalent strains in San Francisco are strongly associated with sympatric 
patient populations. The sums of both unique and clustered cases are shown. (b) The 
propensity of specific mycobacterial lineages to transmit is significantly higher in sympatric 
compared to allopatric patient populations (asterisk: comparison to the other two lineages 
combined: p <0.0001; yellow=Indo-Oceanic lineage, blue=East-Asian lineage, red=Euro-
American lineage). 
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Summary 
In Chad, during a study on tuberculosis in humans and cattle, 52 non-tuberculous 
mycobacteria (NTM) strains were isolated. By means of INNO-LiPA, PRA-hsp65 
amplification and sequencing of 16S rDNA, NTM species of 25/52 isolates were identified. 
M. fortuitum complex (8) was the most frequent species, followed by M. nonchromogenicum 
(4) and M. avium complex (4). PRA method could identify M. fortuitum 3rd variant among 
isolates derived from cattle specimens. This finding could confirm the existence of farcy in 
the Chadian cattle population as M. fortuitum 3rd variant and putitative pathogen M. 
farcinogenes can’t be distinguished by the methods used in this study. Half of the NTM 
isolates could not be specified and we considered them as contaminants from the 
environment. 
 
Keywords: non –tuberculous mycobacteria, Chad, molecular methods, INNO-LiPA assay, 
PRA amplification, sequencing of the 16S gene 
 
Zusammenfassung 
Während einer Studie im Tschad, welche die Tuberkulose bei Menschen und Rindern 
untersucht, wurden 52 nicht-Tuberkulse Mykobakterien (NTM) isoliert. Mit Hilfe von INNO-
LiPA tests, PRA-hsp65 Amplifizierung und Sequenzierung der 16S rDNS, konnten 25/52 
Isolaten identifiziert werden. M. fortuitum complex war die häufigste Species, gefolgt von  M. 
nonchromogenicum (4) und M. avium complex (4). Die PRA Methode konnte bei Isolaten, 
die von Kühen stammen, die dritte Variante von M. fortuitum identifizieren. Dieser Befund 
könnte die Existenz von Farcy in der tschadischen Kuhpopulation bedeuten, weil die dritte 
Variante von M. fortuitum vom vermuteten Farcy Erreger M. farcinogenes nicht mit den in 
dieser Studie angewendeten Methoden unterschieden werden kann. Die Hälfte der NTM 
Isolate konnten nicht identifiziert werden und wir betrachten diese als Kontaminationen aus 
der Umwelt. 
 
Schlüsselwörter:  nicht-Tuberkulse Mykobakterien (NTM), Tschad, molekulare Methoden, 
INNO-LiPA, PRA Amplifizierung, Sequenzierung des 16S Gens 
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Résumé  
Au Tchad, lors d’une étude de la tuberculose humaine et animale, 52 souches de 
mycobactéries non tuberculeuses (MNT) ont été isolées. La caractérisation génétique des 
isolats a été réalisée au moyen des tests INNO-LIPA, PRA-hsp65 et le séquençage du 16 
rDNA. 25/52 isolats ont pu être identifié. M. fortuitum le complexe (8) était l'espèce la plus 
fréquente, suivie par M. nonchromogenicum (4) et M. avium le complexe (4). La méthode 
PRA a pu spécifier M. fortuitum variante 3 chez le bétail. Cette découverte peut apporter une 
preuve supplémentaire sur l'existence du farcin dans le cheptel tchadien, sachant que M. 
fortuitum variante 3 et M. farcinogenes ne peuvent pas être distingués par les méthodes 
utilisées dans cette étude. L’autre moitié des MNT n’ont pas pu être spécifié et nous les avons 
considéré comme étant des polluants environnementaux. 
 
Mots clés : mycobactérie non tuberculeuse, Tchad, méthodes moléculaires, INNO-LiPA, 
PRA-hsp65, séquençage de 16S ADN 
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Introduction 
With the increase in human tuberculosis cases and the advent of HIV/AIDS, there has been 
resurgence in interest in diseases caused by non-tuberculous mycobacteria (NTM). NTM are 
subdivided into rapid and slow growers. Their ecologic niche is the environment, as they have 
been found in soil, plants, house dust and water. In contrast, animals are not considered as an 
important reservoir for NTM (Saiman, 2004). However, they can cause infections in humans 
and animals (Phillips and von Reyn, 2001; Hamid et al., 1991; Alander-Damsten et al., 2003; 
Valheim et al., 2001). Mycobacteria cause a variety of illnesses, which have profound 
individual and public health implications. The clinical symptomatology of these diseases is 
not different from classical tuberculosis (Dvorska et al., 2001), but their therapy is 
problematic due to the high resistance to antituberculous drugs seen for most ubiquitous 
mycobacteria (Schutt-Gerowitt, 1995).  
Reports on NTM infections in humans and animals in Africa are scarce. Most published 
studies are from South Africa, and specifically on investigations in the South African gold 
mines where Mycobacterium kansasii and M. scrofulaceum were the main causes of 
mycobacterial diseases (Churchyard et al., 1999; Corbett et al., 1999) and the first case of 
infection with M. marinum since 1987 was reported (Mousdicas and Saxe, 1987). For the 
others part of Africa, information can be found in studies on AIDS patients. In Burkina Faso, 
Ledru et al. (1996) found that 6.5% of mycobacterial isolations from AIDS patients were 
NTM without further specification, and in Nigeria, Idigbe et al. (1994) identified 20% M. 
avium and 10% M. kansasii among their isolates. In livestock, the serological investigation 
detected antibodies to M. paratuberculosis in camels and goats in Kenya (Paling et al., 1988). 
M. farcinogenes was described as main causal agent of bovine farcy in Sudan (Hamid et al., 
2002). 
In Chad, during a study of two years on tuberculosis in humans and animals, numerous 
Mycobacterium tuberculosis complex (MTC) and NTM isolates were obtained. The purpose 
of the present article is to report the different NTM species found among mycobacterial 
strains from Chad. 
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Materials and Methods 
Isolates and study sites  
1) Specimens collected in 5 Chadian health centres (sputum and urine) and in one 
slaughterhouse (tubercles from lymph nodes, lung, spleen, liver and pleural cavity of 
condemned cattle’s carcass) in N’Djaména, were subjected to decontamination and 
cultivation. Obtained mycobacterial isolates were identified by biochemical testing (Kent and 
Kubica, 1985). On the basis of biochemical tests results, the isolates were categorised in M. 
tuberculosis complex (MTC) and non-tuberculous mycobacteria (NTM). These preliminary 
studies were performed at the “Laboratoire de Recherches Vétérinaires et Zootechniques de 
Farcha (LRVZ/F)” in Chad. 
2) Thirty six NTM had been sent to the Institut Pasteur (IP) in Paris for identification NTM 
species by molecular method. 
3) Sixteen NTM strains were characterized at the National Centre of Mycobacteria (NCM) 
Zurich. 
 
Molecular methods 
1) The INNO-LiPA assay was carried out according to manufacturer’s instructions and using 
the reagents provided with the LiPA kit (Versant® INNO-LiPA HCV II). The protocol 
consisted of PCR amplification, hybridization of the PCR products to the strips, detection and 
interpretation of the results (Suffys et al., 2001) 
2) PRA amplification was performed according to the procedure described by Telenti et al. 
(1993). This method amplified a 439-bp fragment of the hsp65 gene. 
3) Real-time PCR 
DNA extraction and subsequently amplification and identification were carried out according 
to the procedure described by Kraus et al. (2001). This method allowed the classification of 
NTM and MTC strains which were all previously categorised as MTC by biochemistry.  
4) Sequencing of the 16S gene 
The obtained PCR products were used to perform the sequencing of the 16S gene. The 
sequence processing was done with computer software from ABI PRISM™ 310 (Applied 
Biosystems). Alignments of mycobacterial 16S rDNA sequences were done with the Model 
310 (version 3.4.1.) alignment tool. All probe sequences were subsequently matched with 
sequences in the GenBank by using BLAST (www.ncbi.nlm.nih.gov/blast/Blast.cgi) to detect 
sequence similarity. A similarity of 98 to 99% suggests that the obtained sequence likely 
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derives from this species (Turenne et al., 2001). The search was performed at the National 
Centre of Mycobacteria in Zurich. 
 
Results 
At the LRVZ of N-Djaména, biochemical testing revealed a total of 52 NTM isolates, which 
were further characterized by three different molecular methods (INNO-LiPA, PRA-hsp65 
and 16S (rDNA). We analyzed 36 isolates by INNO-LiPA and PRA-hsp65 at the NTM and 
16 isolates by only sequencing of the 16S (rDNA) at the NCM. 25 of 52 isolates resulted in 
the identification of NTM isolates by at least one of these tools (Table 1).  
 
M. fortuitum complex was identified for eight isolates from seven cattle and one human 
origins and was found the most. Six of them were classified as M. fortuitum supsp. perigrum 
(with INNO-LiPA) of which three were further characterized as M. fortuitum 3rd variant by 
PRA-hsp65. Mycobacterium avium complex was found for four isolates of which one and one 
of human (626 UR) and cattle origin (502 GG; Table 1) respectively, were classified as M. 
intracellulare. We received also four M. nonchromogenicum of cattle origin of which two and 
two were classified as subsp. mucogenicum and type I, respectively. The three remaining 
isolates of cattle origin were identified as Mycobacterium IWGMT.90093, M. smiae and M. 
Szulgai/trivialé/brumae. Further human isolates were M. mariokaense (two), M. celatum 
(one), M. chelonae, Mycobacterium sp.N120 and also M. smiae (one) (Table 1). 
Discussion and conclusion 
M. fortuitum complex was the most frequent NTM species (8/25) in this study and among 
them, 3 isolates from cattle were identified as the 3rd variant by PRA. Two studies have 
demonstrated the exact identity of 16S rDNA of M. senegalense, M. farcinogenes and M. 
fortuitum 3rd variant (Kirschner et al., 1992; Turenne et al., 2001). This finding is interesting 
because it confirms the existence of bovine farcy in the Chadian cattle population which has 
not been done since 1963 (Perpézat et al., 1963). However, we can’t draw any conclusion if 
the responsible pathogen for farcy is M. farcinogenes (like in Sudan) or M. senegalense (like 
a case found in Chad), because of the lack of discrimination of the methods used (Hamid et 
al., 2002).  
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Only four isolates were identified as M. avium complex and none was M. kansasii, while 
usually these two mycobacteria are the most common NTM in clinical specimens and 
biopsies (Shih et al., 1997; Marras and Daley, 2002; Thorel, 1980; Pate et al., 2004). 
Concerning the remaining mycobacteria found in our study, they are rarely isolated but most 
of them were described as potential pathogens. Mycobacterium simiae is commonly found in 
the environment and was rarely associated with human disease. However, some cases of 
disease caused by M. simiae in AIDS and non-AIDS patients have been reported (Vandercam 
et al., 1996; Huminer et al., 1993; Bell et al., 1983; Lavy and Yoshpe-Purer, 1982). M. 
celatum was described as cause of fatal pulmonary infection in an old woman (Bux-Gewehr 
et al., 1998) and of disseminated infection in domestic ferret (Valheim et al., 2001). M. 
chelonae was frequently isolated from patients with cystic fibrosis (Hjelt et al., 1994; 
Tomashefski et al., 1996; Fauroux et al., 1997). M. terrae complex is composed of M. 
nonchromogenicum, M. terrae, and M. triviale. They are uncommon colonizers of human 
epithelia and generally regarded as non-pathogenic (Lee et al., 2004). However, M. 
nonchromogenicum may occasionally cause human disease such as pulmonary infection and 
tenosynovitis (Peters and Morice, 1991). 
 
We obtained many NTM usually found in the environment by sequencing because this 
method is not focused on pathogen NTM strains. However, we have not confirmed our 
sequencing results by another molecular method as suggested (Hafner et al. 2004). Generally, 
NTM isolates should be further characterised because NTM infections can cause disease and 
first line antituberculosis drug treatment may be not efficacious. In another hand, it will be 
interesting for veterinarians to know about the importance of NTM in cattle, particularly in 
interpretation of tuberculin test. 
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Table 1 Results of NTM species identification of human and cattle origin from Chad 
with the three methods INNO-LiPA, PRA-hsp65 and16S (rRNA) sequencing. 
N° of strain Origin of 
specimen INNO-LiPA PRA-hsp65 16S rDNA (% identity) 
407CR/G human M. fortuitum subsp. peregrinum M. peregrinum/ M. porcinum N/D 
219GG Cattle (Mbororo) M. fortuitum subsp. peregrinum 
M. fortuitum subsp. 
peregrinum N/D 
446GG Cattle (Mbororo) M. fortuitum subsp. peregrinum M. fortuitum N/D 
455GG Cattle (Mbororo) M. fortuitum subsp. peregrinum M. fortuitum 3
rd
 variant N/D 
454GG Cattle (Arabe) M. fortuitum subsp. peregrinum M. fortuitum 3
rd
 variant N/D 
548PM Cattle (Arabe) M. fortuitum subsp. peregrinum M. fortuitum 3
rd
 variant N/D 
483PM/P Cattle (Arabe) N/D   N/D M. fortuitum (99 %) 
490GG/P Cattle (Arabe) N/D  N/D M. fortuitum (99 %) 
582PM Cattle (Arabe) NI M. nonchromogenicum 
subsp.mucogenicum N/D 
441PM Cattle (Mbororo) NI M. nonchromogenicum subsp. 
mucogenicum N/D 
464FOIE Cattle (Arabe) NI M. nonchromgenicum typeI N/D 
522PM Cattle (Mbororo) NI M. nonchromogenicum type I N/D 
663PM Cattle (Mbororo) M. avium complex M. intracellulare/ MAI/ 
scrofulaceum N/D 
502GG Cattle (Arabe) M. avium complex M. intracellulare N/D 
444GG Cattle (Arabe) M. avium complex - N/D 
626UR human M. intracellulare M. intracell/ MAI/scrofulaceum N/D 
661GG/G Cattle (Arabe) N/D   N/D M. simiae (99 %) 
277CR/G human N/D   N/D M. simiae (100 %) 
280CR/P human N/D  N/D M. moriokaense (99 %) 
381UR/P human N/D  N/D M. moriokaense (98 %) 
637GG/G Cattle (Arabe) N/D  N/D Mycobacterium IWGMT.90093 (99 %) 
269CR/P human N/D  N/D M. celatum (98 %) 
430CR/G human N/D  N/D M. chelonae (99 %) 
685CR/P human N/D  N/D Mycobacterium 
sp.N120 (98 %) 
559PM Cattle (Arabe) NI Szulgai/trivialé/brumae N/D 
 
NI: not identified. N/D: not done. 
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Appendix 3: Methods 
1. Ligation mediated PCR 
1.1 Preparation of the DNA and linker 
 
a) Extraction of DNA 
 
Place 100 µl of TE in 2 ml screw-cap tubes. 
Take sufficient colonies from the culture medium and suspend in the TE 
Incubate in the oven for 30 min at 100°C (to ensure that the bacteria are destroyed and DNA is extracted). 
 
b) Digestion of the DNA with SalI 
 
For 1 reaction: 
 
DNA   17 µl (if TE) 
Neb 4 buffer  2 µl 
SalI   1 µl 
H2O   qsp 20 µl 
 
Incubate for at least 1h at 37°C (dry water bath) 
 
- Check the digestion on a 0.8 % agarose gel. Warning: if no  or  partial digestion occurs, dialyse the samples 
for ½ h on a filter (0.05 µm pore size) and redigest the extract for 1 h at 37°C with 1  µl of SalI + 2 µl of buffer 
- Estimate the amount of DNA to be ligated on 0.8 % agarose gels by loading 2 µl of DNA/ SalI + 2 µl of 
loading buffer. 
 
c) Ligation of DNA to the linker 
 
MIX    1 Reaction   20 Reactions 
 
Ligase T4 buffer10X  2 µl    40 µl 
Linker*    1 µl    20 µl 
Ligase T4 (1 U/µl)  1 µl    20 µl 
DNA     As estimated above 
H2O    qsp 20 µl final 
 
* see appendix ligation mediated PCR for preparation 
* always keep the linker on ice 
 
Ligation conditions: 
 
5 min    5°C 
1 h  16°C 
10 min  65°C 
 
The reaction can be left at +4°C overnight. 
 
d) Digestion of the ligation product with SalI 
 
Ligation product   20 µl 
Buffer H   2.5 µl 
SalI    0.5 µl 
H2O    2.0 µl 
 
- Incubate at 37°C for 15min 
- Dilute the DNA 1/5 (i.e. 25 µl of ligation Mix + 100 µl of H2O). 
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1.2 Amplification of the ligation product with the SALGD linker 
 
 Initial conc. 1 Reaction 20 Reactions Final conc. 
H2O 10 x 28.8 µl 576 µl - 
Taq buffer  5 µl 100 µl 1 x 
DMSO  5 µl 100 µl 10 % 
dNTP 10 mM (each) 1 µl 20 µl 200 µM 
IS2 50 µM 1 µl 20 µl 1 µM 
SALgd 50 µM 1 µl 20 µl 1 µM 
MgCl2 25mM 3 µl 60 µl 1.5 mM 
Taq Cold 5 U/µl 0.2 µl 4 µl 1 U 
 
Add 5 µl of DNA diluted 1 in 5 per reaction. 
 
PCR Programme 
 
Prog. 1 9 min – 94°C  
Prog. 2 
30 sec – 94°C 
30 sec – 55°C 
3 min – 72°C 
35 cycles 
Prog. 3 10 min – 72°C  
 
Separate the products by electrophoresis for 1h ½ at 100V in 2.5 % agarose gel. 
Load: 20 µl of the amplification product + 2 µl of loading buffer. 
Load: 2 µl of 100 bp marker in the end lanes 
 
1.3 Interpretation of the results 
 
The number and size of fragments given by each sample is characteristic. If the results are ambiguous (different 
samples with very similar profiles), the technique should be repeated and/or another marker can be used. 
 
1.4 Appendix ligation mediated PCR 
 
a) Primers 
 
Salgd  TAG CTT ATT CCT CAA GGC ACG AGC 
Salpt  TCG AGC TCG TGC 
IS 2  ACC CCA TCC TTT CCA AGA AC 
 
b) Preparation of the linker 
 
Reaction mix:  
  
 Initial conc. 1 reaction Final conc. 
H2O - 148 µl - 
Taq buffer 10 x 20 µl 1 x 
Salgd 500 µM 10 µl 25 µM 
Salpt 500 µM 10 µl 25 µM 
MgCl2 25 mM 12 µl 1.5 mM 
 
Total volume of the MIX = 200 µl 
 
 
Hybridisation: 
 
Prog. 1  1 min at 80°C (denaturation) 
Prog. 2  -1°C per min from 80 °C to 4°C 
 
Divide the linker into 11 µl aliquots and store at -20°C. 
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1.5 Products ligation mediated PCR 
 
Product name Supplier Reference 
Agarose Gibco BRL 15510027 
Taq gold polymerase Perkin-Elmer M8080245 
dNTP Amersham 2703501 
Buffer H Roche diagnostic 1417991 
Sal1 Gibco-BRL 15217-029 
Neb 4 buffer Biolabs NEBUFFER 007-4 
Ligase T4 Roche diagnostic 716359 
Primers Proligo oligo@proligo.fr 
TBE 10x Sigma T4415 
Size marker Invitrogen 156280.19 
2. Spoligotyping 
 
2.1 Sample preparation 
 
- Place 150 µl of TE in 2 ml screw-cap tubes 
- Using a disposable loop, collect a loop of culture medium containing sufficient colonies and suspend in the TE 
- Incubate in the oven for 30 min at 100°C to extract the DNA and to kill the bacteria 
- Store the DNA at -20°C after extraction. 
 
Notes: 
- The amplification step requires using very little DNA; it is therefore better to take fewer bacteria than to risk 
taking a large amount of medium. 
- It is important that the bacteria are really heated to 100°C for at least 20 minutes to ensure that they have all 
been killed at this stage. 
It is also possible to use DNA extracted by the phenol-chloroform method. 
 
2.2 Preparation of the PCR mixture 
 
The gene is first amplified with the Dra and DRb primers that anneal to sites within the DR and are directed 
outwards. DRs are direct repeat sequences of 36 bp 
- DRa (GGTTTTGGGTCTGACGAC, 5’ biotinylated) 
- DRb (CCGAGAGGGGACGGAAAC). 
The Dra primer is labelled with biotin. The biotin group binds to streptavidin, which is in turn coupled to 
peroxidase, thus making it possible to detect any amplification products. 
Primer DRa is stored at 4°C and DRb is stored at -20°C. 
In a sterile room, prepare the Mix for the numbers of reactions: 
 
 + 1 TE control tube 
 + 1 negative control tube 
 
 For 1 reaction For 10 Reactions Final concentration 
H2O 14.9 µl 149 µl  
Tp chelating          5x 10.0 µl 100 µl 1 x 
MgCl2                50 mM   7.0 µl   70 µl 7 mM 
Primer 1              5 µM   4.0 µl   40 µl 0.4 µM 
Primer 2              5 µM        4.0 µl   40 µl 0.4 µM 
dNTP                 2.5 mM   8.0 µl   80 µl 0.4 µM 
Tth polymerase  5U/ µl   0.1 µl     1 µl 0.5 U/µl 
 
Place 48 µl of the mixture into each 0.5 µl sterile tube; in another room add 2 µl of DNA 
 
 
 
 
 
Appendix 3: Methods 
__________________________________________________________________________________________ 
 
 142 
PCR Programme: 
 
Prog. 1 3 min – 96°C  
Prog. 2 
1 min – 96°C 
1 min – 55°C 
30 sec – 72°C 
30 cycles 
Prog. 3 10 min – 72°C  
 
 2.3 Hybridisation 
 
 The membranes must always be held by their edges. 
 
1. Rinse the membrane twice in about 250 ml of 2xSSPE/0.1%SDS at 60°C for five minutes. 
2. Place the membrane in the miniblotter that has previously been cleaned with soap and water and rinsed 
thoroughly, on a support cushion (that acts as a joint) such that the side with the oligunucleotides 
(spacer) faces the slots, ant so that the slots are perpendicular to the lines of oligonucleotides (spacers) 
on the membrane (use the date in the bottom tight corner as a marker). 
 
Note: The membrane must be placed so that it is exactly aligned with the two ink lines in the upper and lower 
slots, so that the slots cross all the lines of oligonucelotide (spacers) fixed to the membrane. 
 
3. Tightly shut the sic plastic screws to close the press 
4. Dilute 20 µl of each of the PCR products (maximum of 43 / membrane) in 150 µl of 2 
2xSSPE/0.1%SDS buffer. Include one negative control (TE alone) and two positive controls (DNAs 
from the strain H37Rv and from M. bovis BCG). 
5. Heat each tube at 100°C for 10minutes, then immediately place on ice. 
6. Use a vacuum pump to remove all the residual liquid from each to the slots of the miniblotter. 
7. Fill the first slot of the miniblotter with 150 µl of buffer containing 2xSSPE/0.1%SDS. 
8. Fill the remaining slots one by one (max 43) with 150 µl (approximately) of the diluted PCR products, 
kept at 4°C until loading. Note the loading order. 
Note: When filling the slots, take care not to introduce air bubbles (pipette slowly, in both directions, to 
avoid introducing bubbles). Each line must be completely filled, but care must be taken not to 
contaminate the slot underneath as this might lead to the contamination of neighbouring slots (use 
absorbent paper to eliminate excess). 
9. Fill the last slot of the slot of the miniblotter with 150 µl of buffer containing 2xSSPE/0.1%SDS. The 
samples must always be surrounded by buffer to prevent leaking. 
10. Incubate the membrane at 60 °C for one hour, keep the miniblotter horizontal throughout and do NOT 
shake to prevent overflow (and therefore contamination of one line by another). 
11. Remove the samples from the slots by aspiration, in the same order as they were filled. 
12. When all the slots are totally empty, dissemble the miniblotter and carefully remove the membrane. 
13. Wash the membrane twice in250 ml of 2xSSPE/0.5%SDS at 60°Cfor 10minutesin a container with 
shaking. 
 
(Possibly to interrupt the protocol 
 
It is possible to interrupt the protocol at step 13. overnight for example. In this case, proceed to step 13’. 
 
13’. Wash the membrane twice in 250 ml of 2xSSPE at room temperature for 10 minutes, in a container 
with shaking. 
13’’. Keep the membrane at 4°C until the following day, in a sealed plastic envelope or wrapped in Saran-
wrap, to prevent it from drying out. 
 
The following day, if interrupted at step 13: 
 
13’’’. Wash the membrane twice in 250 ml of 2xSSPE/0.5%SDS at 42°C for 10 minutes in a container with 
shaking. 
 
Continue the protocol at step 14. ) 
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14. Place the membrane in a hybridisation bottle, such that the side containing the oligonucleotides 
(spacers) is on the inside of the tube. 
15. Check that the membrane is at a temperature below 42°C (so that the peroxidase is not inactivated). 
16. Incubate the membrane in a solution of straptavidin-peroxidase conjugate diluted 1/4000 (3.5 µl of 
streptavidin-peroxidase conjugate in 14 ml of 2xSSPE/0.5%SDS), at 42°C, for 90 min. 
17. Wash the membrane twice in 250 ml of 2xSSPE/0.5%SDS at 42°C fro 10 minutes, in a container with 
shaking. 
18. Rinse the membrane twice in 250 ml of 2xSSPE fro at least 5 minutes at room temperature in a 
container with shaking. 
19. Immediately before required, prepare 40 ml of E.C.L. detection liquid by mixing 20 ml of each of the 
solutions supplied in the kit. 
20. Incubate the membrane in 40 ml of E.C.L. detection liquid for 2 minutes with gentle manual shaking so 
that the all of the membrane is in uniform contact with the liquid 8thee membranes repel water). 
Remove excess reagent with Whatman paper 
21. Place the membrane in an autoradiography cassette inside a plastic sleeve. Remove any air bubbles, 
taking car not to create static electricity. 
22. Expose an E.C.L film (Hyperfilm-ECL, Amersham) to the side of the membrane containing the  
oligonucleotides in a cassette for 1 minute 
23. Develop the film 
24. Expose another film for 5minutes and then another for 20minutes sot that even weak signals are all 
detected 
25. Wash the membrane twice in 250 ml of 20 mM EDTA pH 8 for 15 minutes at room temperature in a 
container with shaking. 
26. Until the dehybridisation step, store the membrane at 4°C in sealed plastic pouch or wrapped in Saran-
wrap, to prevent it from drying. 
 
2.4 Interpretation 
 
The membrane is read by recording the presence or absence of signals at the sites of DNA/DNA hybridisations. 
Results can be interpreted using appropriate software. 
 
2.5 Dehybridisation of the membranes 
 
The membranes can be re-used if the oligonucleotides can be freed of the attached PCR products. As the 
oligonucleotides (spacers) are covalently fixed to the membranes, the removal method must be highly stringent. 
 
1. Wash the membrane three times by incubating it in 250 ml of 1% SDS at 85°C for 30 minutes in a 
container with shaking 
2. Wash the membrane twice in 250 ml of 20 mM EDTA pH 8 for 15 minutes at room temperature in a 
container with shaking. 
3. Store the membrane at 4°C in a sealed plastic pouch or wrapped in Saran-wrap, to prevent it from 
drying out, until re-use. 
 
2.6 Appendices to spoligotyping 
 
a) Preparation of the buffers 
 
All the buffers must be preheated to the desired temperatures just before use (42°C, 60°C or 80°C). 
 
- 2xSSPE/0.1%SDS (60°C) 100 ml SSPE 20x + 5 ml –SDS 20% + H20 qsp 1 litre 
- 2xSSPE/0.5%SDS (60°C) 100 ml SSPE 20 x + 25 ml SDS 20 % + H20 qsp 1 litre 
Prepare 2 l for 2 membranes 
- 2xSSPE/0.5%SDS (42°C) 100 ml SSPE 20 x + 25 ml SDS 20 % + H20 qsp 1 litre 
Prepare 2 l for 2 membranes 
- 2 SSPE (Room temperature) 200 ml SSPE 20 x + H20 qsp 2 litres 
- EDTA 20 mM (Room temperature) 40ml EDTA 0.5 M + H20 qsp 1 litre 
 
b) Materials 
 
- membrane kit: positive and negative control, primer Dra and Drb and spoligo-membrane 
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Isogen Bioscience B.V. ; Industrieweg 68 ; Box 1179 ; BT Maarsen ; The Netherlands 
- miniblotter MN45: Polylabo ref = 35209 
- foam cushions: order number: PC200 
Immunetics, 63 Rogers Street, Cambridge, Mass. 02139, USA 
Sold by: Interchim s.a., BP 1140-03103 Montlucon, Cedex, France 
-Tth DNA POLMERASE: (vials of 100, 250, 500 and 1000 units) 
MgCl2- free 5x chelating amplification buffer is supplied with the enzyme. 
Eurobio Ref 250U: 018191; Avenue de Sandinavie – 91953 Les Ulis Cedex B-France 
- Streptavidin-POD conjugate, lyophilized, stabilized, 500U, Cat. N° 1089 153; Boehringer Manneim 
Biochemica 
- ECL detection liquid; Cat N°RPN 2106 or 3000. Amersham International, Amersham France SA, Avenue des 
Tropiques, ZA Courtabeouf, Les Ulis. France. 
- Hyperfilm ECL ; Cat. N° RPN 2103 Amersham International, Amersham France SA, Avenue des Tropiques, 
ZA Courtabeouf, Les Ulis. France. 
- SSPE 20 x ; Gibco BRL Ref : 15595-035 (4l) 
- SDS; Sigma Ref: L-4509 
3. MIRU- and ETR-VNTR typing 
Sample preparation and PCR amplification: 
Each MIRU and ETR locus was amplified individually with primers specific for sequences flanking the MIRU 
and ETR units (Table 1). The reaction mixture for all loci contained a 1-µl DNA sample, 1x Taq PCR buffer, 0.5 
U of AmpliTaq DNA polymerase (Perkin-Elmer Applied Biosystems), deoxynucleoside triphosphates (0.2 mM 
each; Amersham Pharmacia Biotech, Piscataway, N.J.), and a 0.5 µM concentration of the primer pair in a final 
volume of 20 µl. For the amplification a GeneAmp 9700PCR system (Perkin-Elmer Applied Biosystems) was 
used. 
 
PCR Programme: 
 
Prog. 1 1 min – 94°C  
Prog. 2 
30 sec. – 94°C 
30 sec. – 65°C 
1 min.  – 72°C 
40 cycles 
Prog. 3 10 min – 72°C  
 
 
Oligonucleotide Sequence Positiona Predicted size of amplicon 
containing 1 MIRU copy + 
size of additional copies 
(bp) 
miru 2a 5'CATCGAATTGGACTTGCAGCAAT 153941 
miru 2b 5'CGACGTCGTAGAGAGCATCGAAT  154521 580 + 53 
miru 4a 5'GTCAAACAGGTCACAACGAGAGGAA   580540 
miru 4b 5'CCTCCACAATCAACACACTGGTCAT  580831 191 + 77 
miru 10a 5'ACCGTCTTATCGGACTGCACTATCAA   960130 
miru 10b 5'CACCTTGGTGATCAGCTACCTCGAT  960508 273 + 53 
miru 16a 5'CGGGTCCAGTCCAAGTACCTCAAT  1644034 
miru 16b 5'GATCCTCCTGATTGCCCTGACCTA  1644508 422 + 53 
miru 20a 5'GCCCTTCGAGTTAGTATCGTCGGTT  2059297 
miru 20b 5'CAATCACCGTTACATCGACGTCATC  2059671 298 + 77 
miru 23a 5'CGAATTCTTCGGTGGTCTCGAGT  2531862 
miru 23b 5'ACCGTCTGACTCATGGTGTCCAA  2532256 130 + 53 
miru 24a 5'CGACCAAGATGTGCAGGAATACAT  2686949 
miru 24b 5'GGGCGAGTTGAGCTCACAGAA  2687395 447 + 52 
miru 26a 5'GCGGATAGGTCTACCGTCGAAATC  2995975 
miru 26b 5'TCCGGGTCATACAGCATGATCA  2996373 297 + 51 
miru 27a 5'TCTGCGTGCCAGTAAGAGCCA  3006884 
miru 27b 5'CTGATGGTGACTTCGGTGCCTT   3007319 330 + 53 
miru 31a 5'CGTCGAAGAGAGCCTCATCAATCAT  3192174 
miru 31b 5'AACCTGCTGACCGATGGCAATATC  3192441 162 + 53 
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miru 39a 5'CGGTCAAGTTCAGCACCTTCTACATC  4348555 
miru 39b 5'CTCGGTGTTCCTTGAAGGTGGTTT  4349319 712 + 53 
miru 40a 5'GATTCCAACAAGACGCAGATCAAGA  802236 
miru 40b 5'TCAGGTCTTTCTCTCACGCTCTCG  802519 284 + 54 
 
Locus name 
 
Sequence of PCR primers (5’-3’) 
 
Location in 
H37Rv map 
(kb) 
No. and size of  
repeat units in 
H37Rv 
Size of PCR 
product in 
H37Rv 
ETR-Aa 5’AAATCGGTCCCATCACCTTCTTAT 3820 
ETR-Ab 5’CGAAGCCTGGGGTGCCCGCGATTT  (3x75)-23 420 
ETR-Ba 5’GCGAACACCAGGACAGCATCATG 4160 
ETR-Bb 5’GGCATGCCGGTGATCGAGTGG  (3x57)-8 292 
ETR-Ca 5’GTGAGTCGCTGCAGAACCTGCAG 1480 
ETR-Cb 5’GGCGTCTTGACCTCCACGAGTG  (4x58)-21 276 
 
Table 1: Primers of MIRUs (above) and ETRs (below) used for VNTR typing 
 
aRefers to position in M. tuberculosis strain H37Rv unless otherwise indicated bay n alternative GenBank 
number 
 
Electrophoresis: 
The PCR products were analyzed on a 2.5% agarose (Gibco-BRL Products, Grand Island, N.Y.) gel in 1x Tris-
borate-EDTA containing 1 µg of ethidium bromide/ml using the Sub-cell Model 192 apparatus (Bio-Rad, 
Hercules, Calif.), a 25- by 25-cm gel tray, and two rows of 51 wells (well width, 0.75 mm). 10 µl of a size 
marker was loaded in each side lane of the gel. For each amplification product, 5 µl of PCR product + 2 µl of 
loading buffer per well, such that samples form the same MIRU/ETR pair are side by side. Subject to 
electrophoresis for 5 hours at 120 V. After, the gel was observed under UV light and a photo taken. The number 
of MIRU repeats at each locus was determined by the size of the amplicon, using the convention described in 
Table 2. 
 
Allele MI 2 MI 4 MI 4a MI 10 MI 16 MI 20 MI 23 MI 24 MI 26 MI 27 MI 31 Mi 39 Mi 40 ETR A ETR BETR C
0 527 114 61 220 369 221 77 395 246 277 109 659 230 195 121 44
1 580 191 138 273 422 298 130 447 297 330 162 712 284 270 178 102
2 633 268 215 326 475 375 183 499 348 383 215 765 338 345 235 160
3 686 345 292 379 528 452 236 551 399 436 268 818 392 420 292 218
4 739 422 369 432 581 529 289 603 450 489 321 871 446 495 349 276
5 792 499 446 485 634 606 342 655 501 542 374 924 500 570 406 334
6 845 576 523 538 687 683 395 707 552 595 427 977 554 645 463 392
7 898 653 600 591 740 760 448 759 603 648 480 1030 608 720 520 450
8 951 730 677 644 793 837 501 811 654 701 533 1083 662 795 577 508
9 1004 807 754 697 846 914 554 863 705 754 586 1136 716 870 634 566
10 1057 884 831 750 899 991 607 915 756 807 639 1189 770 945 691 624
11 1110 961 908 803 952 1068 660 967 807 860 692 1242 824 1020 748 682
12 1163 1038 985 856 1005 1145 713 1019 858 913 745 1295 878 1095 805 740
13 1216 1115 1062 909 1058 1222 766 1071 909 966 798 1348 932 1170 862 798
14 1269 1192 1139 962 1111 1299 819 1123 960 1019 851 1401 986 1245 919 856
15 1322 1269 1216 1015 1164 1376 872 1175 1011 1072 904 1454 1040 1320 976 914
 
 
Table 2: Number of MIRU and ETR-VNTR repetitions depending on the size of amplicons (bp);  
 
a Number of MIRU-VNTR repetitions specific to locus 04 (53 bp unit missing). 
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4. IS6110-Restriction Fragment Length Polymorphism typing 
 
4.1 Extraction of genomic DNA 
 
Operations to be carried out in a Category 3 Laboratory 
 
- Collect an adequate number of colonies on Lowenstein-Jensen medium and suspend them in 500 µl of TE (see 
appendix IS6110-RFLP) 
- Place at 90°C for 30 min. 
 
Operations NOT to be carried out in a Category 3 Laboratory 
 
- Centrifuge the extracts 
- Discard the supernatant and add 50 µl or 100 µl of 20 mg/ml lysozyme (see appendix IS6110-RFLP) to the 
pellet, according to the size of the pellet. 
- Incubate for 1h at 37°C. 
- Add 70 µl of 10% SDS + 5 µl of 10 mg/ml proteinase K (see appendix IS6110-RFLP), or twice as much if the 
pellet is large. 
- Incubate for 1 h at 65 °C 
- Add 100 µl of 5 M NaCl 
 
Steps to be carried out under the Sorbonne flow hood 
 
- Add 1 volume of aquaphenol containing 8-beta-hydroxyquinoline to the extract, mix thoroughly and then 
centrifuge for 15 min in a micorcentrifuge at 149000 rpm at 4°C. 
- Transfer the aqueous phase into a clean Eppendorf tube. 
Note: the aqueous phase is transparent and is generally the upper phase. The phenolic phase is yellow and is 
generally the lower phase. The phases may be inversed if the interface is very large. In this case, or if the 
aqueous phase is cloudy, take the aqueous phase and repeat the phenol extraction step. 
- Add an equal volume of chloroform, mix and centrifuge for 1 min at 14900 rpm. 
- Transfer the aqueous supernatant to a clean Eppendorf tube. 
- divide the sample into two if its volume exceeds 600 µl. 
- Add 1.5 volumes of absolute ethanol (-20°C) to precipitate the nucleic acids. 
- Leave overnight at -20°C or for 30 min at -70°C 
→ Possible to interrupt 
- Centrifuge for 15 min at 14900rpm and 4°C 
- Discard the supernatant by tipping the Eppendorf tube. 
- Wash the pellet with 100 µl of 70% ethanol at -20°C. 
- Centrifuge for 5 min at 14900 rpm and 4°C 
- Discard the supernatant and dry the pellet in a speed-vac for 15 min or under the flow hook. 
- Resuspend the DNA pellet in 20 µl of TE 
- Incubate for 20 min in a 60°C water bath. 
- Homogenise the sample with a pipette. 
- To estimate the concentration of the DNA, run an aliquot in a 0.8% agarose electrophoresis gel (2 µl of extract 
+ 2 µl of loading buffer per well) 
 
4.2 Digestion of genomic DNA 
 
- After estimating the concentration of the DNA, digest the equivalent of 2 µg of DNA with the restriction 
enzyme as follows (amount per reaction): 
 
- X µl of DNA 
- 3 µl of enzyme buffer 
- 2 µl of PvuII 
- H2O (ultrapure) to a final volume of 30 µl 
 
- Leave the enzyme to act for at least 1 h at 37°C or overnight at 37°C.  
→ Possible to interrupt 
- Subject to electrophoresis in a 0.8% agarose gel in 1X TBE to check the digestion and to estimate the amount 
of DNA to load for the Southern blot. 
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Note: If the bands nearest the top of the gel (high molecular weights) are less intense than the bands 
corresponding to lower molecular weights, the digestion has been satisfactory. 
(In the case of incomplete or no digestion: 
- Dialyse the sample with a Millipore filter (0.05 µm pore size): place the entire sample on the filter, leave 
contact with the water for 30 min and collect the DNA. 
- Repeat the digestion step with: 
 - Dialysed DNA 
 - 3 µl of enzyme buffer 
 - 1 µl of PvuII 
- Leave to digest for at least 1 h at 37°C. 
- Check the digestion on a 0.8 % agarose gel.) 
 
4.3 Electrophoresis 
 
- Load the equivalent of 2 µg of digested DNA + 2 µl of loading buffer, on a 1 % agarose gel in 1X TBE 
containing EtBr. 
- Do not load samples in the first or last wells. 
Load 10 µl of the lambda PstI external marker (appendix IS6110-RFLP) in the first lane to monitor the 
migration. 
- Every 5 wells, load the external molecular weight marker: DNA from M. tuberculosis strain MT 14323 
digested with PvuII 
- Start the electrophoresis at 90V for 10 min (until the DNA has left the wells) and then continue overnight at 
40V (i.e. 1-2 V/cm) 
→ Possible to interrupt 
- The following day, stop the electrophoresis when the highest λ molecular weight marker (i.e. the 11500-bp 
band) is 2 cm from the wells and take a photo. 
 
4.4 Treatment of gels 
 
a) Dupurination 
 
- Wash the gel with a solution of 0.25 M HCl (appendix IS6110-RFLP) for 10 min, for depurination 
- This treatment facilities the DNA transfer step by breaking up the large molecular weight molecules. 
Warning: Prolonged treatment can lead to excessive hydrolysis of the DNA and generate DNA fragments that 
are too small to adhere to the membrane correctly. 
- Rinse the gel with distilled water for 1-2 min. 
 
b) Denaturation 
 
-Cover the gel with the denaturing solution (appendix IS6110-RFLP) for 2 x 20 min periods with shaking. 
- Rinse the gel with distilled water for 1-2 min. 
 
c) Neutralisation 
 
Cover the gel with the neutralising solution (appendix IS6110-RFLP) for two 20 min periods with shaking. 
 
4.5 Transfer (Southern Blot) of nucleic acids onto membranes 
 
a) Vacuum transfer 
 
- Cut a piece of Hybond N+ membrane and a piece of Whatman paper to the size of the gel. 
- Soak the Whatman with water and place it on the porous plate, then soak the Hybond N+ membrane with water 
and place on top, taking care not to form any air bubbles. 
- Place the gel in the middle of this pocket. 
- Adjust the clips on the apparatus 
- Fill the gel wells with 1 % agarose, ensuring that no bubbles are formed 
- Connect the vacuum pump. For the transfer of genomic DNA from an agarose gel, the recommended 
conditions are 45-60 mbar for 60-90min. 
- Cover the gel with 20x SSC buffer. 
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b) After the transfer 
 
- Before removing the transferred gel, use a pencil to mark the positions of the first and last wells. 
- Remove the gel and collect the membrane 
- Wrap the membrane in Saran Wrap. 
- Fix the DNA to the membrane by exposing to UV light, either for 4 min at 365 nm or for 1 min at 254 nm 
(DNA side towards the UV light source) 
- Check the transfer efficiency by examining the gel under UV light and ensuring that all traces of DNA have 
disappeared 
- The fixed membrane can be stored at 4°C 
 
4.6 Hybridisation and detection 
 
a) Prehybrdisation 
 
- Place the membrane in a glass hybridisation tube such that the DNA faces the inside of the tube. 
- Prehybridise the membrane for 45 to 60  min at 42°C with rotation in hybridisation buffer (appendix IS6110-
RFLP). Voulume of buffer required = 0.125 ml / cm2 of membrane. 
 
b) Labelling the probe 
 
ECL Kit protocol: 
 
- Dilute the probe to a concentration of 10 ng/µl with the water supplied in the ECL Kit. 
- Heat to 100°C for 5 min, then leave at 0°C for 5 min 
- Add an equal volume of labelling reagent 
- Add the same volume of glutaraldehyde. 
- Incubate for 10 min at 37°C. 
- Keep the labelled probe on ice until use. 
 
Note; The labelled probe can be stored in 50% glycerol at -20°C for 6 months. 
 
c) Hybridisation 
 
- Transfer the hybridisation buffer into a clean tube and add the labelled probe. 
- Mix by rotating 
- Place the buffer + probe in the hybridisation tube with the membrane 
- Incubate overnight at 42°C with rotation 
 
d) Washes 
 
- The following day, discard the hybridisation buffer. 
- Wash the membrane with buffer I (appendix IS6110-RFLP) at 55°C with shaking: 2 x 10 min 
- Wash the membrane with buffer II (appendix IS6110-RFLP) at room temperature with shaking: 2 x 5 min 
 
e) Detection 
 
- With the ECL kit: mix 15 ml of detection reagent 1 with 15 ml of detection reagent 2 in a tube (in the dark). 
- Dry the membrane on a sheet of Whatman paper 
- Place the membrane in a container with the DNA side outwards 
- cover the membrane with the detection mixture and swirl manually for 1 min 
- Remove the membrane in an autoradiography film cassette and cover with a sheet of Saran Wrap 
- Place a film (Hyperfilm) on the membrane, shut the cassette and leave for 1 min 
- Remove the film and immediately replace with another. 
- Develop the first film and estimate the exposure time necessary for the second 
 
4.7 Appendix IS6110-RFLP 
 
a) Preparation of the IS6110 probe 
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The IS6110 probe is generated from a PCR product. 
An 868-bp fragment, corresponding to nucleotides 462 to 1330 of the IS6110 sequence of a strain belonging to 
the M. tuberculosis complex, is amplified (MT 14323). The oligonucleotides used as primers as follows: 
 
G1:  5’ CTGACCGAGCTGGGTGTGCC 
G2: 5’ TCTGATCTGAGACCTCAGCC 
 
Preparation of the MIX for 10 reactions 
 
REAGENT QUANTITIY FINAL CONCENTRATION 
H2O 235 µl  
Taq Buffer 10 x 50 µl 1 x 
DMSO 50 µl 10 % 
MgCl2 25 mM 30 µl 1.5 mM 
dNTP 10 mM 10 µl 200 µM (each) 
G1  50µM 10 µl 1 µM 
G2  50 µM 10 µl 1 µM 
Taq  5U/µl 5 µl 2.5 U 
 
- Place 40 µl of MIX into each PCR tube. 
- Add 10 µl of MT 14323 DNA diluted 1/100 (extracted by the Phenol/Chloroform method) 
 
PCR conditions: 
 
Prog. 1 6 min – 94°C  
Prog. 2 
1 min – 94°C 
2 min – 55°C 
2 min – 72°C 
35 cycles 
Prog. 3 10 min – 72°C  
 
- Subject the PCR product to electrophoresis on a 0.8 % agarose gel 
- Electrophoresis conditions with a 50 ml miniprep: ½ h at 90 V. 
- Load: 1 µl of DNA + 2 µl loading buffer 
- Prepare a 1 % gel with LMP agarose for a Miniprep apparatus, i.e. with 50 ml of 1 x TBE 
- Load 100 bp marker in the end lanes, and all of the amplified samples in the central lane, i.e. 500 µl of PCR 
product + 55 µl of loading buffer. 
- Leave for 30 min to 1h30 at 100 V. (Monitor the migration of the 800-bp band) 
- Identify the 800-bp band by use of the marker, cur the band out, taking care not to take too much agarose. 
- Put the 800-bp fragment in a Petri dish. 
- Weigh the agarose plug and place it in an eppendorf 
 
With the QIAGEN extraction kit (Qiaquick Gel Extraction Kit protocol) 
 
- Add 3 volumes of QG buffer to 1 volume of agarose (100 mg agarose = 100 µl) 
- Incubate at 50°C fro 10 min (the gel must be completely dissolved), vortex gently every 3 min during the 
incubation period 
- When the agarose is completely dissolved, the liquid becomes yellow 
- Add 1 volume of isopropanol and mix 
- Place 1Qiauick column on a 2 ml tube. 
- Place the melted gel containing the DNA to be purified on the column and centrifuge for 1 min at 13000 rpm 
- Discard the liquid in the 2 ml tube and place 0.5 ml of QG buffer on the column, centrifuge for 1 min at 13000 
rpm 
- Wash the column with 0.75 ml of PE buffer and centrifuge for 1 min at 13000 rpm 
- Discard the liquid in the tube and centrifuge again. 
- Place the column on a 1.5 ml eppendorf tube and elute the DNA with 50 µl of the H2O provided in the ECL kit 
for labelling the probe (see below: labelling the  probe) 
- Subject to electrophoresis in a 0.8 % agarose gel in 1 x TBE for 30 min at 90 V 
- Load: 
 - lane n°1= 10 µl λ PstI + 2 µl of loading buffer 
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 - lane n°2= 1 µl IS6110 to be quantified + 10 µl H2O + 2 µl of loading buffer 
 - lane n°3= 1 µl λ HindIII (10 ng) + 10 µl H2O + 2 µl of loading buffer 
 - lane n°4= 5 µl λ HindIII (50 ng) + 10 µl H20 + 2 µl of loading buffer 
 - lane n°5= 10 µl λ HindIII (100 ng) + 10 µl H20 + 2 µl of loading buffer 
 
Labelling the probe: 
 
After calculating the concentration of the purified probe, calculate the amount of probe to be labelled. 
Example: Amount of probe required for a 120 cm2 membrane 
  Final concentration of the probe to be 1 ng/ cm2 
  Thus 120 ng for a 120 cm2 membrane 
  If for example, the concentration of the probe is 10 ng/µl, 12 µl of probe is required 
For the labelling mix: 12 µl of the probe at a concentration of 10 ng/µl 
  + 12 µl Labelling Reagent 
  + 12 µl of Glutaraldehyde 
  Total= 36 µl of labelled probe. 
 
b) Solutions and materials used 
 
Product name Supplier Reference Reference IP 
Tris-Trizma base SIGMA T 1503 52150 
Boric Acid SIGMA B-6768 (1 kg) - 
ETA SIGMA E-5134 (1 kg) - 
Lysozyme SIGMA L-6876 (5kg) - 
Proteinase K ROCHE-Boehringer 1092766 (1 g) 90428 
SDS SIGMA L-4509 (500 g)  
Sodium chloride (NaCl) PROLABO 27 810 295 (500 g) 48700 
Phenol APPLIGENE 130181 (250 ml) - 
8-beta-hydroxquinoline SIGMA H6878 - 
Chloroform CARLO ERBA 438601 49520 
Ethanol MERCK 983 44656 
PvuII GIBCO BRL 15 4120 18 95034 
PstI GIBCO BRL 15 2150 23 90531 
Hydrochloric acid (HCl) PROLABO 20 252 290 44160 
Tri-Sodium citrate PROLABO 27 833 294 48740 
Sodium hydroxide (NaOH) PROLABO 28 245 298 48880 
Filter 0.05 µM/25 mm MILLIPORE VMWP02500 - 
Whatman paper 3  MM 3030 917 - 
Hybond-N+ membrane AMERSHAM RPN 303 B 90803 
Hyperfilm ECL AMERSHAM RPN 2103 K 96098 
ECL Kit AMERSHAM RPN 3000 97059 
Qiaquick Gel Extraction Kit QIAGEN 28704 42792 
Bromophenol Blue SIGMA B5525 - 
Agarose GIBCO BRL 15510027 52171 (500 g) 
Ethidium bromide (EtBr) EUROBIO 17589 99025 
Taq PERIKNELMER M8080161 90085 
dNTP AMERSHAM 2703501 90005 
TBE 10 x SIGMA T4415 52155 (4 l) 
Lambda DNA size markers PHARMACIA 27-4111-01(500 µg/ml) - 
100 bp size markers GIBCO-BRL 156280.19 90637 
 
- Lysozyme: 20  mg/ml stock solution, divided into aliquots and frozen 
- Proteinase K: 10 mg/ml stock solution, divided into aliquots and frozen 
- SDS 10 % in distilled H2O 
- NaCl 5m 
- TE: 1 ml Tris 1 M (=> 89 mM), 0.2 ml EDTA 0.5 M (=>89mM), 100 ml H2O qsp 
- Phenol, saturated in water (pH 8) and coloured with 0.1 % 8-beta-hydroxyuinoline 
- TBE 10 x pH 8: Tris 89 mM, Boric Acid 89 mM, EDTA 2 mM 
- Bromophenol blue solution: 0.25 % bromophenol blue + 40 % sucrose 
- Preparation of lambda-PstI marker 
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 Digest 100 µl of lambda DNA with PstI in a final volume of 250 µl 
 Check the digestion by  agarose gel electrophoresis 
 Add 75 µl of the bromophenol blue solution and 175 µl of TE buffer pH 8 
 Store the marker in 50 µl aliquots at + 4°C 
- Depurination solution: HCl 0.25 M = 13 ml HCl + 500 ml of H2O 
- Denaturation solution: NaCl 1.5 M / NaOH 0.5 M 
- Neutralising solution: NaCl 1.5 M / Tris 1 M pH 8 
- SSC buffer 20 x: NaCl (=> 3 M) 175.3 g/l, Na-Citrate (=> 0.3 M) 88.2 g/l, H20 1 l qsp, Adjust the pH to 7 with 
5M NaOH 
- Hybridisation buffer (Amersham Kit) 
 Heat the hybridisation buffer supplied in the kit to 65°C. 
 Adjust the concentration of NaCl to 0.5 M 
 Add 5 % (w/v) blocking agent 
 Mix, taking care not to allow any lumps to form, using a magnetic stirrer for 1 h at 65°C 
 Store 30 ml aliquots of the buffer at – 20°C for up to 3 months 
 For 200 ml of ECL buffer: 5.84 g of NaCl + 10 g of blocking agent 
- Washing buffer n°1 (SSC 0.5 x, SDS 0.4 %): 25 ml SSC 20 x, 20 ml SDS 20 %, 1 l H2O qsp 
- Washing buffer n°2 (SSC 2 x,): 100 ml SSC 20 x, 1 l H2O qsp.   
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